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Abstract 
 
Fibroblasts are a type of cell which forms the structural framework of the connective tissue 
and are key players of wound closure, fibrosis and cancer. These cells experience mechanical 
perturbations due to matrix remodelling and interstitial fluid movement. Chemical signals 
from the tissue microenvironment such as Transforming growth factor β1 (TGF-β1) promote 
differentiation of fibroblasts to a myofibroblastic phenotype marked by enhanced expression 
of α-smooth muscle actin (α-SMA) rich stress fibres. However most of the evidence for this 
has been derived in static cultures which do not fully recapitulate the mechanically dynamic 
environment in vivo. 
 
The response of primary human fibroblasts to physiological levels of fluid movement and 
chemical perturbations from TGF-β1 is examined in this study. Findings show that fluid flow 
induced widespread changes in gene expression compared to static cultures and up-regulated 
genes such as α-SMA and Collagen 1A1. Surprisingly the combination of flow and 
exogenous TGF-β1 resulted in reduced myofibroblast differentiation.  
 
Myofibroblastic differentiation under flow was partially inhibited by follistatin-288 and 
blocked by TGF-β1 supplementation. This was associated with caveolin-mediated 
internalisation of TGF-β receptor type II.  These findings suggest that fluid flow modulates 
fibroblast response to pro-differentiation signals such as TGF-β1. We propose that this may 
be a novel mechanism by which mechanical forces buffer responses to chemical signals in 
vivo, maintaining a context-specific fibroblast phenotype.  
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1.0 Introduction 
 
Many studies have shown that the architecture of all living cells rely on the tensional integrity 
in the internal and external environment of cells (Ingber, 1993, Ingber et al., 1981). Cells 
perform myriad tasks of building tissues and organs in an incredibly complex environment 
that experiences physical forces, biochemical signals and communications from other cells or 
regulators due to basic movement like respiration, walking, talking etc. (Mammoto and 
Ingber, 2010, O'Connor and Gomez, 2014). These processes are critical for normal 
physiological activities and mediate functions of all tissues including those of the oral cavity. 
Cells adapt to the rapidly changing environment by mechanisms that modulate their 
biochemistry and signalling processes (Berg JM, 2002). It is this ability of the cells to 
respond to perceived signals that forms the basis of all biological processes such as 
development, wound repair, inflammation and cellular homeostasis. 
 
Chemical signals from the environment are initially transmitted into cells via processes like 
diffusion and active transport. Subsequently, chemical signals act as ligands and bind to 
receptors, both surface associated and intra cellular and induce a conformational change in 
the protein structure of receptors, thus invoking a cascade of signalling events inside a cell 
(GM., 2000). However, in vivo both mechanical forces and chemical signals contribute 
synchronously all aspects of development (Mammoto and Ingber, 2010), biological processes 
(Linville et al., 2016) and in disease progression (Janmey and Miller, 2011). Signals can be 
classified into two types: Mechanical forces and chemical signals. 
 
Mechanical forces comprise of signals that are exerted on (endogenous) and generated by 
(endogenous) a cell which results in cytoskeletal contractility and activation of various 
signalling pathways. Examples of exogenous forces include gravity and voluntary actions 
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whereas endogenous forces include fluid-tissue interactions such as blood circulation induced 
by pumping of the heart (Barbee et al., 1994).   This form of signalling is also known as 
mechanotransduction. In this type of signalling, cells respond to extrinsically applied forces 
and to those generated by cell-cell contacts. These signals not only determine its mechanical 
properties such as matrix stiffness and contractility but also the phenotype of a cell. 
Numerous studies have shown that cellular mechanics are determinants of the cell cycle 
(Klein et al., 2009, Winer et al., 2009), transcription (Li et al., 2007, Engler et al., 2007), and 
disease progression (Georges et al., 2007). When force is exerted on the cell membrane some 
of the basic cellular processes such as cell migration (Lo et al., 2000, Masuda and Fujiwara, 
1993), cell growth (Georges et al., 2006), differentiation (Engler et al., 2006, Engler et al., 
2008) and  production of proteases (Wall et al., 2009, Bhadal et al., 2008) are altered. These 
cellular functions are sustained by three processes: detection of signals from the environment, 
transmission of signals to changes in gene expression and transformation of these changes in 
gene and or protein expression to mechanical signals for other cells (Miller and Davidson, 
2013).   
 
Apart from these forces, the stiffness of extracellular matrix also functions as a crucial 
mediator of cellular function. Tissue stiffness (E) is defined as a measure of resistance that a 
material shows to stress and deformation (Handorf et al., 2015). It differs by several orders of 
magnitude ranging from kilo pascals (kPa) in adipose tissue (Samani and Plewes, 2004) to 
giga pascals (GPa) in bone (Rho et al., 1993) and is constantly subjected to variability during 
developmental stages (Handorf et al., 2015). Numerous studies on cellular stiffness revealed 
that cells can generate their own forces which are then exerted on substrate and surrounding 
tissues. With increasing stiffness, cells move slowly (Pelham and Wang, 1997), alter the cell-
cycle (Klein et al., 2009) and limit cellular homeostasis giving rise to an abnormal tissue 
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(Discher et al., 2005). Further, single molecule experiments have shown that cytoskeletal 
proteins like activin (Rief et al., 1999) and filamin (Furuike et al., 2001) can be structurally 
modified when low-magnitude forces in the order of 50-200 pN act on them. These studies 
indicate that protein folding and structure associated changes can either relax or stress the 
cytoskeleton of a cell thus invoking sensor mechanisms that transduce molecular stress. 
  
Chemical signals are generated by chemical molecules that act as ligands and either bind to 
surface receptors or diffuse through cell membranes to bind to intracellular receptors to cause 
a conformational change and cascade of signalling events. These messengers either diffuse 
from their production site to the target cell or are carried to the target locations by interstitial 
fluid flow and blood circulation (Mammoto and Ingber, 2010). Effects of chemical signalling 
depend upon factors such as exposure time and concentration of these messengers. For 
example, when glomerular mesangial cells were treated with TGF-β1, Smad2 mRNA 
expression was reduced (Poncelet et al., 2007). Further, prolonged exposure of mesangial 
cells with TGF-β1 for longer period of 5-7 days induced expression of α-smooth muscle actin 
(α-SMA) and induced epithelial to mesenchymal transition like phenotype in these cells. 
Numerous studies have reported that concentration of chemicals determine the response of 
cells. For example, TGF-β1 exerts a concentration dependant effect on immunoglobulin 
production (McKarns et al., 2003). Reports have also suggested that levels of TGF β receptor 
type II regulate the biological effect of TGF β signalling (Rojas et al., 2009).  These findings 
establish that it is not just the combined effect of mechanical forces and chemical signals that 
drive cellular signalling, but magnitude of the forces and signals also play a vital role in all 
biological processes. Chemical signals however activate different modes of cell- cell 
signalling which can be broadly classified to four types: autocrine signalling, paracrine 
signalling, endocrine and direct signalling via gap junctions. 
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1.1 Types of cell signalling  
 
Cells communicate by various methods that permit chemical signals to reach target locations 
and invoke a response. Extracellular molecules released by signalling cells recognise and 
bind to surface receptors of target cells and elicit a cellular response by means of a signalling 
mechanism. The four types of cell signalling differ from each other in the distance that the 
signals travel to reach target cell (Figure 1.1). 
 
In autocrine signalling, ligands released by cells bind to its own surface receptor suggesting 
that the signalling cell and the target cell are the same. For example, numerous studies have 
shown that all cancer cells produce autocrine growth factors for self-sustenance (Hanahan 
and Weinberg, 2000). One such observation in non-squamous cell lung cancer (NSCLC) 
revealed the frequent expression of epidermal growth factor receptor (EGFR) (Hirsch et al., 
2003) as well as EGF family ligands (Rusch et al., 1997).  
 
Signals acting in localised regions of a tissue between different cell types that lie close to 
each other is known as paracrine signalling. These signals move by diffusion to their target 
cell via the extracellular matrix and last for a short period of time. The released ligand 
molecules are then quickly degraded by enzymes.  One such example of paracrine signalling 
is the transmission of signals across synapses between nerve cells (GM, 2000).  
 
In the epidermis, Wnt signalling molecules convey signals to the underlying fibroblasts. 
These signals act locally via extracellular matrix deposition and by secreting other factors 
that influence fibroblast behaviour in other regions of the skin (Driskell and Watt, 2015). This 
suggests that fibroblasts in the skin experience both autocrine and paracrine signalling. 
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Endocrine signals are signals from hormones that originate from endocrine glands such as 
thyroid and pituitary glands and act on distant target cells. Response from these type of cells 
is slow but lasts longer. Ligands released are present in low concentrations when they reach 
their target cells. For example in neuroendocrine signalling, neurotransmitters released from 
nerve cells invoke release of hormones into the blood stream (Malenka RC, 2009). 
 
Direct signalling happens via gap junctions which appear as connections between plasma 
membranes of cells. These gap junction channels allow diffusion of small molecule signalling 
mediators such as calcium ions (Ca2+) from one cell to another. In the heart, the signal to 
contract muscle cells is passed through gap junctions (Lorber and Rayns, 1977). 
 
These signalling networks work in association with mechanical forces like blood flow, 
interstitial fluid flow and chemical signals to contribute to the development of an organism.  
 
 
 
 
 
 
 
 
 
 
Figure 1.1: Types of chemical signalling i) Autocrine signalling ii) Paracrine signalling iii) Endocrine and iv) 
Direct signalling by gap junction proteins. 
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1.2 Mechanics of fluid flow in development and repair. 
 
The most basic mode of transportation of biochemical products in living organisms is via 
fluids. More complex animals contain multiple networks of tubules that are involved in 
movement of products to facilitate biochemical reactions and sustenance of life. The most 
primitive complex forms of life, single celled organisms use fluids for intracellular transport 
and nutrition (Cartwright et al., 2009). As the complexity of organisms increase, so the 
complexities of fluid transport system increase. Development of the embryo commences with 
formation of a mass of cells from a fertilised egg. Subsequently, cavities and tubes are 
formed in order to carry signalling molecules (Mammoto and Ingber, 2010) and nutrients to 
enable formation of embryonic axis and growth (Freund et al., 2012).  Fluid flow is required 
at all stages of vertebrate development including morphogenesis of kidney (Serluca et al., 
2002), formation of inner ear and otolith (Colantonio et al., 2009), migration of neurons 
(Sawamoto et al., 2006), formation of the heart (Slough et al., 2008), hematopoiesis 
(Pardanaud and Eichmann, 2009)  and in determining symmetry and positioning of organs 
(Nonaka et al., 1998) in a developing fetus. This compelling evidence confirms that in a 
biological system, fluid flow and growth are intertwined right from the beginning of life. 
 
Developmental controls were first explained in mechanical terms by D’Arcy Thompson who 
defined cellular patterning and signalling as “diagram of underlying forces”. He mentioned 
that changes in three dimensional structure of cells occurs as a result of force acting on a 
mass (Thompson, 1917). Embryonic development is the vital process of life which directs all 
processes that sculpt organs and tissues. At this stage the embryo experiences isometric 
tension due to cytoskeletal contraction (Ingber, 2006), stiffness due to tissue elasticity, 
pressure caused by fluid flow induced stress acting perpendicular to embryo surface and 
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shear caused by fluid flow induced friction that acts parallel to the surface (Gjorevski and 
Nelson, 2010). 
 
Isometric cellular contraction and fluid flow mediated shear stresses regulate cellular 
structure, behaviour and fate. Extracellular matrix derived mechanical tension passes through 
membrane bound receptors and is transmitted to the cytoskeleton (Assoian and Klein, 2008) 
to control transit through G1 phase of the cell cycle (Huang and Ingber, 2002). At this stage 
signalling is also regulated by the small GTPase Rho and its effectors Rho Kinase (ROCK). 
Subsequent increase in Rho A activity leads to degradation of cyclin dependant kinase 
inhibitor p27kip1 permitting progression of the G1 cell cycle phase (Mammoto et al., 2004). 
 
Mechanical stresses obtained from tension and fluid flow induced shear also regulate 
programmed cell death.  In these studies the cells rounded up due to decreased cytoskeletal 
tension arising from ECM scaffold depletion (Chen et al., 1997). Direct evidence of apoptotic 
death was observed during physiological involution of the mammary gland (Wicha et al., 
1980).  
 
Apart from cellular proliferation and programmed cell death, embryonic development largely 
relies on changes in cellular phenotype wherein progenitor stem cells differentiate into 
various lineages. Phenotype associated changes are regulated by changes in gene expression 
like downregulation of epithelial markers such as E-cadherin and upregulation of 
mesenchymal markers such as N-cadherin and α- smooth muscle actin (α-SMA) (Kalluri and 
Neilson, 2003). Recent studies have shown that the differentiation process is tightly regulated 
by matrix stiffness (Lv et al., 2015) which in turn is modulated by mechanical forces like 
fluid flow (Kohn J  et al., 2015). These findings were further strengthened when researchers 
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observed in vitro that the rhythmic contractility of embryonic cardiomyocytes is similar to in 
vivo only when the extra cellular matrix (ECM) shows similar mechanical properties to that 
of a heart (Engler et al., 2008).  
 
Transition of an epithelial phenotype to a mesenchymal phenotype, a property termed as 
epithelial mesenchymal transition (EMT) is marked by the detachment of epithelial cells from 
each other increased migratory behaviour. EMT in developing embryos is essential for 
gastrulation and neural crest formation (Thiery et al., 2009). Recent studies have shown that 
EMT could be induced by transforming growth factor- β1 (TGF-β1) interstitial fluid flow in 
cancer cells (Shieh and Swartz, 2011, Rizvi et al., 2013) and proteases like matrix 
metalloproteases (MMP3) (Sternlicht et al., 1999). When mouse mammary epithelial cells 
were treated with MMP3, EMT was observed to occur with changes in cellular morphology 
and increased cell spreading (Radisky et al., 2005). These observations suggest that 
mechanical forces like fluid flow induced changes in cytoskeletal activity resulting in EMT. 
 
Although all cells in the body experience various types of mechanical force induced fluid 
movement from a nanoscale level (active transport, osmosis and diffusion), microscale level 
(interstitial fluid flow, intercellular and intracellular) to a mega scale (blood flow),   in this 
review we shall discuss only the role two main types of fluid flow in development and repair: 
blood flow and interstitial fluid flow. 
 
1.2.1 Blood flow  
 
Blood is a complex fluid which undergoes continuous circulation by directional flow in the 
cardiovascular system to ensure transportation of nutrients, hormones, metabolic wastes, 
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drugs, signalling molecules and oxygen to tissues and organs in the body. Blood circulation is 
one of the most crucial processes for sustenance of all vital processes. 
 
Morphogenesis of heart at the embryo stage is contributed by the combined effect of 
contraction of heart as well as blood flow.  Notably, forces of flow change at every stage of 
heart development. At the primitive stage of embryonic development, the heart appears as a 
tube made up of three layers of cells. Later, the heart undergoes a conformational change 
known as looping to form the chambers. In humans, contraction of heart commences as a 
peristaltic wave from day 22 post fertilization. At this stage flow is unidirectional. However, 
as the ventricles of the heart develop ventricular contraction, a significant fraction of blood 
volume is pushed back into the venous sinus resulting in reverse flow of blood. This flow of 
blood in both directions confers hemodynamic shear stress on the endocardial cells (Boselli et 
al., 2015).  
 
Researchers led by Lonard Zon observed that fluid flow induced stress originating from a 
beating heart triggers haematopoiesis (North et al., 2009). The group found that nitric oxide is 
one of the chemicals produced under mechanical stress and promotes stem cell production. 
They used a Zebrafish model to create an embryo with a mutation termed as ‘silent heart’. In 
this embryo, the heart beat and circulation was absent. These embryos were found to be 
deficient in hematopoietic stem cells. Nitric oxide supplementation to the mutant embryos 
restored blood cell production. Conversely, depletion of nitric oxide from these embryos 
resulted in deficiency of hematopoietic stem cells. The group observed similar results when 
the same experiments were repeated in mouse models. These findings suggest that blood flow 
is vital for blood cell production.  
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Another group validated these findings by studying the effect of fluid flow on mouse 
embryonic stem cells in a miniaturized flow chamber that mimicked fluid shear stresses in a 
developing cardiovascular system (Adamo et al., 2009). The group compared blood vessel 
formation in cells subjected to fluid flow and those that were grown in static conditions. They 
observed cells that experienced fluid flow mediated shear stress showed elevated levels of 
CD31 and transcription factor Runx1, the chief regulator of haematopoiesis suggesting that 
blood flow is essential for angiogenesis. 
 
Besides haematopoiesis and angiogenesis, shear stresses generated due to movement of blood 
forms the basis for mechanotransduction and is vital for repair processes like wound healing. 
Cells detect blood flow induced signals via sensing mechanisms as described in section 1.4. 
As a normal biological process, healing of wounds commences from rapid rushing of blood 
to the injured site followed by four distinctive processes: haemostasis (blood clotting), 
inflammation (clearing damaged and dead cells), proliferation (angiogenesis, collagen 
deposition, formation of granulation tissue, epithelialization and wound contracture)  and 
tissue remodelling (collagen realignment and apoptosis of excess cells) (Gosain and DiPietro, 
2004, Mathieu D, 2006). Although each of these phases are clearly distinctive in functions, 
movement of blood is vital at every stage for wound healing to proceed uninterrupted. For 
example, the inflammatory response is initiated by changes in blood flow, increase in 
permeability of blood vessels, migration of T-lymphocytes, white blood cells and proteins 
(Martin, 1997). Even processes like vascular remodelling largely rely on the flow of blood for 
efficient completion (Tomlinson and Silva, 2013). Blood is also the carrier of oxygen, an 
essential nutrient to all cells thus aiding accelerated wound healing (Tandara and Mustoe, 
2004). Studies have shown that impairment of blood flow due factors like smoking can delay 
wound healing (Mosely and Finsett, 1977).  
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Ageing and disease are the outcome of impaired biological function. All tissues consist of 
cells that remain in an arrested state which is reversible and may start to proliferate when 
stimulated, a property often described as quiescence. This short term resting phase of cells 
often overlaps with senescence where aging cells attain an irreversible growth arrested state 
(Fridlyanskaya et al., 2015, Dimri et al., 1995). Senescence is characterised by cellular arrest, 
usually at G1 and sometimes in G2 phases of the cell cycle and is broadly classified into 
replicative senescence occurring due to loss of telomeric DNA in aging cells (Hodes, 1999) 
and stress induced premature senescence (SIPS) resulting due to harmful environmental and 
chemical stresses which halt cell division (Cmielova et al., 2012). Reports show that 
senescence alters the flow of blood resulting in pathological manifestations (Embleton et al., 
2002, Bridgeman and Brookes, 1996).  Both senescent and quiescent fibroblasts show 
variations in gene expression of cell cycle modulators and cyclin dependent kinase inhibitors 
such as p21Waf-1  and p16Ink4A (Jackson and Pereira-Smith, 2006). Therefore in the presence 
of proliferative signals such as tissue injury or increased cardiac output as is observed during 
cardiac disorders, cells exit from their growth arrested state and proliferate for the purpose of 
cellular replacement(Burton, 2009). For example, endothelial cells in regions of high blood 
flow proliferate faster to replace damaged cells (Alberts B, 2002a). 
 
It is therefore clear that blood flow and circulation is indispensable for normal functioning of 
living cells.  
 
1.2.2 Interstitial fluid flow  
 
Apart from blood and lymphatic fluid there are other fluid flows the tissue is exposed to in 
vivo. Fluid that comprises plasma and transcellular fluid and surrounding the cells in a tissue 
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is known as interstitial fluid (Dorland's, 2012) and comprises approximately 20% of total 
body weight (Aukland and Reed, 1993). Interstitial fluid flow is associated with lymphatic 
flow in vivo and flows between interstitial cells such as fibroblasts, tumour cells, tissue 
immune cells and adipocytes. It flows at a much slower velocity that blood due to the 
resistance imposed by the extracellular matrix (Rutkowski and Swartz, 2007) (Figure 1.2).  In 
normal situations interstitial flow functions as a means to deliver nutrients and signals to 
cells, remove metabolic waste, induce lymphatic regeneration in vivo (Boardman and Swartz, 
2003, Rutkowski et al., 2006), regulate normal functioning of osteocytes and chondrocytes 
(Buschmann et al., 1995, Mow et al., 1984, Grodzinsky et al., 2000), and induce cytokine 
production by smooth muscle cells (Wang and Tarbell, 2000).  Although the exact velocity 
ranges of this flow is not known, it has been observed that during pathological conditions like 
cancer and ruptured vasculature, interstitial fluid flow can activate fibroblasts (Ng and 
Swartz, 2003) (Dan et al., 2010) and smooth muscle cells (Wang and Tarbell, 2000, Shi and 
Tarbell, 2011)  with shear stress values reach up to 0.1-1 dynes/cm2 (0.01-0.1 Pascals) (Shi 
and Tarbell, 2011). 
 
Further, during conditions like inflammation and acute edema the velocity ranges are 
increased to 0.1-2 µms-1 (Guyton et al., 1966). Although the flow velocity is miniscule, 
interstitial fluid flow exerts effects on tissue morphogenesis, cellular migration, 
differentiation and matrix remodelling (Swartz and Fleury, 2007). Mechanisms by which 
interstitial fluid flow drives these processes may be dependent on shear stresses induced by 
physical forces and environmental damage. 
 
Interstitial fluid flow is driven by pressure gradients resulting from hydrostatic pressure 
arising from differences between blood and the interstitial space (Swartz and Fleury, 2007) 
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and eventually controls the formation of lymphatic fluid. Pressure gradients between the 
interstitium and lymphatic capillaries enable flowing of interstitial fluid into the lymphatic 
system (Swartz and Fleury, 2007).  Flow is further maintained by pumping forces in 
lymphatic capillaries.  
 
Recent studies have shown that interstitial flow in the cartilage is driven by exogenously 
applied physical forces that act on this tissue (Kwan et al., 1984). Interstitial fluid flow 
induced in this manner helps to circulate nutrients and biomolecules between cells and 
transport cellular waste from chondrocytes that are distant from blood capillaries. 
 
Morphogens could be defined as biochemical signals that regulate directional and positioning 
of organs in an embryo. In the early stage embryonic development, morphogen transport and 
gradient patterning is known to regulate branching of developing lungs (Warburton et al., 
2005). Embryonic lung movement induced interstitial fluid flow influences morphogen 
distribution which in turn contributes to overall development of the growing foetus (Nonaka 
et al., 1998).  In a skin regeneration model, researchers have shown that lymphatic cells 
migrate in the direction of interstitial flow and organise themselves around fluid channels. In 
the absence of flow they are unable to organise themselves into functional capillaries 
(Boardman and Swartz, 2003, Rutkowski et al., 2006). These studies seem to suggest that 
interstitial flow itself can act as a morphogenic cue.  Wound healing is process that requires 
migration of epithelial and endothelial (Li et al., 2005) cells which can be activated by shear 
stress suggesting the interstitial fluid flow promotes blood and capillary formation (Ng et al., 
2004). 
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These compelling evidences suggest that regardless of composition, fluid flow is vital for the 
normal functioning of life processes and interrupted flow could invoke detrimental responses 
in vivo. 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Types of fluid flow experienced by living cells. 
 
1.3 Mechanotransduction in living cells 
 
Mechanotransduction describes the cellular processes that translates mechanical stimuli into 
biochemical signals, thus enabling cells to adapt to their physical surroundings. Cells within 
tissues are constantly subjected to mechanical forces due to mobility and respiration. Even 
during normal activities like walking or running, the force acting on the heels can reach 
several Kilo Newtons, and induce a stress in the order of Mega Pascals. Stress is defined as 
force per area and it is often measured as Newtons per metre-2 or Pascals (Paszek et al., 
2005).  
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Mechanical stresses influence cell shape and cytoskeletal structure (Wang et al., 1993, Wille 
et al., 2004). This process therefore controls many cellular processes involving tissue 
development, including migration, growth, and differentiation, apoptosis and stem cell 
lineage switching (Ingber and Folkman, 1989, McBeath et al., 2004).  These stress signals are 
transmitted to cells embedded in the extracellular matrix (ECM) or are transferred to the 
contractile cytoskeleton of individual cells. However both types of forces converge on 
sensory molecules such as primary cilia (Nauli et al., 2008), glycocalyx (Weinbaum et al., 
2007), plasma membrane mechanodetectors such as caveolae (Sinha et al., 2011), and 
transmembrane integrin receptors which connect the ECM to the cytoskeleton (Ingber, 1997, 
Geiger and Bershadsky, 2001).  
 
1.3.1 Physical force and chemical signal induced mechanotransduction 
 
Cells adapt to forces by increasing ECM rigidity. Therefore, mechanical stiffness of the cell 
increases linearly with increasing levels of stress (Wang et al., 1993, Galbraith et al., 2002). 
This enhances the ability of the cell to resist mechanical injury (e.g. prevent membrane 
tearing) (Wang et al., 2001). There are three types of stress stimuli: compression, shear stress 
and tension (Figure 1.3). Cells respond to these stimuli and undergo changes in shape, 
function and behaviour (Vogel and Sheetz, 2006). 
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Figure 1.3: Overview of three different types of stress acting on cells plated on a surface i) Fx , stress acting 
parallel to the surface ii) Fy , stress acting in perpendicular direction towards the surface and iii) –Fy , stress 
acting perpendicular direction away from the surface. 
 
Chemical responses to stress signals include activation of signalling cascades and / or release 
of Ca2+ ions from ion channels in the plasma membrane (Butcher et al., 2009). Proteins in 
the extracellular matrix stretch in response to stress. Furthermore, the nucleus itself acts as a 
mechanoreceptor and influences chromatin conformation (Butcher et al., 2009). 
 
Studies have revealed the role played by mechanotransduction in a broad range of tissue 
functions and that this is not limited to a specific type of cell. The process maintains tissue 
homeostasis and is crucial for development and tissue specific differentiation. Hence it is 
imperative for all cells to respond to mechanical stress, no matter how primitive they are 
(Ingber, 2006). For example, stress fibres reorient during bone remodelling after fracture 
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(Burger and Klein-Nulend, 1999) and cells in the cardiovascular system experience pulsatile 
shear stress arising from cyclical pressure generated during heartbeat. It is this shear stress 
which activates the endothelial cells and induces the cytoskeletal network to mature, elongate 
and align in the direction of blood flow (Pritchard et al., 1995, Takahashi et al., 1997). 
Reports indicate that mechanical cues are important components of the stem cell niche (Jones 
and Wagers, 2008) and mechanical tension regulates epithelial morphogenesis in nematodes 
(Zhang et al., 2011b). The molecular mechanisms by which mechanical forces control stem 
cell function include chromatin remodelling, nuclear translocation of transcription factors, 
and modulation of signalling proteins (Christopher B. Wolf, 2009). 
 
Whilst there is compelling evidence for the role of mechanical stress in determining whether 
the tissue performs its normal function or not, a question arises about how cells of connective 
tissue respond to mechanical stimuli? All cells respond to stress signals by three methods i) 
Signalling pathways ii) Co-operation between growth factor and integrin signalling and iii) 
mechanical control of cell differentiation and growth (Chiquet et al., 2009). 
 
Some of the common events observed to be activated in adherent cell types at the cell-ECM 
interface when mechanically stressed are i) activation of calcium-dependent signalling due to 
influx of calcium through ion channels  ii) Activation of nuclear factor kappa-B (NFκB) due 
to generation of Reactive oxygen species iii) Stimulation of small GTPases of the Ras family 
and of mitogen-activated protein kinases (MAPKs) iv) Altered activity of small GTPases of 
the Rho family resulting in changes in  cytoskeletal dynamics (Chiquet et al., 2009). 
 
It is intriguing to observe that transcription factors are the first to be activated upon 
mechanical stimulation. Smooth muscle cells subjected to cyclic strain revealed an increase 
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in promoter activity of profibrotic factor CCN2 due to increased actin polymerisation and 
NFκ B activation (Chaqour et al., 2006). 
 
A number of reports have focussed on studying the co-ordinated effects of integrins and 
growth factor receptors in mediating intracellular signalling cascades (Zhang et al., 1995, 
Miyamoto et al., 1996, Mainiero et al., 1997, Schlaepfer et al., 1998). Both these components 
function synergistically due to their physical interactions with the ECM. Integrins are cell 
surface receptors that form structural and functional linkages between the ECM and the 
intracellular cytoskeletal linker proteins. Binding of integrins with ECM ligands not only 
leads to clustering and engagement with cytoskeletal proteins, but it also activates signalling 
cascades such as the MAPKinase pathway which is involved in cell growth and 
differentiation. Therefore, association of integrins with growth factor receptors enables cells 
to integrate mechanical and growth factor associated signals and influence subsequent 
cellular responses. These responses include anchorage dependant growth and Anoikis, a type 
of programmed cell death triggered when anchorage dependant cells remain suspended for 
prolonged periods. 
 
Mechanical cues also mediate autocrine signalling in mesenchymal stem cells which are the 
precursors of fibroblasts. The first evidence of the effect of adhesion mediated autocrine 
signalling directing stem cell differentiation was provided by C.S.Chen’s laboratory. The 
group demonstrated that mechanical cues created by a micropatterning technique which 
control cell shape and cell spreading with single-cell precision can act as a switch in directing 
the differentiation of stem cells into either an osteoblast or adipocyte lineage (McBeath et al., 
2004). They plated mesenchymal stem cells on fibronectin squares of different areas (1000–
10,000 μm2). Cells which attached on large squares spread extensively and started expressing 
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alkaline phosphatase, a marker of osteoblastic lineage. Conversely, the cells on smaller 
squares adopted a rounded shape and started accumulating lipid droplets, as seen in adipocyte 
differentiation. The authors concluded that mechanical cues experienced by a cell in an 
autocrine manner due to restrictions in surface area determine the fate of mesenchymal stem 
cells. In another study, experiments were conducted to study the effect of mechanical strain 
on protease production by keratinocytes.  Lewis et.al (2008) studied the effect of mechanical 
strain on protease production in normal and transformed keratinocytes. Keratinocytes were 
seeded on membranes coated with type I collagen or type II collagen. They were then 
subjected to mechanical strain. Supernatants were then assayed for Urokinase-type 
plasminogen activator (uPA), a serine protease known to play a critical role in wound healing 
responses (Jensen and Lavker, 1999). Their results revealed that under static strain, 
production of uPA was down regulated in both normal human keratinocyte cultures as well as 
human papilloma virus transformed keratinocytes. Notably, uPA levels returned to resting 
levels when tension was restored in these cells. Interestingly, this feature was representative 
of wound healing response in vivo wherein wounding upregulates the levels of uPA (Huang 
et al., 2002).  Notably, this study confirms the theory that mechanical forces are an important 
signal during wound healing.  Another study reported that tensile stress in combination with 
TGF-β (Wipff et al., 2007) is required for the expression of myofibroblast specific markers 
such as α- Smooth muscle actin (Zhao et al., 2007). 
 
Anchorage substrate dependant mechanical features also play a role in cellular processes like 
proliferation, both in single cells as well as in tissue aggregates. Previous studies on 3D 
collagen matrices reveal the dual nature of fibroblasts in switching between quiescent and 
proliferative phenotypes, depending upon whether matrices are attached or floating during 
matrix modelling. One of the research groups initially observed a decrease in ERK mediated 
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cell signalling in floating matrices. Fringer and Grinnell (2003) reported that serum 
stimulation of fibroblasts in floating matrices does not result in ERK translocation to the 
nucleus. Another study on fibroblasts in 3D matrices showed that under tension or relaxed 
conditions these cells respond differently to growth factor stimulation. Furthermore, 
switching the mechanical environment between loaded and unloaded conditions influences 
whether cells acquire proliferative or resting phenotypes. 
 
1.3.2 Fluid flow induced mechanotransduction 
 
Endothelial cells line the blood vessels and are adapted to withstand shear stresses generated 
by movement of blood. Recent evidence that interstitial flow can direct mechanotransduction 
events came from studies on the endothelial glycocalyx which plays a role in moderating 
fluid stresses to cell surface (Tarbell and Pahakis, 2006). Components of the glycocalyx 
include hyaluronan, chondroitin sulphate and heparin sulphate. When these components were 
selectively degraded and exposed to shear stress, it was observed that responses such as 
release of nitric oxide were eliminated (Moon et al., 2005). Recently, a group using atomic 
force and fluorescence microscopy observed that the endothelial surface glycocalyx regulates 
nitric oxide production by activation of TRP ion channels (Dragovich et al., 2016). In human 
placental trophoblastic cells, fluid shear stress mediated microvilli formation and flow 
induced Ca2+ influx was regulated by transient receptor potential, vanilloid family type 6 
(TRPV6) thus providing an understanding of signal perception and mechanotransduction 
(Miura et al., 2015).  
 
In cultured MC3T3-E1 osteoblasts, application of fluid shear invoked reorganisation of actin 
filaments into contractile stress fibers involving recruitment of β1 integrins and α-actinins to 
focal adhesions (Pavalko et al., 1998). Two proteins related to mechanotransduction in vivo 
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cyclooxygenase-2 (COX-2) and product of c-fos were also observed to be elevated. Chicken 
osteocytes showed signs of mechanotransduction by increasing their levels of prostaglandin 
E2 within 1 hr. following treatment with pulsating fluid flow leading to disruption of the actin 
cytoskeleton (Ajubi et al., 1996). 
 
In endothelial and epithelial cells the transcription factor Egr-1 gene is rapidly activated 
following fluid shear stress via integrin-dependent activation of the Ras/Erk-1/2 pathway 
(Schwachtgen et al., 1998). The group showed that the Egr-1 expression increased by five to 
nine fold in human aortic endothelial cells and Hela cells when subjected to fluid shear stress. 
In periodontal fibroblasts c-Fos, an AP-1 transcription factor gets rapidly induced within 30 
minutes of exposure to mechanical tension stress (Yamaguchi et al., 2002). Zhao et.al (2007) 
showed that mechanical stimulation of smooth muscle cells promoted nuclear translocation of 
MAL, a myocardin-related transcriptional co-activator of serum response factor (SRF). The 
authors also reported MAL/SRF-dependent activation of the α-SMA gene promoter in these 
cells. 
 
 
1.4 Sensory elements of mechanotransduction 
 
An obvious question related to biological flow is what the mechanisms cells use to detect and 
translate these signals. Since these physical forces differ in strength, it is not surprising that 
different molecular mechanisms are employed by cells to detect these forces (Freund et al., 
2012).  Few such components that mediate mechanotransduction in cells are detailed below. 
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1.4.1 Low-speed flow sensing: This happens via primary cilia (Figure 4). Since they 
protrude into the flow, these structures act as first line detectors of fluid flow associated 
signals. Ciliary mechanotransduction is associated with embryonic heart development and 
left to right patterning of heart and during renal development.  The mechanosensory complex 
includes glycoproteins polycystin1 (PKD1) and polycystin2 (PKD2) in renal cells (Nauli et 
al., 2003), and PKD1 and PKD2 in the LR organizer (Field et al., 2011). PKD1 senses 
luminal shear stress though it’s extracellular domain and regulates the gating of calcium –
permeable channel PKD2 in renal epithelial cells (Nauli et al., 2003).  In endothelial cells and 
in kidney epithelial cells, the PKD1-PKD2 complex is involved only in fluid flow associated 
mechanotransduction and not in mechanical loading associated mechanotransduction 
(AbouAlaiwi et al., 2009, Poelmann et al., 2008). However, primary cilia are fragile and 
cannot withstand strong fluid flows (Nauli et al., 2008). For example 2 hours of laminar shear 
stress at 15 dynes/cm2 disassembles most of the cilia in human umbilical vein endothelial 
cells (HUVECs) (Iomini et al., 2004). Surprisingly, lack of cilia is associated with shear 
induced epithelial to mesenchymal transition, a process that is activated during 
valvulogenesis (Egorova et al., 2011).  
 
1.4.2 High-speed flow sensing: In regions of high levels of cardiac output, blood flows 
a higher speed resulting in a higher fluid shear stress (Figure 1.4). Such high levels of flow 
require other mechanosensitive mechanisms for sustained high shear flows. 
 
1.4.2.1: Glycocalyx: Amongst all the mechanisms, the glycocalyx has received the most 
attention in the recent years. The glycocalyx is a 3D meshwork of glycoproteins that covers 
the plasma membrane surface in a bush like pattern. It is seen as a major transducer of 
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mechanical forces to the underlying endothelial cytoskeleton (Tarbell and Pahakis, 2006). 
Studies using a hydrodynamic model have shown that the stiff core proteins of the glycocalyx 
transmit fluid forces at its tips through a localized torque which further transduces into an 
integrated torque in the underlying cytoskeleton (Weinbaum et al., 2007). The glycocalyx is 
present in a developing vasculature (Henry et al., 1995), however its role during 
embryogenesis needs to be further explored. 
 
1.4.2.2: Mechanosensitive membrane channels: These channels exist in almost every 
organism and are gated by forces that convert mechanical signals to electrical ones or 
regulate release of secondary messengers which eventually gate the ion channels rapidly with 
a short latency. These channels are activated by mechanical stretching as is observed in 
transient receptor potential cation channel sub family C (TRPC1) (Maroto et al., 2005). TRP 
channels such as PKD1 are mechanosensitive channels that indirectly activate other 
mechanosensitive channels (Sharif-Naeini et al., 2009). In the cilia of kidney cells, TRPV4 
interacts with PKD2 to form a calcium specific channel for mechanotransduction (Kottgen et 
al., 2008).  
 
1.4.2.3: Plasma membrane mechanodetectors: Cells have different ways to maintain their 
plasma membrane integrity whilst experiences shear stresses due to fluid movement and 
mechanical loading.  For example, some of the recent studies have shown that endothelial 
cells can respond rapidly to tension changes in their membrane through membrane 
invaginations known as caveolae (Sinha et al., 2011). 
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1.4.2.4: Adhesive mechanosensory receptors: An important component of the 
mechanoresponsive machinery lies in the cytoskeleton of cells, specifically in the molecules 
that anchors it to the neighbouring cells (Galbraith et al., 1998). Although changes in 
cytoskeleton are observed under influence of fluid flow mediated shear stresses, there is little 
evidence that the cytoskeleton can directly sense flows. The cytoskeleton of an endothelial 
cell, however contains membrane adhesion receptors which transmits signals from the outside 
to the inside of the cell. Flow dependant activation of vascular endothelial growth factor 
receptor type II (VEGFRII) has been observed in these cells (Tzima et al., 2005). 
Downstream signalling is mediated by phosphoinositide-3- kinase (PI3K) and the Akt 
complex which eventually phosphorylates endothelial NO synthase, thus promoting vessel 
relaxation (Fleming et al., 2005). Integrins and small GTPases (Rho, Rac and Cdc42) also 
support flow dependant cytoskeletal reorganization (Fleming et al., 2005). Coordinated 
efforts of two transcription regulators, Yorkie-homologues YAP and TAZ sense signals from 
integrins and translocate to the nucleus to promote differentiation in mesenchymal stem cells 
as well as in survival of endothelial cells (Dupont et al., 2011). 
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Figure 1.4: Sensory components of flow, A) low speed sensing by primary cilia, B) Plasma membrane 
bound detectors such as Caveolae, C) Membrane bound ion channels and D) Glycocalyx. 
 
1.5 TGF- β signalling and associated processes 
 
The transforming growth factor beta (TGF-β) pathway is crucial for various cellular 
functions. TGF-β signalling is known to exert pleiotropic effects on developmental processes 
including cardiovascular development (Di Guglielmo et al., 2003b), normal tissue 
homeostasis, cellular differentiation, proliferation (Huang and Huang, 2005), migration, 
apoptosis, and extracellular matrix production (Runyan et al., 2005). In wound healing, it is 
known to promote wound closure by increasing production of contractile proteins. However 
in fibrotic diseases, excessive production results in compromised tissue function (Mitchell et 
al., 2004a). Given that this pathway is involved in numerous normal biological and 
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pathologic processes, it is not surprising that the pathway is also involved in 
mechanotransduction (Chowdhury et al., 2004).   
1.5.1: TGF-β ligands- The TGF-β superfamily consists of 30 ligands that are structurally 
related and interact with cell surface receptors to mediate downstream signalling and 
transcriptional events. The activin/nodal subfamily and the bone morphogenetic protein 
(BMP)/ growth and differentiation factor (GDF) also form a part of this signalling family 
(Ehrlich et al., 2001). In the canonical pathway, there are three variant forms that are 
conserved through evolution- TGF-β1, TGF-β2 and TGF-β3 (Table 1). The three ligands are 
produced by different cell types, although TGF-β1 is the predominant type in adults 
(Moustakas et al., 1993, Huang and Huang, 2005). All these ligands share significant 
sequence homology of greater than 76% (Derynck and Feng, 1997). Despite similarities in 
structure, these ligands have different affinities for different receptors. The TGF-β receptor 
type II (TGFβRII) binds with higher affinity to TGF-β1 and TGF-β3. TGF-β2 needs the 
presence of TGF-β receptor type III (TGFβRIII) to bind to TGFβRII (Criswell et al., 2008). 
During wound healing conditions, myofibroblast differentiation and ECM production, TGF-
β1 is produced in excess in the tissue microenvironment (Buczek et al., 2016). 
 1.5.2: TGF-β Receptors- The canonical TGF-β pathway has three types of receptors: 
TGF-β receptor type I (TGFβRI), TGF-β receptor type II (TGFβRII) and TGF-β receptor type 
III (TGFβRIII) along with three types of co-receptors known as betaglycan, endoglin and 
CD109 (Nagaraj and Datta, 2010) (Table 1). TGF-β receptor type III primarily functions to 
present ligands to TGFβRI and TGFβRII (Nagaraj and Datta, 2010). In the type II receptor 
subfamily, there are about five types which forms a complex with the ligand: Act- RIIA, Act- 
RIIB, BMPR-II, AMHR-II and TGFβRII. In the classical pathway, T RII is the most widely 
occurring type II receptor (Antony et al., 2010). It is a 62 KDa protein, consisting of a short 
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cysteine-rich, N-glycosylated extracellular domain. In the type I subfamily there are 7 
receptors known as activin linked kinases (ALKS) 1 through 7.  
 
 
 
 
 
 
 
Table 1.1: Major signalling components of the TGF-β pathway. 
1.5.3: TGF- β Signalling cascade- TGF-β signalling is propagated when the ligand is 
presented by TGFβRIII to TGFβRII (Papageorgis, 2015). This binding leads to the formation 
of a receptor- ligand complex of two TGFβRII and one TGFβRI resulting in phosphorylation 
of TGFβRI which further drives the signal transduction process by activating a group of 
transcription factors known as Smads. The three classes of Smads transcription factors are 
regulated by TGF-β superfamily of ligands: the receptor-regulated Smads (R-Smads, Smad 1, 
2, 3, 5 and 8) that interact with type I receptor. Smad6 and Smad7 compete with R-Smads for 
receptor binding and degrade the TGF-β receptors (Gordon and Blobe, 2008). TGF-β1 
phosphorylates the R-Smads at the C-terminal of Smad2 and 3. These phosphorylated 
residues function as docking sites for Smad4 and promote dissociation of Smad2 from 
TGFβRI. This dissociation results in formation of the heterotrimeric complex with Smad4 
(Gordon and Blobe, 2008). In unstimulated conditions Smad2 is located in the cytoplasm. 
Ligands TGF-β1, TGF-β2 and TGF-β3. 
Receptors TGF-β receptor type I (TGF-βRI), TGF-β receptor type II 
(TGF-βRII) and TGF-β receptor type III (TGF-βRIII). 
Receptor 
subtypes 
TGF- β receptor type I – activin linked kinases (ALKs 1, 
ALKs 2, ALKs 3, ALKs 4, ALKs 5, ALKs 6 and ALKs 7). 
 
TGF-β receptor type II – activin receptor (Act- RIIA & Act- 
RIIB), Bone morphogenetic protein receptor type II (BMPR-II), 
Anti-Müllerian hormone type II receptor (AMHR-II) and 
TGFβRII. 
Co. receptors  betaglycan, endoglin and CD109.  
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However upon stimulation, it translocates to the nucleus with Smad4. Inside the nucleus the 
complex binds to promoters and transcriptional co-activators or co-repressors to induce cell 
specific transcriptional activity (Pierreux et al., 2000). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5a: TGF-β receptors and Smad mediated signalling in fibroblasts. 
 
1.5.4 TGF-β pathway associated molecules- The TGF-β superfamily is a family of 
pleiotrophic ligands and are subdivided into four major sub-classes: the bone morphogenetic 
proteins (BMPs), activins, NODAL and Growth and differentiation factors (GDFs) (Figure 
1.5b).  Activins are a homologous family of homodimers and heterodimers and one of the 
most widely studied members of the TGF- β superfamily. These molecules are known to play 
crucial roles in early embryonic development and maintenance of tissue homeostasis (Wu and 
Hill, 2009). An imbalance in their activity can potentially transform the cellular fate to a 
tumorigenic state (Oshimori and Fuchs, 2012). In this chapter, we shall however discuss only 
about activins, These dimeric proteins are linked to one another by a single disulphide bond 
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(Ying, 1987). Both activin A and B can be detected in blood and other biological fluids using 
ELISAs (Ludlow et al., 2009) and their expression is stimulated via proinflammatory and 
immunoregulatory pathways. The most common activin complexes identified till date are 
activin A, activin AB and activin B which differ in their dimer subunits as βA βA ,  βA βB  
and   βB βB respectively (Kingsley, 1994). Of all the forms, the first-identified and best 
studied family member is activin A. It was initially identified in ovary, and later from bone 
marrow cell culture (Brosh et al., 1995). The subunits of activin A and B are products of 
genes known as inhibin beta A (INHBA) and inhibin beta B (INHBB) respectively (Mason et 
al., 1986). 
 
Follistatin is an autocrine glycoprotein encoded by the FST gene. It is expressed in all tissues 
of higher animals as three known isoforms, FS-288, FS-300 and FS-315 (Tortoriello et al., 
2001) and is produced by the folliculostellate (FS) cells of the anterior pituitary 
(Gospodarowicz and Lau, 1989). Its expression can be detected in mid and late stages of 
embryogenesis (Roberts and Barth, 1994), ovary (Fleming et al., 1995), testis (Michel et al., 
1993), vascular smooth muscle cells (Inoue et al., 1995), liver (Kojima et al., 1995) and other 
tissues.  It plays the role of a cellular guard protecting the cells from uncontrolled 
proliferation and contributes towards tissue building and repair by inhibiting activin binding 
to type II receptors,  thereby abolishing the biological effects of activins (Nakamura et al., 
1990). Although it is a product of a single gene, two mRNA transcripts are produced due to 
alternative splicing, each encoding a 288 amino acid protein (FST 288) and 315 amino acid 
(FST 315) (Shimasaki et al., 1988). Both proteins clear activins by binding to them which 
initiates removal through the lysosomal degradation pathway (Hashimoto et al., 1997). 
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CD109 is a TGF-β binding protein and a member of the α2-macroglobulin family and is 
expressed as a cell surface antigen on normal hematopoietic cells and hematopoietic tumour 
cells (Sutherland et al., 1991, Murray et al., 1999). Although the significance of CD109 in the 
pathology of tumours remain unclear, its expression has been largely studied in tumour 
tissues including squamous cell carcinoma (SCCs) of oral cavity esophagus, lung, uterus, 
melanomas and soft tissue sarcomas (Hashimoto et al., 2004). These expression studies 
suggest that CD109 might be a cancer associated protein. However, it was also found to be a 
component of the TGF-β receptor system and abolishes TGF-β signalling in human 
keratinocytes (Finnson et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5b: Ligands and signalling molecules associated with TGF-β1 signalling family. 
 
1.5.5 TGF-β pathway associated processes – Although the signalling pathway is 
associated with numerous biological process, in this review our focus will remain in 
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describing endocytosis as a crucial regulator of TGF-β signalling. Endocytosis refers to the 
process by which cell surface associated molecules enter the cell without passing though 
membrane. In this process the plasma membrane invaginates to form a vesicle which contains 
the internalized cargo (Lodish H, 2000). In mammalian cells, the endocytic pathway consists 
of specialised compartments that internalise the molecules and either recycle them back to 
surface or sort them for degradation. These principal components are early endosomes (EE), 
late endosomes (LE) and Lysosomes (Figure 1.6). EE are the primary compartment where 
molecules such as ligands, receptors and viruses are engulfed into vesicles. Late endosomes 
receive the internalised material from EE, trans-Golgi network (TGN) and the phagosomes. 
Being acidic in nature and composed of numerous vesicles, the late endosomes primarily 
deliver the ingested material to lysosomes.  Lysosomes are the final component of the 
endocytic pathway. They are acidic in nature and are composed of large vacuoles containing 
hydrolases.  Endocytosis regulates cell signalling via four different mechanisms namely 
clathrin mediated, caveolae mediated, micropinocytosis and phagocytosis.  However, in this 
review we shall focus only on clathrin and caveolin mediated endocytosis. 
 
Clathrin mediated endocytosis is regulated by a complex of vesicles and pits that are found in 
in the plasma membrane. Clathrin proteins are known to be involved in two important 
processes. 1) Fluid phase endocytosis from membrane to endosomes and 2) Transportation 
from the trans golgi network to the endosomes. These pits can concentrate large molecules 
and endocytose ligands such as transferrin and low density lipoprotein. (Marsh and 
McMahon, 1999). Epidermal growth factor receptor (EGFR),  G-protein coupled receptors 
such as β2 adrenergic receptor and TGF-β undergo clathrin dependant endocytosis by direct 
interaction of their cytoplasmic domains with the clathrin adaptor protein complex AP2 
(Sorkin and von Zastrow, 2009, Yao et al., 2002).  
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Caveolae are flask shaped pits which act as scaffolding proteins within caveolar membranes 
of mammalian cells and are involved in processes such as lipid regulation, mechanosensing 
(Parton and Simons, 2007), endocytosis (Kirkham and Parton, 2005) and compartmentalising 
signalling molecules for membrane trafficking. The caveolins consist of three members: 
caveolin-1 (CAV1), caveolin-2 (CAV2), and caveolin-3 (CAV3) and display very little 
difference in their structure (Anderson, 1998). However, they all form hairpin loop like 
invaginations into the cell membrane. In these proteins, both the C-terminus and the N-
terminus face the cytoplasm of the cell. Caveolin-1 has two isoforms: caveolin-1A (CAV-1A) 
and caveolin-1B (CAV-1B). Occurrence of both CAV1 and CAV2 is predominant in 
endothelial, fibrous and adipose tissue whereas CAV3 is restricted to striated and smooth 
muscle cells. They are primarily synthesized as monomers and transported to the golgi 
apparatus. Subsequently, during the secretory phase when they associate with lipid rafts, they 
become oligomers to form the hairpin like structure to participate in vesicular transport.  
 
Several studies have shown that caveolins contribute towards the pathology of diseases such 
as cancer, vascular proliferative disease, cardiac hypertrophy, insulin signalling and diabetes, 
and muscular dystrophy. CAV1 has been shown to inhibit cellular proliferation suggesting 
that they may play a role in carcinogenesis (Razani et al., 2000).  Analysis of tumour tissue 
obtained from breast cancer patients showed that nearly 16% of these tumours harbour a 
dominant negative point mutation in the caveolin-1 gene (Hayashi et al., 2001).  Similarly 
reduced expression of caveolin-1 in proliferating vascular smooth muscle cells of atheroma 
suggests its expression is inversely correlated in human vasculature (Schwencke et al., 2005) 
and loss of caveolin-1 promotes changes such as epithelial to mesenchymal transition which 
further leads to tumourigenesis (Shivshankar et al., 2012). Interestingly, expression of 
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caveolin-1 is increased in prostate cancer and is expressed even further in metastatic prostrate 
cells (Yang et al., 1999) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6: Representation of the endocytosis pathway and components involved. 
 
1.6 Fluid flow mediated mechanotransduction in pathological 
conditions. 
 
Although it seems that developmental mechanisms try to maintain normal rhythms of fluid 
flow in vivo, in certain diseased conditions cellular mechanisms lose direction from their 
normal path and invoke pathological mechanisms. Blood velocity is highly variable and is 
largely reliant on cyclical contraction of the heart suggesting that except in smaller vessels, 
flow is never steady in vivo (Freund et al., 2012).  Whilst pulsatile contraction associated 
flow is considered as ‘healthy’ flow, the heart is also known to experience turbulent flows. In 
the heart, these turbulent flows in association with other chemical signals give rise to disease 
conditions such as atherosclerosis in adults (Hahn and Schwartz, 2009) and congenital heart 
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defects (Armstrong and Bischoff, 2004). Reversal of blood flow can also be observed in 
developing valves such as mitral valve, the valve between atrium and ventricle. In 
underdeveloped valves, due to diastolic and systolic contractions lead to blood flows out in a 
reverse direction from the ventricles to the atrium, a condition known as Ebstein’s anomaly 
(Safi et al., 2016). 
 
Tumours are known to have a highly developed vasculature with leaky and tortuous blood 
vessels that supply blood and oxygen to the developing cancer cells in a hypoxic 
microenvironment. Microcirculation of blood and interstitial fluid play and important role in 
tumour growth, metastasis and in the treatment of tumours.  These blood vessels lack the 
normal architecture of arteries, arterioles and capillaries (Konerding et al., 1999, Warren et 
al., 1978). Changes in pericytes in these blood vessels leads to changes in stability of the 
vessel which in turn results in changes in blood flow. Some vessels may not perfuse with 
blood, whereas other may experience chaotic blood flow along with reverse flow of blood 
(Baluk et al., 2005) as is observed in Ebstein’s anomaly. Recent studies have shown that viral 
cirrhotic primary liver cancer cells are characterised by hepatic fibrosis that is an outcome of 
disturbances in blood flow such as lobular vein obstruction, portal vein fistula and portal vein 
counter current (Liu et al., 2011). 
 
Numerous studies have shown that as well as changes in blood flow, disturbances in 
interstitial fluid flow also contributes to pathological manifestations such as cancer (Munson 
and Shieh, 2014), edema (Scallan J, 2010) and central nervous system associated diseases 
such as Alzheimer disease, multiple sclerosis (Weller, 1998). Tumours are known to display 
increased mechanical stiffness that exerts pressure on the surrounding tissue. Pressure 
differences between the tumour and the tissue leads to pressure gradients resulting in 
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development of interstitial fluid flow through the stroma (Butler et al., 1975). The first 
evidence of this fluid flow came from murine mammary tumours.  Edema is another 
pathological condition of faulty fluid flow that manifests itself as  excessive interstitial fluid 
accumulation either within the cells (cellular edema) or within interstitial spaces (interstitial 
edema) distributed within the stroma matrix across the microvascular walls (Dongaonkar et 
al., 2008, Reed et al., 2010). 
 
Extracellular fluid in the central nervous system (CNS) is made up cerebro spinal fluid (CSF) 
from the choroid plexus and interstitial fluid (IF) in the gray and white matter. Lymphatic 
drainage of interstitial fluid contributes to accumulation of prion proteins in the extracellular 
spaces of gray matter contributing to Alzheimer disease (AD) and Multiple Sclerosis (MS) 
(Weller, 1998). 
 
1.7 Fibroblasts in normal, diseased and healing tissues.  
 
The functions of fibroblasts include deposition of extracellular matrix, epithelial 
differentiation and regulation of inflammation in wound healing and other pathological 
processes that involve uncontrolled growth of cells (Tomasek et al., 2002, Parsonage et al., 
2005). Fibroblasts are considered as the main mediators of scar formation and fibrosis and are 
the primary sources of host derived VEGF (Fukumura et al., 1998), the key molecule 
responsible for angiogenesis in tumours. 
 
Fibroblasts can trans-differentiate into a specific type of fibroblast which forms part of the 
tumour stroma with expression of a contractile phenotype (Kalluri and Zeisberg, 2006). This 
process is known as Mesenchymal Mesenchymal Transition (MMT). These fibroblasts 
deposit high amounts of collagen and express α- smooth muscle actin upon stimulation with 
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TGF-β1 (Pellegrin and Mellor, 2007). Accumulation of α-SMA allows fibroblasts to generate 
increased contractile forces and it is considered a marker for myofibroblast cells. 
Myofibroblasts usually originate from residing fibroblasts, pericytes, smooth muscle cells 
from vasculature, mesenchymal stem cells or due to Epithelial Mesenchymal Transition 
(EMT)/Endothelial Mesenchymal Transition (EndoMT) and play a role in biological 
processes such as tissue regeneration and cancer progression. Studies have revealed that up to 
40% of the fibroblasts in tumours could be EndMT derived and that it plays a key role in 
angiogenic sprouting (Potenta et al., 2008). 
 
Studies conducted on fibroblasts isolated from healing wounds reveal that they secrete high 
levels of the extracellular matrix components and are highly proliferative in comparison to 
their counterparts in normal tissue (Rodemann and Muller, 1991). Such enhanced activity is 
defined as ‘activation’ (Castor et al., 1979). Activation of fibroblasts is associated with 
enhanced capillary density, collagen type 1A, α-smooth muscle actin, ED-A fibrin deposition 
and increased proliferation (Kohan et al., 2010, Hinz et al., 2001). Recently it was found that 
migrating epithelial cells in wound margins and deep epithelial ridges gain mesenchymal 
features like expression of vimentin. Elevated levels of EMT related genes were observed in 
hypertrophic scars and Tumour Necrosis Factor-α induced EMT in human skin by induction 
of BMP-2 (Yan et al., 2010). 
 
A number of studies have been conducted to assess the role of fibroblasts in tumours. Studies 
in chickens infected with Rous sarcoma virus have demonstrated that wounding leads to 
invasive carcinomas, thus establishing the tumour promoting role of activated stroma 
(Dolberg et al., 1985, Sieweke et al., 1990). Conditions such as wound healing and fibrosis 
share a requirement for tissue remodelling. In such conditions, quiescent fibroblasts undergo 
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activation to become myofibroblasts (Figure 1.7) as originally identified by Gabbiani et al. 
(1971) in the granulation tissue of healing wounds. These myofibroblasts acquire contractile 
stress fibres and express proteins such as collagen type I, ED-A splice variant of fibronectin 
and α- smooth muscle actin, proteins normally expressed in vascular smooth muscle cells and 
that Upon completion of wound healing, activated fibroblasts undergo a type of programmed 
cell death known as nemosis. Cancer associated fibroblasts (CAFs) share similarities with 
myofibroblasts, but they remain activated indefinitely and are not removed by nemosis 
(Dvorak, 1986). TGF-β1 regulates the levels of expression of activation associated proteins 
(Varga, 2002, Mori et al., 2003). 
 
TGF-β is a pleiotropic growth factor which plays a tumour supressing role in normal cells 
and a tumour promoting role in cancer cells by differentiating cells into an invasive 
phenotype (Massague, 2008). Of all the variants, TGF-β1 has received the most experimental 
attention for reasons that it is produced by macrophages, fibroblasts, keratinocytes and 
platelets (Eppley et al., 2004, Lee and Eun, 1999, Mani et al., 2002). It plays a role in 
inflammation, angiogenesis, reepithelialisation and connective tissue regeneration during 
wound healing (Kopecki et al., 2007, Kane et al., 1991). This growth factor is chemotactic for 
fibroblasts, keratinocytes and inflammatory cells. Each isoform performs specific roles in 
wound healing and cancer (Schrementi et al., 2008). Furthermore, it promotes inflammatory 
cell recruitment (Moses et al., 1990) and regulates hypertrophic scarring (Russell et al., 
1988). Recent studies revealed that SMA-positive, myofibroblastic stroma is the strongest 
predictor of oral squamous cell carcinoma mortality and αvβ6-dependent TGF-β1 activation 
mediates myofibroblast trans-differentiation (Marsh et al., 2011). TGF-β1 mediates Epithelial 
Mesenchymal Transition (EMT) of breast cancer cells to cancer associated fibroblasts 
(CAFs) by paracrine signalling (Yu et al., 2014).  
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Figure 1.7: Fate of TGF-β stimulated myofibroblasts. 
 
Cancer associated fibroblasts (CAF’s) are myofibroblasts which form a crucial part of the 
tumour’s stromal compartment and are more potent in promoting tumour growth when 
compared to those obtained from normal tissue. This property came to light when researchers 
studied the growth rate of tumours injected with CAFs and those injected with normal 
fibroblasts in xenografts. The group found that growth rate was significantly higher in those 
which were injected with CAFs (Orimo et al., 2005, Ostman, 2004). Subsequent studies from 
our laboratory also showed that senescent cancer associated fibroblasts develop a unique 
phenotype known as senescence associate secretory phenotype (SASP) which contributes to 
cancer progression via a novel miRNA/ PTEN regulated pathway (Kabir et al., 2016). 
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Studies on humans and 4NQO- induced rat tongue carcinogenesis revealed the presence of 
myofibroblasts in highly malignant tissues while they were absent in precancerous tissue 
(Vered et al., 2009). Subsequently, pathological studies have revealed the presence of stromal 
CAFs is an indicator of poor prognosis of all stages of oral squamous cell carcinoma (Bello et 
al., 2011, Vered et al., 2010). In vitro studies revealed that TGF-β1 released by OSCC’s was 
responsible for the trans-differentiation of normal fibroblasts to CAF’s. The CAF’s secrete 
high levels of growth factors that enhance proliferation in OSCC’s (Kellermann et al., 2008). 
 
Recently, studies were conducted to analyse a series of matched CAF’s and normal 
fibroblasts for expression of activation markers (α-SMA, SDF-1, FAP, vimentin and 
cytokeratin). CAFs showed significantly higher α-SMA protein levels, and mRNA levels of 
α-SMA, SDF1, and FAP. Furthermore, co-cultures of CAFs and normal fibroblasts induced 
expression of EMT markers like vimentin, fibronectin and enhanced invasion of SCC9 cells 
(Zhou et al., 2014). 
 
1.8 Parallels between Skin and Oral mucosa. 
 
Based on morphology and differentiation patterns epithelial tissues are broadly classified into 
three classes: keratinising (cornified) stratified squamous epithelium, non-keratinising 
stratified epithelium and non –stratified epithelium (Eurell JA, 2006). A critical aspect of 
stratified keratinising epithelium is that cells undergo a terminal differentiation programme 
which results in formation of a mechanically tough surface of cells known as corneocytes. 
These corneocytes are filled with keratin filaments and are devoid of nuclei and cellular 
organelles. 
55 | P a g e  
 
 
Keratinocytes are the most abundantly occurring cells in the epithelium. They are tightly 
connected to each by desmosomes in an organised matrix containing Langerhans cells, 
melanocytes, Merkel cells, fibroblasts, extracellular matrix proteins like collagen (type I and 
III). The epidermis is sub-divided into four layers; Stratum Corneum, Stratum granulosum, 
Stratum spinosum, and stratum basale (McGrath, 2004). During normal tissue turnover, 
keratinocytes which proliferate in the stratum basale migrate and differentiate to form the 
stratum corneum. Figure 1.7 illustrates the various layers of the epidermis in skin mucosa and 
their counterpart in oral mucosa. Apart from the presence of four layers as observed in 
epidermis, oral mucosa also consists of a lamina propria and a sub mucosal layer which is 
attached to muscle or bone.  The submucosal layer is the deepest layer containing fibroblasts, 
mast cells and adipocytes. Functions of this layer include maintenance of thermoregulation, 
protection from injury and provision of nutrients. 
 
Oral epithelium could either be keratinised or non-keratinised based on the location. This site 
specific keratinisation is largely dependent on the functions performed by different parts of 
the mouth (Squier and Kremer, 2001). Other difference between both mucosa include 
presence of sweat glands, hair follicles in the skin which are absent in the oral mucosa. 
 
Although both mucosa have similar ECM composition, non-keratinised oral mucosa has a 
loose ECM structure with presence of elastin which mediates expression of keratins and its 
variants (Hsieh et al., 2010). Overall, oral and dermal mucosa differs very little in their 
architecture, inflammatory molecule production, blood vessel density, cell–cell interactions 
and extracellular components. 
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Although healing mechanisms are similar in skin and oral mucosa, mechanisms leading to 
faster wound healing in oral mucosa remain a challenge to understand fully. Many research 
groups have vested efforts in studying the cause and effect relationship of this variance in 
both mucosa. Some studies report that one of the key factors which contribute to faster 
wound healing is saliva (Veerman et al., 2011). Reports show that the humid environment 
created by the saliva improves survival and functioning of inflammatory molecules that 
contribute to wound healing (Dawes et al., 2015). Further, saliva contains proteins which 
accelerate blood clotting and epidermal growth factor which promotes proliferation of 
epithelial cells (Nagy, 2003).  The tissue degrading activity of enzymes such as elastase and 
trypsin is neutralised by secretory leucocyte protease inhibitor and its absence delays wound 
healing (Brand and Veerman, 2013). 
 
Under normal conditions similar numbers of blood vessels exist in dermal and oral tissue. 
However, Wong et al (2009) compared wound healing in pig’s oral mucosa to similar 
experimental wounds created in human subjects. Significantly higher numbers of blood 
vessels in skin than oral tissue, although number of blood vessels increased in both tissues 
were observed. Their results concluded wound healing in oral mucosa results in reduced scar 
formation as compared with skin (Wong et al., 2009). 
 
Another study revealed that under normal conditions there were no differences in VEGF 
levels in both oral and dermal mucosa. However, in wounded conditions, oral wounds 
expressed lower levels of VEGF than their dermal equivalents (Szpaderska et al., 2005). 
These results complement previous research which showed similar numbers of blood vessels 
in both tissues. Nevertheless, in wounded conditions, skin tissue exhibited more blood vessels 
(Mak et al., 2009). 
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Oral and dermal keratinocytes display differences in their responses to inflammatory stimuli 
which may influence the rate of wound healing. Human oral keratinocytes produce a rapid 
increase and enhanced expression of IL-6 in response to tumour necrosis factor (TNF)-α, 
interferon (IFN)-γ, or IL-4 (Li et al., 1996). 
 
Oral wounds in mice reepithelialise and close within 24 hrs of wounding whereas dermal 
wounds tend to close after 60 hours to 7 days post wounding (Szpaderska et al., 2003). 
Unlike dermal mucosa, different regions of the oral cavity heal in a different manner. 
Incisions in the buccal mucosa result in scars whereas gingival grafting heals without scars 
(Larjava et al., 2011). Numerous molecular alterations are observed in oral versus dermal 
wound healing (Table 1.2). 
 
Studies of differences between extracellular matrix components in oral and dermal mucosa 
reveal similar collagen fibril diameter in normal and wounded oral tissue. Nevertheless, in 
wounded dermal tissue collagen fibres were thinner in diameter (Schrementi et al., 2008). 
During wounded conditions in pigs, the number of cells expressing pro collagen I was 
significantly increased in oral wounds than in skin wounds (Wong et al., 2009).  
 
The fibroblast compartment significantly differs in normal and wounded conditions in oral 
and dermal mucosa. Lee and Eun provided initial evidences of differences between 
fibroblasts of oral and dermal origin (Lee and Eun, 1999).  They showed that oral fibroblasts 
proliferate at a higher rate than dermal cells. Whilst dermal fibroblasts in a collagen gel had a 
greater contraction potential than their oral counterparts, oral fibroblasts contracted earlier 
than the dermal ones. Studies also reported that wound healing with minimal scar formation 
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may be an outcome of increased matrix metalloproteinase-3 production by oral fibroblasts 
(McKeown et al., 2007). Transforming growth factor- β1 (TGF-β1) is one of the most studied 
growth factor in relation to wound healing. It is secreted by the platelets during the initial 
phases after wounding and acts as a chemo attractant for leukocytes and parenchymatous 
cells. Although there were no changes in basal collagen synthesis, when fibroblasts from both 
dermal and oral origin were stimulated by TGF-β1, oral fibroblasts started synthesizing more 
collagen than the dermal ones. Subsequent findings confirmed that oral fibroblasts displayed 
accelerated collagen production (Shannon et al., 2006). It was also shown that oral fibroblasts 
expressed significantly high levels of epithelial growth factors such as keratinocyte growth 
factor (KGF) and hepatocyte growth factor/scatter factor (HGF) and surprisingly low levels 
of Alpha smooth muscle actin.  
 
Alpha smooth muscle actin (α-SMA) is used as a marker for myofibroblast identification and 
is abundantly incorporated into actin stress fibres of fibroblasts under stress conditions and 
contributes towards increased contractile force. Transforming growth factor-beta 1 induces 
alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent 
and growing cultured fibroblasts (Gabbiani et al., 1971).  Interestingly, another study showed 
that oral fibroblasts express more α-SMA than dermal equivalents. Paradoxically, TGF-β1 
stimulated oral fibroblasts to express lower levels of α-SMA than dermal fibroblasts (Lygoe 
et al., 2007). 
Wounds of the oral cavity are known to display healing with little or minimal scarring. When 
gingival and dermal fibroblasts were induced to express a wound healing transcriptome in 3D 
cultures, gingival fibroblasts expressed high levels of inflammatory molecules and genes 
related to ECM remodelling whereas dermal fibroblasts expressed high levels of TGF-β 
signalling related molecules and contractility related genes. These findings suggested that 
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increased expression of  ECM remodelling associated genes inherent to the phenotype of oral 
fibroblasts contributed to faster scar free healing of oral wounds (Mah et al., 2014). 
Subsequently, a comparison of the gene profile of oral & dermal fibroblasts and induced 
pluripotent stem cells using microarray and in silico data analysis revealed that senescence-
related genes in the p53 pathway are inactive in human oral fibroblasts (hOFs) (Miyoshi et 
al., 2015).  
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 Normal  tissue Wounded tissue 
 Oral Dermal Oral Dermal 
Blood Vessels     
Interleukin -6 (in response to 
tumor necrosis factor (TNF)-α, 
interferon (IFN)-γ, or IL-4). 
 ND  
 
ND 
Reepithelialise and closure (in 
mice) 
ND ND 24hrs 60 hours – 
7 days 
Vascular Endothelial growth 
factor (VEGF) 
    
 
Collagen fibril diameter  
 
ND ND  thinner in 
diameter 
Pro collagen I (in pigs ) ND ND ND   
ND 
Transforming growth factor - β1 
(TGF-β1) 
ND ND ND  ND 
Transforming growth factor - β1 
(TGF-β1) mediated proliferation 
in fibroblasts  
ND ND ND  ND  
Alpha – Smooth Muscle Actin (α-
SMA) 
 
ND 
ND ND ND 
TGF-β1 stimulated oral 
fibroblasts 
ND ND ND  ND 
CC-chemokine ligand (CCL) 5, 
CCL12 and CXC chemokine 
ligand (CXCL) 10 (mouse) 
ND ND Present in 
tongue 
ND 
CCL3, CCL20, CXCL3, CXCL7 
and CXCL13 (mouse) 
ND ND ND Present 
 
Table 1.2: Molecular differences between oral and dermal mucosa in normal and wounded conditions. ↑, 
increased in oral tissue/wounds compared with dermal; ↓, decreased in oral tissue/wounds compared with 
dermal; =, equal between oral and dermal tissue/wounds. (Glim et al., 2013). ‘ND’ represents not defined. 
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Figure 1.8: Skin and oral mucosa histology. The epidermis and oral epithelium consist of keratinocytes and a 
few Langerhans cells. Dermis and lamina propria are separated by a basal lamina followed by the subcutaneous 
layer. 
 
 
1.9 Immune response in oral and dermal wounds  
 
During wound healing, an inflammatory response is essential as its rapid resolution aids the 
repair process. In order to determine role of inflammatory molecules, Szpaderska AM et al 
(2003) compared the inflammatory cell infiltrate and cytokine production in oral and skin 
wounds. Significantly lower levels of macrophage, neutrophil, and T-cell infiltration were 
observed in oral wounds than their dermal counterparts. RT-PCR analysis revealed 
significantly lower IL-6 levels in oral wounds compared to skin wounds. Similarly, levels of 
the pro-fibrotic cytokine TGF-β1 were lower in oral wounds than in skin wounds. Anti-
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inflammatory cytokines like IL-10 and the TGF- β1 modulators did not vary significantly 
(Szpaderska et al., 2003). Another study in mice revealed that IL-6 or IL-1 receptor 
antagonist deficiency causes a delay in wound healing (Ishida et al., 2006). IL-1 receptor 
deficiency delays the wound healing rate in oral wounds but not in dermal wounds (Graves et 
al., 2001). The effect appeared to be due to limited clearance of infection as administration of 
antibiotics reversed the wound healing rate. 
 
Chemokines, CC-chemokine ligand (CCL) 5, CCL12 and CXC chemokine ligand (CXCL) 10 
appear in mouse tongue wounds whereas CCL3, CCL20, CXCL3, CXCL7 and CXCL13 are 
present only in dermal wounds (Chen et al., 2010). Functional analysis of these chemokines 
indicates that oral wounds express chemokines chemotactic for monocytes and dermal 
wounds mainly express neutrophil attracting chemokines. Mast cells are bone marrow 
derived immune cells found mainly in the perivascular spaces within skin. These are 
stimulated following tissue injury and degranulate releasing inflammatory agents such as 
histamine, proteases, prostaglandins, leukotrienes, inflammatory mediators (such as IL-1, 
Transforming growth factor–α) and growth factors (TGF-β1, platelet derived growth factor 
[PDGF]).  
 
Neutrophils are some of the first immune cells which infiltrate the site of injury. In one study, 
a research group injected mice with antigen ovalbumin (OVA) and made a thoracic incision. 
This resulted in minimal recruitment of neutrophils, mast cells and lymphocytes to lesion. 
Further, the OVA tolerant mice showed diminished scarring and normal extracellular matrix 
deposition (Costa et al., 2011). Another study in mice showed presence of lower numbers of 
neutrophils in oral wounds than in dermal ones (Szpaderska et al., 2003).  These findings 
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suggest that a reduced number of neutrophils could be responsible for reduced scar formation 
in oral wounds. 
 
Macrophages are another group of immune cells which respond to tissue injury. These cells 
produce high amounts of pro inflammatory cytokines and mediate anti-microbial activity. 
These can be classified into M1 or M2 phenotypes (Mosser and Edwards, 2008). M1 
macrophages are the first ones to respond to injury. M2 macrophages are crucial for tissue 
restoration and express extracellular matrix molecules (ECM) like fibronectin and tenascin –
C (TN-C) suggesting that they are involved in ECM deposition and tissue remodelling in the 
later phase of tissue repair (Deonarine et al., 2007). In an experiment where activated 
macrophages were co cultured with a fibroblast cell line, M2 macrophages induce fibroblast 
proliferation and collagen production. On the contrary M1 macrophages reduced collagen 
production (Song et al., 2000). In other studies reduced numbers of macrophages were found 
in mouse and pig oral wounds compared to their dermal counterparts (Szpaderska et al., 
2003, Mak et al., 2009). These studies strengthen our understanding that macrophages are 
essential for proper repair. However the presence of lower numbers in oral wounds makes us 
to contemplate whether a smaller number of these cells promote wound healing and greater 
numbers promote scarring. Further studies need to be pursued to explore this in dermal and 
oral wounds. 
 
T-cells play a role in tissue remodelling and potentially increase collagen synthesis and 
induce α-SMA in dermal fibroblasts. They are found in epidermis and produce the growth 
factor, Insulin like growth factor -1 (IGF-1) (Toulon et al., 2009) to support keratinocyte 
survival and proliferation.  These experimental findings indicate that reduced inflammation 
could contribute to scarless and accelerated healing of oral mucosa. 
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A question now emerges whether wound healing is similar to cancer. Tumours could develop 
at sites of chronic wounds or untreated mouth ulcers (Dunham, 1972). Liver inflammation 
due to Helicobacter pylori infection, cirrhosis or hepatitis could lead to cancer (Ruggiero, 
2010). Such associations and comparison of histological sections of healing wounds and 
tumour sections has led to a hypothesis that cancer are wounds that do not heal (Dvorak, 
1986, Byun and Gardner, 2013).  
 
1.10 Overview of the bioreactor technology. 
 
A bioreactor is defined as an engineered apparatus which supports live cell culture in a 
biologically active environment. There are numerous types of bioreactor available on the 
market, with the majority of them providing media transport and additional benefits for the 
tissues and cells cultured in them. In bioreactors which display medium movement, a 
resultant force is applied to the cells due to the movement of fluid over the surface. These 
bioreactors are engineered such that they provide all the optimal conditions to emulate the in 
vivo environment that the cells would normally be exposed to. Bioreactors are broadly 
divided into five main categories i) spinner flask, ii) rotating wall, iii) compression, iv) strain, 
v) hydrostatic pressure and vi) flow perfusion (Plunkett and O'Brien, 2011). Each of these 
bioreactors differ in their mass transfer characteristics and the physical environment to which 
cells are exposed. Spinner flask bioreactors are used in applications which require high mass 
transport, high shear and a turbulent environment whereas rotating wall bioreactors are used 
in applications which require high mass transport and a low shear environment (Oragui et al., 
2011). These bioreactors have limited applications as it cannot be used for differentiating 
cells into a particular tissue type. Compression bioreactors are used in cartilage engineering 
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since they are designed such that both static and dynamic loading can be applied (Shahin and 
Doran, 2015). Tensile strain bioreactors are used to engineer numerous types of tissues. They 
are designed in a similar way to compression bioreactors, only differing in the way the force 
is transferred to the construct (Goodhart et al., 2014). Hydrostatic pressure bioreactors are 
used in applications which require application of a mechanical stimulus to cell-seeded 
constructs (Elder and Athanasiou, 2009). Scaffolds are cultured in static conditions and then 
moved to a hydrostatic chamber for loading purposes. 
 
Flow perfusion bioreactors are considered as the best bioreactor for fluid transport. The 
bioreactor consists of a pump and a scaffold chamber joined together by tubing. A fluid pump 
forces media to flow through the cell-seeded scaffold. Cells seeded in scaffolds or coverslips 
are placed in chambers that are designed to direct flow through the interior of the scaffold, 
thus enhancing fluid transport. The earliest example of a flow bioreactor is the 1951 Hu 
‘perfusion chamber’. Experiments involved studying the effect of radioactive isotope 
phosphorous 32 in epidermal cells that were cultured on coverslips (Everett et al., 1951). 
Media in these bioreactors is continuously pumped through the chambers in which the cells 
are placed. These bioreactors are often combined as part of a microfluidic device where 
multiple chambers are connected in series. Hence they serve as an excellent tool to study and 
model multiple tissue types in a combined culture and represent good in vitro models. 
However, the small scale and size of these bioreactors result in limitations for clinical 
applications.  
 
Recent studies using flow bioreactors revealed the positive effect of flow in proliferation of 
mesenchymal stem cells (MSCs) grown in bioreactors compared to those cells grown in static 
cultures. When cells were treated with osteogenic media, cellular mineralisation was 
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observed in the bioreactor (Zeng et al., 2006). Another interesting study pursued by Kim and 
Ma (2012) compared the expansion of MSC’s in a flow bioreactor and in a perfusion 
bioreactor. Cells were expanded in both the bioreactors types for 7 days and then treated with 
osteogenic media for another 7 days at a flow rate of 0.2ml/min. The study suggested that 
cells cultured in the flow bioreactor were found to be in at an earlier differentiation stage than 
cells cultured in the perfusion bioreactor due the reduced shear stress under flow (Kim and 
Ma, 2012). 
 
Overall the bioreactor technology exposes cells to two key processes, i) mass transport of 
media and ii) fluid shear forces. Fluid shear forces play a critical role in modulating the 
response of cells to their environment. 
 
In endothelial cells, laminar flow directly up regulates intercellular adhesion molecule 1 
(ICAM-1) expression on cell surface and enhances leucocyte adhesion (Nagel et al., 1994). 
Other studies suggest a role for shear stress in vascular remodelling and arterial tone. In 
bovine aortic endothelial cells shear stress induces conformational activation of αvβ3 integrin 
resulting in increased binding of cells to its extracellular matrix proteins, transient 
inactivation of Rho and cytoskeletal alignment in the direction of flow (Tzima et al., 2001). 
Recent studies reveal the role of fluid shear stress in modulating mechanical tension by 
PECAM-1 initiated signalling (Conway et al., 2013). In Glioma cells fluid shear stress 
regulates the invasive potential via modulation of migratory activity and matrix 
metalloproteinase expression (Qazi et al., 2011). 
 
In the current study, efforts were to study the response of cells in a physiologically relevant 
flow perfusion environment where cells are constantly exposed to chemical signals and fluid 
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signals arising due to movement of blood, tissue fluid etc. Since the primary objective of the 
project was to assess if perfusion flow could induce differentiation in fibroblasts. Other 
bioreactors such as spinner flask bioreactor, tensile strain bioreactor and compression 
bioreactors have limited applications as described above and hence cannot be used for 
studying cellular differentiation. Therefore, in this study the Quasi vivo ® bioreactor system 
(Figure 2.1) originally developed by Dr Ahluwalia et al. at the University of Pisa and 
commercialised by Kirkstall ltd. was used. The basic design is of a flow perfusion bioreactor. 
It was adapted from a fully contained Poly-dimethyl-siloxane (PDMS) unit which housed the 
chambers to a modular system of interconnecting loops which can be setup in a user specific 
manner (Mazzei et al., 2008). The original design was used for high throughput drug 
screening and consisted of a simple PDMS circuit with chambers that held different cell 
types. The design features ensure incorporation of laminar flow at a definable level of shear 
stress and this was validated with finite element modelling (Mazzei et al., 2008). 
 
In the first experiments with Quasi Vivo® bioreactor, primary murine hepatocytes and human 
umbilical vein endothelial cells were cultured in separate chambers and connected in series. It 
was observed that there was no reduction in hepatocyte viability whilst they were cultured in 
the bio-reactor. The hepatocytes cultured in series with HUVEC’s produced higher levels of 
albumin and urea in comparison to the hepatocytes grown on their own. When the researchers 
normalised the differences in media volume between both conditions, a 60 fold increase in 
albumin production compared to static culture was observed. These results prompted the 
authors to conclude that the bio-reactor and the fluid shear stress induced in the bio-reactor 
provides an improved cell culture environment (Vozzi et al., 2009). 
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In 2009 the bio-reactor was re-designed to provide a modular system for cell culture. Before 
being manufactured the system was modelled for fluid dynamics for shear stress, turbulence 
and oxygen diffusion using hepatocytes. Shear stress is a physiological state where the stress 
is parallel to cells or tissues. Maximum wall shear stress for chambers with a 13mm diameter, 
3mm distance from the top to the reactor and 1mm fluid outlets with a variable distance “h” 
between tubes and base at maximal flow rate was calculated as 10-5 Pa (Vinci et al., 2011). 
The design produced optimal fluid dynamic parameters and a turbulence free flow of 500 
µL/min. Primary rat hepatocytes were tested in this model and the results indicated that there 
was no difference in albumin production between static and bio-reactor grown cells. In 
another study where adipocytes were cultured with HepG2 cells, a significant increase in 
albumin production, glucose consumption and free fatty acid uptake was observed in cells 
under flow (Vinci et al., 2010).  
 
Since 2010 there has been activity in the application of the Quasi Vivo ® bio-reactor to a 
number of cell types and further characterisation of the effect on cells in comparison to a 
static culture. In recent drug toxicity studies rat hepatocytes and glioblastoma cells were 
exposed to Diclofenac. Results showed that flow improved toxicity screening, with reduction 
in concentration of drug causing toxicity suggesting that concentration of drug administered  
in vivo was 10.2x greater (A.Ahluwalia 2011). Vinci et al. (2011) used the modular bio-
reactor for primary human hepatocyte culture. The result confirmed previous studies showing 
that medium flow stimulates expression and activity of detoxification genes in hepatocytes 
(Vinci et al., 2011). 
From the body of documented research using the Kirkstall system benefits of the system over 
static culture is evident. For these reasons, we suggest that the Quasi vivo® provides an ideal 
platform to study cell-cell communication studies under medium flow conditions. 
69 | P a g e  
 
1.11: Hypothesis 
 
The tissue dynamics of healing wounds and growing tumors differ from normal tissue where 
cells such as fibroblasts experience a highly dynamic mechanical environment with increased 
matrix stiffness and changes in chemical signaling.  Whilst the primary inducer of fibroblast-
to-myofibroblast differentiation is Transforming growth factor β1 (TGF-β1) (Desmouliere et 
al., 1993, Evans et al., 2003), it is likely that fibroblasts may respond differently to TGF-β1 
under the influence of fluid flow.  
We hypothesize that fibroblasts from different tissue origin may be activated by 
physiologically relevant interstitial fluid flow like signals (Mazzei et al., 2008, Chary and 
Jain, 1989) and that their response may be modulated differently in the presence of chemical 
signals such as TGF-β1 and other signaling molecules of the TGF-β pathway. 
 
1.12: Aims of the project 
 
We aimed to study the effect of low levels of fluid movement to model interstitial fluid flow 
and chemical signals such as TGF-β1 on normal fibroblasts obtained from different tissue 
origin. 
Specific objectives of project are  
To study changes in global gene expression profile of normal fibroblast subjected to 
fluid flow treatment and compare changes with those treated in static conditions. 
Examine the effect of flow on responsiveness of fibroblasts to TGF-β1by studying the 
expression of fibroblast activation markers in normal fibroblasts. 
Study the effect of fluid movement on fibroblast associated signalling mechanisms in 
both normal and TGF-β1 stimulated conditions. 
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We propose that an in-depth analysis of signaling mechanisms involved in fibroblast 
differentiation in a physiologically relevant environment that supports both mechanical 
signals such as interstitial fluid flow and chemical signals such as TGF-β1 may help towards 
gaining a better understanding of fibroblast behavior in tissues of different origin. Our project 
will add significantly to the literature on mechanotransduction biology of fibroblasts and will 
help towards isolating novel molecules which may be targeted for designing anti-fibrotic 
therapeutics. Further, there is also a potential to identify key genes which may be of use to 
indicate the effectiveness of skin and oral pharmaceutical agents. 
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Chapter 2-Materials and Methods 
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2.1: Cell culture. 
 
Primary human oral fibroblasts, human dermal fibroblasts and human endothelial cells were 
routinely cultured as described below. 
2.2: Fibroblasts. 
 
Normal oral fibroblasts (NOF-320) were obtained from ethically approved waste tissues 
produced during oral surgical procedures undertaken at the School of Clinical Dentistry, 
Charles Clifford Dental Hospital, Sheffield, UK. Normal human dermal fibroblasts (NHDFC) 
were purchased from Promocell. Fibroblasts from both oral and dermal sources were cultured 
in DMEM (Life Technologies) supplemented with 10% (v/v) foetal calf serum (FCS) (Sigma) 
and 2.5 mg/L of both penicillin and streptomycin (Sigma). For all experimental purposes, 
cells at passage numbers ranging from 3 to 5 were used. This study is approved by the 
University of Sheffield Ethics committee (Ref: 07/H1309/105).  
 
2.3: Quasi-Vivo® bioreactor set-up. 
 
The Quasi-Vivo® bioreactor (Figure 2.1) is composed of chambers of poly-dimethyl-siloxane 
(PDMS), a biocompatible silicone polymer interconnected in a series. External dimensions of 
Quasi-Vivo® chambers are 23 mm in height and 37 mm in diameter. Internal volume of each 
chamber is 2 ml and accommodates 12 mm diameter cover slips. The chambers are connected 
to a pump (Parker) which circulates media through the chambers. The inlet and outlet tubes 
of the series are connected to a reservoir bottle which contains minimal media (DMEM 
containing 0.5% (v/v) FCS). 
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Figure 2.1: The Quasi-vivo® bioreactor set-up.  
 
 
 
 
 
 
 
 
 
 
Figure 2.2:  Schematic diagram of Quasi-vivo® set up. Red arrows indicate direction of medium flow. Black 
arrows indicate parts of the set up. 
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2.4: Preparing the system for use. 
 
The initial set up involves connecting the chambers to connectors, manifold tubing and 
reservoir bottle as per configuration (Figure 2.2). To ensure consistency, inlet tubing was 
connected with female connectors and outlet tubing with male connectors. The reservoir 
bottle has three tubes connected to it, the longest tube being the outlet; while the shorter inlet 
tube brings in medium from last chamber of loop and finally the shortest tube is connected to 
a 0.2µm filter which permits gas exchange. The entire set-up is connected under aseptic 
conditions in a laminar hood. The connected system is then sterilised and prepared for use. 
 
2.5: Disinfecting the Quasi-Vivo® bioreactor. 
 
The chambers were disinfected by treatment with 70% ethanol for 20 mins, PBS for 20 mins 
and 0.5% serum containing medium for 20 mins. At the end of an experimental run, the 
chambers were first washed with PBS for 20 mins before sterilising. 
 
2.6: Opening and closing the chamber.  
 
The chambers were opened by gripping the bottom of the chamber between three fingers, and 
twisting the top of the chamber in an anti-clockwise direction and lifting the top. Chambers 
were closed by pushing the top chamber onto the bottom and twisting the top in a clockwise 
direction. 
 
2.7: Determining optimal flow rate. 
 
The system was calibrated by running sterile PBS at various pump settings and collecting the 
liquid output from the final chamber for a period of 1 minute. The volume of liquid collected 
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at each speed setting was measured and noted. The whole procedure was repeated three times 
and mean value was determined. Previous studies in our laboratory revealed that primary 
fibroblasts are resilient to flow rates from 10 – 150 µL/min. Hence in all our experiments, we 
used a flow rate of 150 µL/min for primary fibroblasts from both oral and dermal sources. 
 
 2.8: Treatment of coverslips. 
 
Cells were plated on two types of cover slips (plain glass or on collagen coated Thermonox 
cover slips) depending upon experimental needs. Glass cover slips were placed in 24-well 
plates and sterilised with 70% ethanol prior to plating of cells. Sterile Thermonox cover slips 
were pre-treated with collagen coating (1:10 dilution; rat tail type I) for a minimum of an 
hour in 37ºC incubator in 5% CO2.  
 
2.9: Treating fibroblasts with fluid flow in the Quasi-Vivo® 
bioreactor. 
 
Primary fibroblasts (55,000 cells/well) from both dermal and oral origin were counted and 
plated on six cover slips (plain glass or on collagen coated Thermonox cover slips) and 
allowed to attach in 37ºC incubator in 5% CO2 for 48 h. Cover slips with cells were 
transferred carefully into three Quasi-vivo® chambers and 1 ml of minimal media (0.5% 
serum containing DMEM) was added into each chamber to ensure that cells remain hydrated 
until all the chambers are filled with the circulating medium. 12 mls of media was added into 
the reservoir bottle and the entire loop was connected to the pump which circulated minimal 
medium (0.1% FBS containing DMEM) at flow rate of 150µL/min. Cover slips placed in 
petridishes and treated with minimal media were used as static controls.  
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2.10: Stimulation of fibroblasts with TGF-β1. 
 
Cells on cover slips were stimulated with 10ng/ml TGF-β1 (Human recombinant TGF-β1, 
R&D Systems) in 0.5% fetal bovine serum containing media. Static cultures were incubated 
with 0.5ml /well of TGF-β1 containing media. Cells subjected to flow were circulated with 
18 ml of TGF-β1 containing media. The plates and bioreactor were returned to 37ºC 
incubator in 5% CO2 for 24 hrs. Controls were treated with 0.5% fetal bovine serum 
containing DMEM media.  Microarray based studies were pursued on dermal fibroblasts 
treated in static conditions and under flow in the absence of supplemented TGF-β1.  
 
2.11: Preparation of conditioned medium. 
 
Dermal fibroblasts (55,000 cells/well) were seeded on coverslips placed in a 24 well plate. 
After incubation for 48h., they were subjected to fluid flow (150µl/min) for 24h. Cells were 
also treated in static conditions for experimental controls. Medium that was conditioned on 
dermal fibroblasts that were subjected to fluid flow treatment and static conditions for 24h. 
was collected and concentrated by 5 times its total volume in centrifugal filter units (Amicon) 
by centrifugation for 20 mins at 1000 rpm. The concentrated conditioned medium was then 
used for study purposes. 
 
2.12: Staining dermal fibroblasts for detecting α – smooth muscle 
actin (α-SMA) expression. 
Static and flow treated (150µl/min) cover slips were removed from the chambers of 
bioreactor and placed in a 24-well plate along with the controls. Medium from the cells were 
removed and cells were washed twice with PBS. Cells were then washed with 0.5ml of 4 mM 
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sodium deoxycholate in PBS once and permeabilised in the same solution for 10 minutes. 
The cover slips were then blocked in 2.5% Bovine Serum albumin (BSA) in PBS for 30 
minutes at room temperature followed by incubation with 0.2ml of FITC conjugated anti-
alpha smooth muscle actin (α-SMA) antibody (Sigma, Clone1A.4, 1:100 dilution) for one 
hour at 37ºC. Cells treated with 2.5% BSA were used as a control. Cover slips were then 
washed twice with PBS and then mounted in DAPI containing antifade reagent (Sigma) and 
viewed under Plan Neofluar 100X magnification lens with numerical aperture 1.30 (oil 
immersion) in a fluorescent microscope (Zeiss Axiovert 200). Images were captured with 
Image proplus software, Version 7.0.1. 
 
2.13: Quantification of cellular fluorescence by Image J. 
Images of cells captured by imaging software Image proplus 7.0.1 were loaded on to Image J 
software and the fluorescence density of each image was determined. A total of three images 
were analysed for every condition and corrected total cell fluorescence (CTCF) was 
calculated in accordance with the following formula (McCloy et al., 2014). 
 
CTCF= Integrated density - (selected area * mean florescence of background readings) 
 
2.14: Immunoflorescence analysis of dermal fibroblasts under 
flow. 
Static and flow treated (150µl/min) cover slips were removed from the chambers of 
bioreactor and placed in a 24-well plate along with the controls. Cells were washed with 1X 
PBS and fixed cells in 4% paraformaldehyde for 15 mins at room temperature. Coverslips 
were permeabilized in 0.5% Triton-X 100 for 15 mins. Coverslips were then blocked in 1% 
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BSA in PBS overnight at 40C and incubated with various primary antibodies (Table 2.1). 
Primary antibodies were detected by FITC conjugated secondary antibodies and slides were 
mounted DAPI containing antifade reagent (Sigma) and viewed under 100X magnification 
lens (oil immersion) in a fluorescent microscope. (Zeiss Axioplan2, Imaging software proplus 
7.0.1).  
Antigen Manufacturer Application 
Monoclonal anti-actin, α-smooth muscle - FITC (αSMA) 
antibody produced in mouse (clone 1A4, F3777) 
Sigma-Aldrich 1:100 for IF 
Rabbit polyclonal anti-caveolin-1 (ab 2910) Abcam 1:100 for IF 
Rabbit monoclonal anti-Smad3 phospho S423 + S425 antibody 
(ab52903) 
Abcam 1:100 for IF, 
1:1000 for WB 
Rabbit polyclonal transforming growth factor beta receptor 
Type II (TGFβRII: L-21: SC-220) 
Santa Cruz 
Biotechnology 
1:50 for IF 
Mouse monoclonal early endosomal antigen-1 (610456) B.D Biosciences 1:100 for IF 
Anti-rabbit HRP-linked antibody (7074) New England Biolabs 1:3000 for WB 
Donkey anti- rabbit alexa flour CY3 conjugated secondary 
antibody 
Molecular probes 1:200 for IF 
Donkey anti- mouse alexa flour FITC conjugated antibody. Molecular probes 1:200 for IF 
Monoclonal anti β actin produced in mouse (A1978) Sigma 1:10,000 for WB 
Anti-mouse HRP conjugated secondary antibody (7076) Cell signalling  1:3000 for WB 
TGF-β1 antibody (aa22-50) LS-C161825 Lifespan Biosciences 1:50 for IF 
 
IF: Immunofluorescence; WB: Western Blot 
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Table 2.1: Table of antibodies used for immunolabelling studies. 
2.15: X-gal staining. 
Static and flow treated (150µl/min) cover slips were removed from the chambers of 
bioreactor and placed in a 24-well plate along with the controls. Cells were washed with 1X 
PBS and fixed in the fixative provided in the SA-βgal Staining kit (Abcam) for 20 minutes at 
room temperature. The coverslips were washed with 1X PBS and stained with 20mg/ml of X-
gal dissolved in 1x staining solution provided with the kit and incubated overnight at 37ºC. 
Stained coverslips were visualised under 20X magnification using an inverted microscope 
(Olympus CKX41). Images were captured and the total number of stained and unstained cells 
were counted by Image J software. 
 
2.16: pH RODO Dextran staining. 
Static and flow treated (150µl/min) cover slips were removed from the chambers of 
bioreactor and placed in a 24-well plate along with the controls. Cells were washed with 1X 
PBS and replaced with live cell imaging solution (Molecular probes) containing pHrodo 
dextran (20µg/ml) for 15 minutes at 37ºC. Cells were washed with live cell imaging solution. 
Slides were mounted DAPI containing antifade reagent (Sigma) and viewed under 100X 
magnification lens (oil immersion) in a fluorescent microscope. (Zeiss Axioplan2, Imaging 
software proplus 7.0.1).  
 
2.17: Extraction of RNA from fibroblasts. 
Total RNA was extracted using the Isolate II RNA mini kit (Bioline) according to the 
manufacturer’s protocol. Briefly the cells were ruptured in the lysis buffer and homogenised 
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by pipetting up and down. After homogenisation, 70% ethanol was added to the lysate which 
was further processed through a spin column to which the RNA binds. Additional step of 
incubating samples with RNase free DNase I eliminates contamination by genomic DNA. 
Impurities like salt metabolites and cellular components are removed by subsequent washing 
with different buffers. High quality purified total RNA is finally eluted with RNase –free 
water. 
 
2.18: cDNA synthesis. 
The concentration of the RNA obtained was measured by Nanodrop (ND-1000) Ultra violet 
visible spectrophotometer (Thermo scientific) at wavelength 260nm/280nm using ND-1000, 
version 3.7.0 software.  A ratio value range from 1.8-1.9 indicates purity of sample. 100ng of 
pure total RNA was used for cDNA synthesis using Applied Biosystem’s 100mM dNTP’s 
(0.8µl), Multiscribe reverse transcriptase (50U/µl;1.0µl), random primers (2.0µl), Reverse 
transcriptase buffer (2.0µl) and nuclease free water (according to the volume of RNA)  to 
make up a reaction volume of 20µl . The tubes were placed into a thermal cycler (DNA 
engine DYAD) at 25ºC for 10 minutes, 37ºC for 2 hours, and 85 º C for 5 mins and then held 
in 4ºC. 
 
2.19: Quantitative PCR for gene expression studies. 
The cDNA (0.5µl) was added to qRTPCR mastermix containing 1x SYBR green mixture 
(Applied Bio systems) with 0.25 µM gene specific primers for α-smooth muscle actin (α-
SMA), Collagen IA1 (Col1A1), activin A (INHBA), CD109, Transforming growth factor –β 
receptor type II  (TGFβRII) and Angiopoietin like 4 (ANGPTL-4) (Table 2.2). Assays were 
performed in triplicates on a 7900HT Fast real time PCR machine (Applied Biosystems) SDS 
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version 2.4 was used to programme the real time device (95ºC for 15 secs, 60ºC for 60 
seconds and 95ºC for 15 seconds) for 40 cycles and RQ Manager version 1.2.1 was used to 
record the CT values. The values were determined from the software and the delta CT values 
with reference to endogenous controls (U6) were calculated manually. 
 
 
Gene Forward Reverse 
 
U6 5’ CTCGCTTCGGCAGCACA 3’ 5′ AACGCTTCACGAATTTGCGT 3’ 
α-SMA 5’ GAAGAAGAGGACAGCACTG3’ 5’TCCCATTCCCACCATCAA3’ 
Collagen 1A1 5’GTGGCCATCCAGCTGACC 3’ 5’ AGTGGTAGGTGATGTTCTGGGAG 3’ 
INHBA 5’CCCCTTTGCCAACCTCAAA 3’ 5’CATGGACATGGGTCTCAGCTT 3’ 
CD109 5’AGCTGCTCAAGACAGCATCA3’ 5’TTGGGGTCTGATGGAAGAGT3’ 
ANGPTL-4 
 
5’ CTGCAACCAAGCGGGTCTTA3’ 5’TCTTAGGTAGCCTGGGAGCG3’ 
TGFβRII 
 
5’AGTCGGATGTGGAAATGGAGG3’ 5’GGAAACTTGACTGCACCGTTGT3’ 
 
Table 2.2: Gene expression primers used for RT-PCR. 
 
2.20: Microarray analysis. 
RNA was obtained from dermal fibroblasts treated with 75µL/ min and 150µL/ min flow 
obtained from three different experiments.  Linear amplification of the RNA was performed 
using The GeneChip® 3' IVT Express Kit (Affymetrix) according to the manufacturer’s 
guidelines. Briefly, 200ng mRNA was reverse transcribed using an oligo (dT) primer and 
then converted to double-stranded cDNA containing a T7 polymerase promoter site. Linear 
amplification was driven by a T7 promoter for 16 hours at 40oC and generated labelled aRNA 
using biotinylated dUTPs. 15µg of aRNA was fragmented in buffer containing Mg2+, at 94 
0C for 30 minutes and analysed using an RNA 6000 Nano Chip on the 2100 Bioanalyzer 
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(Agilent). Hybridisation was carried out using the GeneChip® Hybridization, Wash, and 
Stain Kit (Affymetrix). Briefly 12.5 µg of fragmented aRNA was added to the mastermix 
solution containing pre-labelled hybridization controls (bioB, bioC, bioD, and cre genes) and 
positive oligonucleotide B2 control (B2 oligo). After 16 hours hybridisation at 42oC with 
rotation at 60 rpm, the GeneChips were washed and stained in a GeneChip Fluidics Station 
450 (Affymetrix) as per the protocol prescribed in GeneChip® Expression Wash, Stain and 
Scan User Manual. Scanning was carried out on a GeneChip Scanner 3000 7G (Affymetrix). 
The scanned image files (.CEL) were processed using the Expression Console software 
(Affymetrix) for quality control checks and to generate an RMA normalised dataset of the 
signal intensity for each probeset. Differential gene expression was determined using the 
Qlucore ‘omiics explorer package (Qlucore). DAVID Gene Functional Classification Tool 
was used to identify genes on Go Term & KEGG pathway maps. 
 
2.21: Western Blot Analysis. 
Protein samples were extracted in RIPA lysis buffer containing protease and phosphatase 
inhibitors (Roche). Protein concentration in each sample was determined using the BCA 
Protein Assay Kit (Thermo Fisher Scientific). 20 µg of total protein extract were reduced in 
Sample Reducing Agent (10x), loaded with LDS Sample loading buffer (4X) (Nupage) and 
electrophoresed in 12-15% (v/v) polyacrylamide gels along with EZ-RunTM Prestained Rec 
Protein Ladder (Fisher Bioreagents). Protein was transferred to a 0.2 µm nitrocellulose 
membrane (ProTran, GE Healthcare using Trans-Blot® Turbo™ Transfer System (GE 
Healthcare). The membranes were blocked in 5% Bovine Serum albumin in 1X TBS 
containing 0.1% tween-20 overnight at 4°C. Membranes were incubated with Rabbit 
monoclonal Anti-Smad3 phospho S423 + S425 antibody for 1 h at room temperature.  
Nitrocellulose membranes were washed three times in TBS-Tween and then incubated with 
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HRP conjugated anti-rabbit secondary antibody for 1 hr. at room temperature and washed 
three times in TBS-T. Protein bands were visualized using a chemiluminescence detection kit 
(Pierce ECL Western Blotting Substrate) and developed using XPosure film and X-Ray 
automatic processor. In order to determine loading efficiency, membranes were routinely 
stripped with Restore™ Western Blot Stripping Buffer (Thermo Scientific), blocked in TBS 
Tween for 1 hr. and reprobed with β-actin antibody for 1 hr. Membranes were washed three 
times with TBS Tween and probed with HRP conjugated secondary antibody for 1hr. The 
membranes were visualised as described above.  
 
2.22: Detection of TGF-β1 by Enzyme linked immunosorbent 
assay. 
Cell lysate samples was obtained using RIPA lysis buffer containing protease inhibitors & 
protein concentration was determined as above. TGF-β1 protein was detected in the samples 
using the TGFβ1 Emax ® ImmunoAssay System according to manufacturer’s instructions in 
a 96-well plate. The plate was coated with TGFβ Coat mAb (provided in kit) and incubated 
overnight at 4°C. It was then blocked with 5X TGFβ block buffer for 35 minutes at 37°C. 
Standard curve was prepared by serially diluting the TGF-β1 standard six times in 1X sample 
buffer. Protein samples were also diluted in the sample buffer and added to the plate. The 
plate was incubated in the shaker for 1.5 hrs at room temperature. After several washes to 
remove the unbound protein, 100µl of TGFβ HRP conjugate was added to each well and 
incubated with shaking for 2 h. at room temperature. 100µl of TMB one solution was added 
to each well to and incubated without shaking for 15 minutes at room temperature. The 
reaction was stopped with 100µl of 1N hydrochloric acid. Optical density of each well was 
using a microplate reader (Tecan) set to absorbance at 450 nm with wavelength correction set 
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to 570 nm. Absorbance values of the standard curve was plotted on Graphpad prism 7 and 
total concentration of the protein was estimated by interpolating absorbance values of the test 
samples.  
2.23: Detection of activin A by Enzyme linked immunosorbent 
assay. 
Cellular lysate samples was obtained using RIPA lysis buffer containing protease inhibitors 
and conditioned medium was obtained from fibroblasts subjected to treatment by fluid flow 
and static conditions. Samples were also obtained from fibroblasts stimulated with TGF-β1. 
Prior to adding the protein samples to the streptavidin coated 96-well plate provided in the 
Quantikine Elisa kit (R&D systems), activin A biotinylated antibody was pipetted into the 
wells of the plate and incubated for 15 mins at room temperature on an orbital shaker set at 
500 rpm. Activin A standards were serially diluted ranging from 1000pg/ml to 15.6pg/ml 
from the standard provided in the kit. Protein samples were diluted in 100 µl of Assay diluent 
RD 1-98 (provided in kit) and added to each well. The plates were incubated for 3 h. at room 
temperature on an orbital shaker set at 500 rpm. Following incubation, plates were washed 
with wash buffer and incubated with 200 µl of activin A conjugate for 1h. The plate was 
washed again with wash buffer and 200 µl of substrate solution was added on to the plate. 
After 30 mins incubation the colour change was stopped by adding 50 µl of stop solution to 
each well. Optical density of each well was using a microplate reader (Tecan) set to 
absorbance at 450 nm with wavelength correction set to 570 nm. Absorbance values of the 
standard curve was plotted on Graphpad prism 7 and total concentration of the protein was 
estimated by interpolating absorbance values of the test samples. 
 
85 | P a g e  
 
2.24: Statistical analyses. 
Statistical significance of data was tested with one-way ANOVA with multiple comparisons’ 
test using Graph Pad Prism 7.0. 
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Chapter 3- Optimising cell number 
and coating methods for use in QV 
Bioreactor. 
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3.1 Introduction. 
Cellular engineering is an interdisciplinary field which involves culturing primary cells in 
vitro on surfaces that are compatible for optimal growth, differentiation and proliferation 
prior to using them for various applications and testing purposes. We know that 2 
dimensional cell culture does not represent a physiologically relevant cellular environment 
wherein cells are not only close to each other, but are also mechanically supported by matrix 
associated proteins and exposed to physical and chemical signals (Jorgensen and Tyers, 
2004). Hence these cells that are removed from their natural environment display preferential 
attachment only to chemically modified surfaces or those that are coated with matrix proteins. 
It should be noted that surface chemistry associated factors such as stiffness, roughness, 
microstructure, porosity, surface area, mechanical properties and chemical composition of the 
surface are known to influence cellular behaviour such as adhesion, growth and 
differentiation of cells (Wang, 2011).  When cells attach to an artificial surface, numerous 
physico-chemical reactions take place between cell and its surface. Cells attach to their 
surface and release active compounds for signalling, proliferation and differentiation. Hence 
in order to attain optimal cellular development, it is vital to understand the factors that 
influence the adhesion of cells. Some of the known factors that affect focal adhesion of cells 
are surface hydrophobicity, protein adsorption, surface charge, roughness and stiffness 
(Wang, 2011). For example, mouse osteoblast-like cell line MC3T3-E1 displayed a fractured 
morphology on hydrophilic surfaces (Jianhua et al., 2009). A similar phenomenon was 
observed in neuronal cell spreading on surfaces with reduced hydrophobicity (Khorasani et 
al., 2008). Hydrophobic surfaces are known to adsorb more proteins whereas hydrophilic 
surfaces resist adsorption (Xu and Siedlecki, 2007). However, Tamada et.al reported that 
water wettability does not influence cell adhesion (Tamada and Ikada, 1993). They observed 
that preadsorption of serum albumin prevented fibroblast adhesion to substrates whereas 
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fibroblast adhesion was enhanced by preadsorbed fibronectin. Other than hydrophobicity and 
protein adsorption, cell adhesion is also influenced by surface charges. Studies have shown 
that the amount of surface charges can also influence cell behaviour (Ishikawa et al., 2007). 
For example, chondrocytes exhibited enhanced differentiation with increased expression of 
collagen and glycosaminoglycan expression when cultured on negatively charged oligo 
polyethylene glycol hydrogel scaffolds compared to neutral or positively charged hydrogels 
(Dadsetan et al., 2011).  
 
Surface roughness and stiffness are other factors that influence cell adhesion and behaviour 
(Wang, 2011). Numerous studies have reported that cells that grow on micro-rough surfaces 
demonstrate enhanced differentiation. For instance, foetal osteoblasts (hFOB 1.19) showed 
increased spreading and proliferation on rough surfaces but the cellular response to roughness 
is dependent on the individual cell type (Lim et al., 2005).  For example, osteoblastic cells 
(MC3T3-E1) proliferated at a higher rate on smoother regions (0.55nm) of dendrimer films 
than on rougher (13nm) regions (Washburn et al., 2004). Stiffness on the other hand is known 
to be a crucial determinant of cellular differentiation as is observed in fibroblasts. Tan and 
Teoh observed that 3t3 fibroblasts preferred soft surfaces for proliferation (Zein et al., 2002). 
Another group used a rheometer to measure adhesion of kidney epithelial (MDCK) cells on 
surfaces with different softness (O’Brien et al., 2005). Cellular adhesion was seen to increase 
with decreasing substrate stiffness and this correlated to the area of cell spreading. These 
observations suggest that properties such as the hydrophilic nature of the surface, 
composition of the adsorbed protein, surface roughness and stiffness are major factors 
contributing towards nature of cellular behaviour when they contact different surfaces.  
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One approach to encourage cells to grow on artificial surfaces is to seed them on glass or 
plastic surfaces that are pre coated with proteins which resemble matrix proteins. Classically, 
most primary cells are cultured in tissue culture flasks made of polystyrene. However cells 
that require special support to attach to the surface can be seeded on surfaces coated with 
proteins such as poly-lysine, fibronectin, gelatin, and collagen. 
 
Poly-Lysine is a poly-cationic molecule that binds to negatively charged proteins and DNA. 
It promotes the electrostatic interaction between glass surface and negatively charged 
membrane bound ions. In other words, it increases the number of positive charges available 
for binding on the surface of the coverslip. Poly-Lysine does not occur naturally and can be 
synthesized in ‘L’ and ‘D’ forms (Sitterley G, 2008). However, it should be noted that Poly-
L-Lysine can be digested by some cells in which case Poly-D-Lysine could be used (Shima et 
al., 1984). This molecule has been used in culturing neuronal cell lines, glial cells, prostate 
cancer (PC12) cells etc. 
 
Fibronectin is a high molecular weight glycoprotein which promotes cellular attachment 
through the association of its cell binding domain sequence to membrane spanning receptor 
proteins called integrins (Pankov and Yamada, 2002). Endothelial cells, smooth muscle cells, 
human myeloma cells, Chinese hamster ovary (CHO) cells, fibroblasts and neuroblastoma 
cells are few of the cell types which attach to fibronectin (Schwarz and Juliano, 1984, 
Lewandowska et al., 1987). 
 
Collagen is the main extracellular matrix protein associated with the extracellular space of 
connective tissues of animals and promotes cellular adherence and growth. To date about 28 
types of collagen have been identified (Sherman et al., 2015).  However, Collagen type I is 
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the type which is often used for coating coverslips and slides since this form constitutes over 
90% of total collagen in body and is readily available commercially. Human umbilical vein 
endothelial cells (HUVECs), CHO cell lines, muscle cells, fibroblasts are compatible with 
collagen coated artificial surfaces (Saunders and Hammer, 2010, Gaudet et al., 2003). 
 
3.2. Dermal and oral fibroblasts can attach on glass surfaces. 
This chapter describes experiments carried out to optimise the cell number and coverslip 
coating conditions for optimal growth and proliferation of fibroblasts in the Quasi-vivo® 
(QV-500) bioreactor.  
 
3.2.1 Methods. 
 
Two types of cover slips (glass & Thermanox) both of 12mm diameter were used to optimise 
coating method for optimal attachment of cells. Cover slips were treated with different 
coating proteins namely collagen type I from rat tail (0.2mg/ml, Sigma), fibronectin 
(0.2mg/ml, Sigma) and poly-l-lysine (0.2mg/ml, Sigma) for 1 hour in 37 ºC incubator.  
Primary oral fibroblasts (75,000 cells) were plated on cover slips coated with different 
proteins and incubated at 37 ºC for 24 hours. Cells were also plated on uncoated sterilised 
glass and Thermanox cover slips as controls. Bright field images were captured using a 
NIKON Eclipse TS100 camera. Images were analysed by Spot Software Version 5.1.  
 
To optimise cell numbers to be seeded per well, primary dermal fibroblasts (NHDFC) were 
seeded at varying cell numbers (3125; 6250; 12,500; 25,000; 50,000; 100,000 cells/well) and 
plates were returned to 37ºC incubator in 5% CO2 for 24 hrs. Before the end of the incubation 
period, bright field images were captured using a NIKON Eclipse TS100 camera. Images 
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were analysed by Spot Software Version 5.1. Approximately 2 h. before the end of the 
incubation period, cells were treated with CellTiter 96® AQueous One Solution (Promega) as 
per the manufacturer’s instructions and the absorbance was determined at 490nm. 
 
3.2.2 Results 
 
Results revealed that fibroblasts prefer to attach to plain glass cover slips or on collagen 
coated Thermanox cover slips (Figure 3.1). Whilst they attach to fibronectin coated surfaces, 
cell spreading and morphology was altered on Poly-L-Lysine coated surfaces. Cells did not 
attach to ECM protein modified glass surfaces, fibronectin coated glass being an exception. 
Bright field images (Figure 3.2) and results from CellTiter 96® AQueous One Solution assay 
(Figure 3.3) suggested that cell numbers greater than 50,000 cells/well would enable optimal 
spreading and metabolic activity of NHDFC cells. 
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Figure 3.1: Representative images of oral fibroblasts (NOF) (n=3) cultured for 24h. on coverslips coated with 
different proteins. a) On plain glass; b) on collagen coated Thermonox; c) on fibronectin coated glass; d) on 
Poly-L-lysine coated glass; e) on fibronectin coated Thermonox; f) on Poly-L-lysine coated Thermonox. Images 
were captured under 20X magnification lens on an inverted bright field microscope (Olympus CKX41) 
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Figure 3.2: Representative images of dermal fibroblasts (NHDFC) (n=3) cultured for 24h. on coverslips seeded 
on uncoated glass coverslips at different cell numbers a) 3125; b) 6250; c) 12,500; d) 25,000; e) 50,000; f) 
100,000 cells/well. Images were captured under 20X magnification lens on an inverted bright field microscope 
(Olympus CKX41) 
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Figure 3.3: Metabolic activity of dermal fibroblasts (NHDFC) on coverslips seeded on uncoated glass coverslips 
at different cell numbers (3125; 6250; 12,500; 25,000; 50,000; 100,000 cells/well) and treated in static 
conditions. 
 
3.3: Fibroblasts respond to low levels of fluid flow. 
 
3.3.1 Method. 
 
Fibroblasts (NHDFC’s) were plated on coverslips for 24hr. and treated with minimal media at 
a flow rate of 150 µl/min.  At the end of the incubation period, cells were imaged under 
microscope. Bright field images were captured by NIKON Eclipse TS100 camera. Images 
were analysed by Spot Software Version 5.1.  
3.3.2 Results. 
 
Cells subjected to 150 µl/min remained attached to cover slips and appear stretched in 
comparison to cells under static conditions (Figure 3.4). Very few cellular debris were also 
observed. 
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Figure 3.4:  Representative images of dermal fibroblasts (55,000 cells/well) (n=3) when subjected to flow (150 
µl/min) for 24h.  A) Static controls B) flow. Images were captured under 20X magnification lens on an inverted 
bright field microscope (Olympus CKX41) 
 
3.4: Cellular metabolic activity of fibroblasts is altered at varying 
flow rates. 
3.4.1 Method. 
 
Coverslips with cells (NOF’S and NHDFC’s) were transferred carefully into the Quasi-vivo® 
chambers and 1 ml of minimal media (0.5% serum containing media) was added into each 
chamber to ensure that cells remain hydrated until all the chambers are filled with the 
circulating medium. 11mls of media was added to the reservoir bottle and the entire loop was 
connected to a pump. The pump was run at flow rates 75µL/min and 150µL/min for a period 
of 24hrs. Control cells were subjected to static culture conditions wherein the cover slips 
were placed in wells of a 24-well plate and treated with minimal media. The plate was 
returned to 37ºC incubator in 5% CO2 for 24 hrs. Approximately 2 hours before the end of 
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incubation, cover slips from the chambers was transferred into a 24-well plate and Cell Titer 
96® AQueous One Solution (Promega) was added. The absorbance was measured at 490nm 
after 2hrs. Experiments were performed three times on three coverslips per experiment and 
mean values were plotted. 
 
3.4.2 Results. 
 
Metabolic activity of primary fibroblasts cells from both sources (Dermal and Oral) are 
reduced at both flow rates of 75µL/min and 150µL/min (Figure 3.5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5: Medium flow alters cellular metabolic activity of Primary fibroblasts a) dermal (NHDFC) and b) 
oral (NOF320) at flow rates 0µL/min, 75µL/min and 150µL/min for 24h. (n=3) (Mean ± SEM). 
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3.5 Discussion. 
Cellular attachment to modified surfaces is particularly important during culturing of cells as 
poor attachment can lead to apoptosis of unattached cells. Pre-coating of plastic and glass 
surfaces with ECM proteins to enable optimal attachment of cells has been a common 
practice in tissue culture (Sherratt et al., 2005). The purpose of these optimisation 
experiments was to assess a range of ECM proteins for their efﬁcacy in encouraging 
attachment and growth of primary human fibroblast cells and to study the effect of fluid flow 
on the metabolic activity of fibroblasts.  
 
3.5.1 Role of surface chemistry and coating proteins on cellular 
attachment 
Collagen is the main structural component of the connective tissue (Di Lullo et al., 2002). It 
provides the tensile strength of the extracellular matrix (ECM). It is found in abundance in 
cartilage, bones, blood vessels, intervertebral discs and the dentin in teeth. The first evidence 
of its role in promoting cell attachment came when George Gey (1956) coated rat tail 
collagen on glass surfaces. He observed that collagen coating improved cellular attachment 
and growth. Clinical studies reveal that in the presence of collagen dressings, healthy 
granulation tissue is able to form in skin burns (Singh et al., 2011).  Owing to properties like 
stability, permeability, hydrophilicity and pore size, collagen scaffolds serve as ideal matrices 
for deposition of cells. Once human dermal fibroblasts are inserted in these scaffolds, growth 
continues as normal (Hadjipanayi et al., 2009). Our results complement these findings in that 
fibroblasts attach well on Thermonox surfaces coated with matrix attachment proteins like 
collagen I. Fibroblasts preferred to attach to plain glass cover slips or on collagen coated 
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Thermonox cover slips whereas they failed to attach on glass surfaces which were modified 
with ECM proteins.  
 
Thermanox coverslips are made of polyester polymer which is highly resistant to most 
chemicals, alcohols, aldehydes, hydrocarbons, dilute acids (<10%) and dilute alkalis (<2%) 
and has a low oxygen content. These coverslips offer several advantages of being easy to 
handle and being packaged in sterile conditions.  It is significant to observe that while glass 
and plastic growth surfaces are flat and optically clear they differ in many ways which affects 
their performance in various applications. Cellular attachment and spreading on these two 
growth surfaces may be affected by the chemical composition of surface material. 
 
Glass cover slips are made of German borosilicate glass and offer a hydrophilic surface 
which enables cells to attach even in the absence of attachment enhancement proteins. Other 
than fibronectin coated glass coverslips, fibroblasts failed to attach on surfaces coated with 
Collagen I and Poly-lysine. This suggests that surface chemistry of plain glass is well suited 
for optimal growth of fibroblasts. However due to technical limitations owing to the fragile 
nature of cover slips, we considered using modified Thermanox cover slips. 
 
Further, results from optimisation experiments also revealed that cells spread and attach well 
on collagen coated Thermanox cover slips. Although, cells attached well on Thermanox 
coverslips coated with fibronectin and poly-L-lysine, cells did not spread uniformly 
throughout the coverslip. Nonetheless, the Thermanox cover slips had their limitations. 
Although, they are flat and clear under a bright field microscope, these were not compatible 
for immunofluorescence studies. It was difficult to image cells under a fluorescent 
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microscope as the image quality was poor. Hence it was decided to use plain glass cover slips 
for detection of proteins by immunofluorescence.  
 
It was decided to use a cell seeding density of 55,000 cells per well for reasons that cellular 
spreading was more uniform over the coverslip, although some cells clustered at the centre of 
the coverslip at all seeding densities. This clustering almost certainly relates to surface 
tension forces between the culture medium and plastic culture flasks. It is possible that cells 
spread more uniformly and that cellular clustering is not likely to occur in 3 dimensional 
cultures which resemble the in vivo environment more closely. 
 
Whilst a strong body of evidence shows that endothelial cell alignment along the direction of 
laminar fluid flow defines morphological feature of vascular homeostasis (Steward et al., 
2015, Wang et al., 2013), fibroblasts also align along the direction of interstitial fluid flow 
(Ng and Swartz, 2003) and myofibroblast differentiation and collagen alignment along the 
direction of flow has also been observed (Ng et al., 2005). Subsequent findings showed that 
fibroblasts, endothelial cells and tumour cells restrict their migration to the direction of 
interstitial flow in a microfluidic cell culture system (Polacheck et al., 2011). However, it was 
not obvious from our experiments that dermal fibroblasts aligned along the direction of flow. 
This may relate to the design of the flow chambers which induce a gradient of shear stress 
which is maximum at the base of the chamber and the lowest at the edges of the coverslips. 
These gradients of shear stress may in turn influence cellular alignment as is observed in 
human mesenchymal stem cells which displayed differentiation and cellular alignment only 
in flow-induced shear stresses of 0.10 and 0.25 Pa (Jeon et al., 2014). 
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3.5.2 Fibroblasts respond to medium flow conditions by altering 
cellular activity  
From prokaryotes to higher level organisms, survival is based on methods in which the 
organism responds to environmental pressures (Farge, 2011). All cells in the human body are 
subjected to forces acting on them due to breathing, movement and venous blood flow. 
Almost all cells in multicellular tissues undergo a myriad of forces such as compressive, 
tensile, fluid and hydrostatic forces each of which play a critical role in the shaping, 
development and maintenance of the tissue homeostasis (Wozniak and Chen, 2009). 
 
Several studies suggest that stress mediated by fluid flow plays a crucial role in maintaining 
basic cellular functions. Resnick et al (2011) reported that fluid flow modifies the 
transepithelial sodium current, cell proliferation, and the actin cytoskeleton in renal 
epithelium. He aimed to explore whether differentiated epithelial monolayers are sensitive to 
the flow conditions and whether flow can alter mechanosensation by the cells after 
differentiation has occurred. Results confirmed that cells differentiated in the presence of 
flow and displayed a graded response to flow. Changes in flow induced cells to 
hyperproliferate. Furthermore, the actin cytoskeleton underwent extensive remodelling in the 
presence of flow. These findings threw light on the role of fluid flow acting via  primary cilia 
to alter epithelial physiology and progression of autosomal dominant polycystic kidney 
disease (ADPKD) (Resnick, 2011).  
 
Forces acting on and within a cell are defined as stress. Stress is force per unit area and is 
represented in Newton’s metre-2 or Pascal. The Quasi Vivo® bioreactor was designed to 
induce low shear stresses and mimic fluid flow in cells and in tissues. The apparatus permits 
flow of fluid on cells at set velocities over stipulated intervals of time. Estimation of surface 
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shear stress values for healing and cancerous tissues exposed to interstitial ﬂow are difﬁcult 
to calculate, but are relatively low in comparison to those experienced in the vasculature 
which equates to 4.0 to 30.0 dyn cm−2 in the arterial circulation.  For interstitial ﬂow rates of 
1x 10-6 ms−1 in tumour cells, one study estimated a ﬂuid shear stress range of 7 x 10-3 – 1.5 x 
10-2 dyn cm−2 (Pedersen et al., 2007) which is in orders of magnitude lesser than the 
maximum maximal flow rates set in the QV-500 bioreactor. Shear stresses in blood vessels 
aorta and at arterial blood flow separation regions are ~40-50 dynes cm-2 (Ku et al., 1985) 
and during episodes of increased cardiac output it is ~ 100 dynes cm-2 (Nerem et al., 1993). 
Based on studies which characterised the multi compartmental modular bioreactor (MCmB) 
(Mazzei et al., 2010), the prototype of the Quasi vivo®  (QV-500) bioreactor, we estimated 
that shear stresses produced at a fluid flow rate of 75 & 150 µl/min were 1.8 x 10-5 dynes cm-
2 and 3.6 x 10-5 dynes cm-2 respectively. The flow velocities generated at a fluid flow rate of 
75 & 150 µl/min were 3 x 10-7 m/s and 5 x 10-7 m/s respectively. Based on previous 
literature which shows that average interstitial flow velocities in normal and neoplastic 
tissues is  6 x 10-7 m/s (Chary and Jain, 1989), it can be concluded that flow velocities in the 
same range as those experienced by tumour tissues.  Although, fluid flow treated fibroblasts 
from oral and dermal sources do not display major differences in metabolic profile, dramatic 
changes can be observed in their global gene expression profile as discussed in chapter 4.  
 
Results from this study conclude fibroblasts of both oral and dermal origin respond to low 
levels of fluid flow. When fibroblasts were subjected to flow conditions with medium flow 
rate of 150µl/min they appeared elongated and stretched. It appears that fluid flow induced by 
the Quasi-Vivo® bioreactor’s pump activates the fibroblasts to secrete contractile proteins 
and initiate cellular signalling mechanisms. This supplements previous studies which claim 
that the Quasi-Vivo Bioreactor mimics fluid flow in tissues (Vinci et al., 2011). Appearance 
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of cellular debris suggests that some cells which couldn’t withstand flow detached from 
surfaces of cover slips and started to circulate in the medium. Further analysis of the 
circulating cells would indicate whether these circulating cells have detached and acquired 
activation markers like α-SMA, Collagen IA (Pellegrin and Mellor, 2007) or are just dead 
cells. Notably, fibroblasts from both oral and dermal sources behave in a similar fashion 
when subjected to varying flow rates.  
 
3.5.3: Cellular activity of primary oral and dermal fibroblasts is 
altered during flow conditions.  
The CellTiter 96 AQueous One Solution Reagent contains a novel tetrazolium compound [3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium,inner salt; MTS] and an electron coupling reagent (phenazineethosulfate; PES). 
This compound is bio reduced by cells into a coloured formazan product and is soluble in 
tissue culture medium. Tetrazolium dye is reduced in presence of NAD (P) H-dependent 
oxidoreductase enzymes which are largely present in the cytosolic compartment of the cell. 
Therefore, reduction of MTS reflects upon cellular metabolic activity due to NAD (P) H flux. 
Both oral and dermal fibroblasts displayed a reduction in cellular activity when subjected to 
varying flow rates (75 µl/min and 150 µl/min). In order to understand whether this reduction 
in cellular activity resulted due to reduced mitochondrial activity or due to loss of cells, we 
counted the total number of cells present at the end of experiment. Reduction in cellular 
activity may be due to loss of cells which probably detach from the coverslip and circulate in 
the flowing medium.   
 
Although fibroblasts from both oral and dermal sources display similar metabolic activity 
under flow, it appears that the oral and dermal microenvironment may contribute to 
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differences in fibroblast phenotype and signalling responses. It is highly possible that 
mechanical forces induced by chewing, action of salivary amylases and inflammatory 
molecules are crucial contributors to faster and non-fibrotic wound healing responses in the 
oral cavity. These results suggest that the cellular responses are influenced by mechanical 
forces as well as chemical signals from the microenvironment in vivo. In our efforts to 
explore differences in fibroblast responses we studied the response of both dermal and oral 
fibroblasts to both fluid flow induced mechanical signals and chemical signal such as TGF-β1 
in the Quasi vivo®  bioreactor that mimics physiological interstitial fluid flow like signals. 
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Chapter 4- Dermal fibroblasts show 
variations in gene expression profile 
under flow. 
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4.1 Introduction. 
 
Cells in vivo are constantly exposed to a number of different physical forces such as shear 
stresses and interstitial fluid flow. These biophysical cues can work concurrently or 
independently to regulate various signalling activities that define tissue integrity in normal 
and pathological circumstances, thus controlling cellular processes involving tissue 
development, migration, growth, and differentiation, apoptosis and stem cell lineage 
switching (Ingber and Folkman, 1989, McBeath et al., 2004). Fibroblasts in vivo will also 
experience fluid flow induced biophysical cues.  
 
Fibroblasts are mesenchymal cells which synthesize the extracellular matrix including 
collagen, form the stromal framework of tissues and influence processes such as wound 
healing and tumorigenesis (Alberts B, 2002b). These cells can alter their phenotype and 
genotype in response to chemical signals and exist as fibroblasts in ‘less active’ state or as 
myofibroblasts in an ‘activated’ state. It has been known for a century that fibroblasts 
respond to chemical signals such as transforming growth factor-β1 (TGF- β1) by 
differentiating to an activated state marked by an increased gene expression of contractile 
proteins such as α-smooth muscle actin (αSMA) (Hinsley et al., 2012, Das et al., 2013). 
When a tissue is ruptured, fibroblasts surrounding the wounded site proliferate and migrate 
into the wound producing huge amounts of matrix which augments repair of damaged tissue.  
 
Arsenite, a widely distributed and ingested compound is known to be involved with many 
diseases such as atherosclerosis, black foot disease and cancers. When human fibroblasts 
were exposed to arsenite, abnormal changes were observed in cell cycle, chromosomes and 
oxidative damage. Microarray studies showed that these cellular changes manifested in gene 
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expression changes in 94 genes which were associated with processes such as signal 
transduction, transcriptional regulation, cell cycle control, cellular stress and proteolytic 
enzymes (Yih et al., 2002).  In another study where researchers undertook a systematic 
microarray based approach to study the gene expression profile of ras v12/ E1A- transformed 
mouse embryonic fibroblasts, it was observed that 815 genes showed variations in 
transformed fibroblasts in comparison to controls (Vasseur et al., 2003). Among the known 
genes 202 genes were up-regulated and 410 genes were down regulated. Notably, genes 
encoding DNA replication and repair and cell growth related proteins were up-regulated and 
genes encoding receptor, secretory and structural proteins were down-regulated. These 
studies suggest that cellular changes invoked by exposure to chemical signals manifest in 
gene expression changes in fibroblasts. 
 
Fibroblasts not only respond to chemical signals as mentioned above, but they also 
experience shear stresses induced by fluid flow (Garanich et al., 2007, Steward et al., 2011). 
Not surprisingly, they display changes in gene expression of actin during conditions such as 
wound healing and tumours where blood and fluid flow dynamics differ in comparison to 
normal tissues (Munson and Shieh, 2014). As described earlier, production of extracellular 
matrix is a major response of fibroblast to shear stresses as is observed in wound healing, 
fibrosis, tumours etc (Xue and Jackson, 2015, Fan et al., 2012, Nakayama et al., 2016). As a 
result of dynamic changes in fluid movement over tissues as observed in these diseased 
conditions, fibroblasts acquire contractile properties similar to that of smooth muscle cells. 
However, the onset of changes in genes expression is slow and is regulated indirectly 
possibly by induction of transcription factors which induces changes in regulated genes. For 
example, in cultured primary fibroblasts, changes in fibronectin gene expression are observed 
only after 24h. of cyclic tensile strain (Chiquet et al., 2004). Induction of the transcription 
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factor Egr-1 is an immediate response of fluid shear stress in endothelial cells (Schwachtgen 
et al., 1998). In glioblastoma cells, Egr-1 is known to transactivate the fibronectin gene by 
binding to specific sites in its promoter (Liu et al., 2000). Although comparable studies in 
fibroblasts have not been carried out, it is likely that induction of changes in gene expression 
of fibronectin is preceded by early changes in Egr-1 transcription in fibroblasts. 
 
From the available body of literature, it is evident that changes in physical stimuli like 
mechanical strain and chemical signals like TGF-β1 cause variations in gene expression of 
fibroblasts. Most of these classical studies have been pursued in cells which are treated in 
static conditions in the absence of in vivo like conditions such as blood flow or interstitial 
fluid flow. The effect of fluid flow in inducing changes in fibroblasts remains to be explored.  
 
This chapter details experiments that aim to explore gene expression associated changes in 
dermal fibroblasts that are exposed to fluid flow. A systems biology approach using micro 
array studies was adopted to study global gene variations associated with the fibroblasts 
subjected to fluid flow treatment in the Quasi vivo®  bioreactor compared to those in static 
culture conditions. 
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4.2: Fluid flow alters the gene expression profile of dermal 
fibroblasts. 
4.2.1 Methods 
 
Primary dermal fibroblasts were treated with fluid flow as described in section 2.10 for 24 hr 
and RNA was extracted as described in section 2.17. Three coverslips were used per test 
condition and the entire experiment was performed three times. RNA samples from three 
separate experiments were subjected to microarray analysis as described in section 2.19.  
4.2.2 Results  
 
Microarray-based genome analysis on dermal fibroblasts subjected to 75 and 150 µl/min fluid 
flow rate was performed.  As shown in the heat map (Figure 4.1a) representing hierarchical 
cluster analysis of the three study groups, 54700 genes were differentially expressed which 
includes 28060 overexpressed genes, 26590 under expressed genes and 44 genes that display 
fold change ≥ 2.0 at 75µl/min flow rate compared to gene expression of fibroblasts at static 
conditions. At a flow rate of 150µl/min, 25718 genes were overexpressed, 28967 genes were 
under-expressed with 55 genes that display fold change ≥ 2.0 in comparison to gene 
expression of fibroblasts at static conditions. 2944 transcripts were identified to display 
statistical significance score (t-test, p<0.05). Factorisation by principal components was 
performed for fibroblast expression of these 2944 transcripts which are altered under flow (75 
and 150 μl/min).  Fibroblasts exposed to 75μL/min are plotted in yellow, those exposed to 
150 μl/min are plotted in cyan and the ones in static conditions are plotted in blue.  This 
Principal Component Analysis (PCA) plot of the 2944 genes shows that the first principal 
component containing the majority of variability in these genes clearly separates the samples 
exposed to static conditions from the others (Figure 4.1b).  
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Figure 4.1: Gene expression changes when dermal fibroblasts were subjected to fluid flow (0, 75 and 150 
μl/min). a)  Heat map of 2944 differentially expressed transcripts (upregulated genes= red, downregulated= 
green) (t-test, p-value<0.05), b). Principal Component Analysis (PCA) plot of genes altered in dermal 
fibroblasts exposed to 75μL/min (yellow), 150 μl/min (magenta) and static conditions (blue). c) Volcano plot of 
the top 100 differentially expressed transcripts in dermal fibroblasts sorted by p-value and fold change. 
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4.3 Differential gene expression of fibroblasts under flow validates 
microarray based studies. 
4.3.1 Methods 
 
Validation of differential gene expression at different flow rates were performed by studying 
the expression of collagen IA1 (COL1A1), transforming growth factor receptor type II 
(TGFβRII) and angiopoietin-like 4 (ANGPTL-4) by quantitative PCR as described in section 
2.19.  Three coverslips were used per test condition and the entire experiment was performed 
three times. RNA samples from two separate experiments were subjected to quantitative PCR 
analysis of genes listed above. 
 
4.3.2 Results 
 
The amplified RNA (aRNA) samples obtained from microarray experiments subjected to 
gene expression validation studies revealed an increased expression of ANGPTL-4 (Figure 
4.2a), COL1A1 (Figure 4.2b) and TGFβRII (Figure 4.2c), and, under flow. In comparison to 
statics, gene expression of ANGPTL-4 and TGFβRII was increased by 60 fold and 21.45 fold 
respectively at a flow rate of 75µl/min.  Under a flow rate of 150µl/min gene expression of 
ANGPTL-4, COL1A1and TGFβRII were increased by 16.3 fold, 2.29 fold and 2.15 fold 
respectively.  
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Figure 4.2: Global gene expression plotted as fold change relative to endogenous control in a) Angiopoietin like 
4 (ANGPTL-4) (blue)  b) Collagen I A1 (COL1A1 (red) and c) Transforming Growth Factor β receptor type II 
(TGFβRII) (green) in amplified RNA samples obtained microarray analysis performed on fibroblasts subjected 
to flow rates (0, 75 and 150 μl/min). FC relative to EC represents fold change relative to endogenous control. 
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4.4: Fluid flow mediated gene alterations are functionally 
associated with the TGF-β pathway. 
 
4.4.1 Methods 
 
Qlucore software generated 2944 genes (p<0.05) obtained from the microarray analysis of 
dermal fibroblasts subjected to fluid flow were subjected to biological term enrichment by 
Gene ontology Term enrichment (GOTERM) and the enrichment scores (E. Score) were 
noted. Highly enriched biological terms were functionally analysed by Kyoto Encyclopaedia 
of Genes and Genomes (KEGG) analysis using the DAVID software.  
 
4.4.2 Results 
 
The GOTERM and KEGG pathways showed that the regulated genes relate to vascular 
development, angiogenesis, blood vessel morphogenesis, cell morphogenesis, cell motion, 
cell migration, muscle cell differentiation, regulation of apoptosis, tube development, 
patterning of blood vessels and TGF-β signal pathway (Figure 4.3). Functional clustering of 
genes altered under fluid flow (Table 4.1) with enrichment score (E. Score) > 1.5 relate to 
cell motion migration, programmed cell death, muscle cell differentiation and tissue 
development, cell morphogenesis, and vascular and blood vessel development.  Biological 
pathways predicted were the pentose phosphate pathway, clathrin and caveolin mediated 
endocytosis pathway and TGF-beta signalling pathway. Top 20 genes associated with TGF-β 
pathway and endocytosis altered under both flow rates (75 & 150 µL/min) are shown in 
Figure 4.4. 
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Figure 4.3: Biological functions altered under fluid flow (75 µl/min and 150 µl/min) for 24 h. as assessed by 
GOTERM and KEGG pathway. 
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Table 4.1: Functional clustering of genes altered under fluid flow (75 µl/min and 150 µl/min) based on 
enrichment score (E.Score) (Pink), biological process (yellow), P value (green), Fold change (purple). 
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TGF-β pathway 
Endocytosis pathway 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4: Functional analysis of genes altered under both flow rates (75 µl/min and 150 µl/min) for 24 h.  in 
dermal fibroblasts, The TGF-β pathway (top) and the endocytosis pathway (bottom). 
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4.5 Discussion  
As outlined previously, it is known that fibroblasts respond to physical and chemical signals 
by incorporating contractile stress fibres and acquiring a smooth muscle cell like phenotype 
and these changes are associated with gene expression changes either mediated directly or 
indirectly by transactivation of transcription factors.  Although a huge body of evidence show 
that in diseased conditions such as cancer, wound healing and fibrosis cells display changes 
in gene expression, it is unclear as to the contribution of mechanical cues such as fluid 
movement in interstitial spaces, blood flow and lymphatic flow. This is partly because most 
of the studies were either performed on samples obtained from in vivo conditions where cells 
remain embedded in a tissue matrix or in static conditions wherein cells are cultured in 2D 
cultures in the absence of fluid flow and oxygen conditions that cells experience in vivo. In 
this chapter, gene expression changes in fibroblasts associated with fluid movement that 
mimics interstitial fluid flow were investigated. 
 
4.5.1 Fluid flow alters gene expression profile of dermal 
fibroblasts. 
Findings from microarray based experiments have shown that fluid flow causes variations in 
the gene expression profile of dermal fibroblasts.  A total of 54700 genes were altered of 
which 2944 genes were highly significant changes. The heat map shows a visual 
representation of upregulated genes highlighted in red and downregulated genes in green 
colour. Notably, it is clear that when dermal fibroblasts experience fluid flow at both flow 
rates of 75 µl/min and 150 µl/min the same set of genes such as inhibitor of DNA binding 
(ID3, ID1, and ID4), Smad family member 9 (Smad9), Angiopoietin like-4 (ANGPTL-4) etc. 
are up-regulated in comparison to statics. Similarly, genes that are upregulated in static 
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conditions are downregulated under flow treatment. This phenomenon may be because fluid 
flow acts only on mechanosensory receptors such as primary cilium, receptors, ion channels 
and caveolae as explained in section 1.6 possibly causing changes in transcription regulators 
such as the yorkie homologues YAP and TAZ which sense signals from integrins. Recent 
studies have shown that expression of α-smooth muscle actin (α-SMA) correlated with 
expression of yes associated protein (YAP) wherein overexpression of α-SMA translocated 
YAP to the nucleus (Talele et al., 2015).  These transcription factors are mechanoregulators 
of TGF-β signalling (Szeto et al., 2016), a crucial mechanism known to induce fibrosis, 
fibroblast differentiation etc. (Piersma et al., 2015b).  
 
Other genes which were altered under both fluid flow rates (75 & 150 µL/min) displaying 
fold change > 4.0 are inhibitor of DNA binding (ID3, ID1, and ID4), solute carrier family 7 
(SLC7A11) (p<0.001), NmrA-like family domain containing 1 pseudogene (LOC344887) 
(p<0.001), Smad family member 9 (Smad 9), heme oxygenase 1 (HMOX1), FBJ murine 
osteosarcoma viral oncogene homolog B (FOSB), transmembrane protein 155 (TMEM155) 
(p<0.001), cartilage oligomeric matrix protein (COMP). Although these genes displayed fold 
changes greater than 4.0 at both flow rates in comparison to fibroblasts treated in static 
conditions, they were not functionally associated with GOTERM and KEGG analysed TGF-β 
pathway or the endocytosis pathway. Further, these genes did not relate to biological 
functions such as cell motion migration, programmed cell death, muscle cell differentiation 
and tissue development, cell morphogenesis, and vascular and blood vessel development as 
listed in Table 5. Hence for experimental purposes, genes were subjected to functional 
annotational analysis by DAVID software and gene enrichment analysis. Genes altered under 
both flow rates (75 & 150 µL/min) and associated with TGF-β pathway and endocytosis 
118 | P a g e  
 
pathway as analysed by GOTERM and KEGG were isolated and subjected to further analysis 
as explained in future chapters. 
 
4.5.2 Differential gene expression analysis by quantitative PCR 
validate microarray based studies. 
Validation of microarray studies by analysis of three genes ANGPTL-4, Col1A1 and 
TGFβRII is underscored by results that show that highly enriched genes with enrichment 
score were related to Angiogenesis (E. Score = 2.96) and cellular differentiation (E. Score= 
2.35) (Table 4.1). ANGPTL-4 is a marker of angiogenesis, Col1A1 is a marker of fibroblast 
differentiation and TGFβRII is a vital component of TGF-β pathway. Observations show that 
under a flow rate of 150µl/min gene expression of ANGPTL-4, Col1A1 and TGFβRII were 
increased by 16.3 fold, 2.29 fold and 2.15 fold respectively as assessed by RT-qPCR.  Fold 
changes in gene expression of ANGPTL-4, COL1A1 and TGFβRII as revealed by the 
Qlucore software were 5.12, 1.10 and 1.09 respectively at the same flow rate. Both RT-qPCR 
and Qlucore use different platforms with different technology including sample preparation 
prior to final quantification and this may account for differences in fold changes of gene 
expression obtained by two different techniques. However, it is noteworthy to observe that 
the qPCR results validate Qlucore based findings and show similar pattern of increased gene 
expression of ANGPTL-4, COL1A1and TGFβRII in dermal fibroblasts treated with fluid 
flow rate of 150µl/min. 
 
Notably there are profound fold change differences in the chosen genes at two different flow 
rates. The increase in fold endogenous gene expression with reference to static control is 
higher for ANGPTL-4 and TGFβRII at a flow rate of 75µl/min than in 150µl/min suggesting 
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that the same set of genes are predisposed to show changes in different orders of magnitude at 
different flow rates.  This observation is particularly interesting since it shows that fibroblasts 
are not only sensitive to fluid flow induced shear stresses but gene expression is also directed 
by the magnitude of shear stresses (Park et al., 2010).  
 
4.5.3 Fluid flow mediated gene alterations are functionally 
associated with TGF-β pathway. 
The gene ontology (GO) defines concepts used to describe gene function and relationships 
between these concepts. Functions are classified on the basis of three aspects: molecular 
function of gene product, components where the products are active and biological pathways. 
GO annotations are statements that describe biological functions of a specified gene.  The GO 
enrichment analysis tool performs an enrichment analysis of GO terms that are over 
represented for a given set of up-regulated / down-regulated genes and generates a table with 
following components A) Background frequency: Genes annotated to the GO Term in the 
background set, B) Over/under represented terms: Over represented and underrepresented 
genes expressed as ‘+’ and as ‘-’ symbols, C) P-value: probability of observing x number of 
genes out of total n genes in the background distribution of annotation. Therefore, closer the 
p-value is to zero, the higher is the significance of the specific GO Term associated group of 
genes.  In the current study GO Term pathways for 2944 transcripts that displayed statistical 
significance score (t-test, p<0.01) were assessed. Of these transcripts, genes which showed 
high enrichment score greater than 2.3 were associated with TGF-β pathway related 
processes such as muscle cell differentiation (Owens et al., 2004), vascular development & 
angiogenesis (Gaengel et al., 2009),  apoptosis (Jang et al., 2002), cell morphogenesis (Ogata 
et al., 2007), cell migration (Vo et al., 2013) and cell motion (Yang and Moses, 1990). Gene 
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expression of the Smad proteins 1, 5, 6, 7 and 9 are altered under flow (Figure 4.4). Smad 
proteins are transcription factor which function as pivotal mediators of TGF-β pathway. 
Interestingly, it was observed that Smad7, an inhibitory Smad protein was also upregulated 
under both flow rates (75µl/min and 150µl/min) (Figure 4.4).  Literature has shown that 
Smad7 acts as a negative regulator of the TGF-β pathway (Nakao et al., 1997) and its 
presence calls for further investigation of signalling mechanisms induced by flow in 
fibroblasts.  
 
The KEGG pathway is the collection of pathway maps that brings together multiple entities 
such as protein, RNA, genes, chemical compounds, glycans and chemical targets. Pathway 
maps are classified as separate sections on metabolism, information processing, cellular 
processes, diseases and drug development. KEGG categories enriched were the pentose 
phosphate pathway, clathrin and caveolin mediated endocytosis and TGF- β signalling 
pathway.  Pentose phosphate pathway is a metabolic pathway which resembles glycolysis 
pathway and generates 5-carbon sugars and NADPH (Keller et al., 2014). Changes in cellular 
metabolism affects migration and invasion of cancer cells (Han et al., 2013). In cancer cells, 
glycolysis is used to produce ATP and substrates to the pentose phosphate pathway for 
nucleotide synthesis. Tumours are known to experience insufficient oxygen supply which is 
incapable of catering to growing demands of the developing vasculature (Vaupel and Mayer, 
2007).  In such low oxygen conditions, Pyruvate, the final product of glycolysis is converted 
to lactate by an enzyme called lactate dehydrogenase. In glioma cells, TGF-β2 mediated cell 
migration is regulated by lactate metabolism (Baumann et al., 2009) suggesting that TGF-β 
pathway and metabolic pathways such as pentose phosphate pathway are intertwined in 
disease and health. Similarly, it is also well documented that processes such as clathrin and 
caveolin mediated endocytosis are known to regulate TGF-β pathway (Chen, 2009). For 
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example, in human embryonic kidney HEK293 cells, internalisation studies revealed that 
both TGFβRI and TGFβRII are endocytosed. 
 
The TGF-β pathway has received enormous attention as a signalling process regulating 
cellular differentiation (Hinz, 2015) in normal fibroblasts, as a promoter of  Epithelial to 
Mesenchymal transition (EMT) (Tchafa et al., 2015, O'Connor and Gomez, 2014) and 
Endothelial to Mesenchymal Transition (EndoMT) and as a stress induced 
mechanotransductor in the extracellular matrix (Klingberg et al., 2014, Maller et al., 2013, 
Hao et al., 2015). Reports show that in dermal fibroblasts cultured in a 3 dimensional 
environment which mimics interstitial fluid flow, displayed increased fibroblast-to-
myofibroblast differentiation, proliferation and collagen alignment even in the absence of 
exogenous mediators (Ng et al., 2005). The study shows that these remarkable changes 
observed in fibroblasts under fluid flow were associated with TGF-β1 induction. Subsequent 
reports showed that interstitial fluid flow and cyclic strain differentially regulate cardiac 
fibroblast activation via Angiotensin II type I receptor (AT1R) and TGF-β1 (Galie et al., 
2012).  These studies suggest that the TGF-β pathway functions as a crucial regulator of fluid 
flow associated changes in gene expression profile of dermal fibroblasts and calls for the 
exploration of the effect of fluid flow in fibroblasts in the presence of chemical signals like 
TGF-β1 that are supplemented exogenously.  
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Chapter 5 - Fluid flow mediated 
activation of fibroblasts is transient 
and is regulated by the TGF-β 
pathway 
 
 
 
 
 
 
 
 
 
 
123 | P a g e  
 
 
5.1 Introduction  
 
Fibroblasts are influenced by tissue turnover, repair and homeostasis. The term ‘Fibroblast’ 
denotes all stromal cells that which do not express marks of any other mesenchymal cell type 
such as smooth muscle cells or progenitor cells. However the fibroblast phenotype is highly 
heterogeneous with the oral cavity itself housing a variety of fibroblast sub populations 
(Hinz, 2013). A good example of fibroblast heterogeneity is observed in the skin where 
different layers of the dermis have different fibroblast subpopulations (Nolte et al., 2008, 
Sorrell and Caplan, 2004). Fibroblast heterogeneity in the oral cavity can be seen in the 
periodontium where fibroblasts from gingiva and periodontal ligaments are highly 
heterogeneous in function and contain a fraction of cells with stem cell characteristics 
(McCulloch and Bordin, 1991, Nanci and Bosshardt, 2006). Fibroblasts from the periodontal 
ligament orient along the collagen fibres and account for high levels of collagen turnover in 
the ligament pockets (McCulloch et al., 2000). On the other hand, gingival fibroblasts are 
responsible for preservation of connective tissue architecture (Coletta and Graner, 2006). A 
dysregulation in signalling mechanisms leads to gingival overgrowth as is observed in 
gingival fibromatosis (Trackman and Kantarci, 2004). Oral fibroblasts from gingival and 
periodontal sources respond to environmental factors such as mechanical stimulation (Pender 
and McCulloch, 1991) and infection (Scheres et al., 2010).  
 
Fibroblasts respond to mechanical signals by forming stress fibres and developing contractile 
features which aid mechanotransduction. Cells displaying this type of an ‘activated’ 
phenotype are termed as a ‘myofibroblasts’. They were first discovered in wound granulation 
tissue wherein they displayed contractile microfilament bundles and a prominent endoplasmic 
reticulum (Gabbiani et al., 1971). Another hallmark of these fibroblasts is the expression of 
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α-smooth muscle actin (α-SMA) in the stress fibres which confers the contractility in these 
cells (Hinz, 2007). The percentage of fibroblasts which acquire α-SMA positive fibres largely 
depend on the species and tissue origin (Hinz, 2010, Rohr, 2011). For example, during 
pathological conditions of a liver disease, it has been reported that myofibroblastic cells 
expressing α-smooth muscle actin are derived either from hepatic stellate cells or from portal 
fibroblasts (Desmouliere, 2007). 
 
Transforming growth factor-β1 (TGF-β1) is the pivotal cytokine which induces fibroblast 
differentiation to a myofibroblast phenotype (Desmouliere et al., 1993). Differentiated 
myofibroblasts can produce their own TGF-β1 for persistence of fibrosis  (Wynn and 
Ramalingam, 2012). TGF-β1 triggers the expression of ED-A form of fibronectin (Oyama et 
al., 1989) which supports enhanced expression of α-SMA and collagen type I (Serini et al., 
1998). Connective tissue growth factor (CTGF) is another profibrotic protein secreted by 
endothelial cells and is known to play a role in downstream mediation of TGF-β signalling in 
fibroblasts (Leask et al., 2004, Grotendorst, 1997).  However, in this study focus will largely 
be on effects of TGF-β signalling in fibroblast differentiation. 
 
TGF-β1, 2 and 3 are the ligands associated with the inhibition of proliferation in most types 
of cells. However, in mesenchymal cells they induce proliferation, production of extracellular 
matrix and induce fibrosis in vivo (Otranto et al., 2012, McCartney-Francis et al., 1998). The 
TGF-β isoforms are initially synthesized as latent precursors bound to binding proteins 
(LTBP-1, 2 and 3). LTBP, which is predominately found in the matrix (Werb, 1997) is 
proteolytically cleaved and releases the active forms of TGF-β ligands (Annes et al., 2003). 
Once the ligands are activated, they bind to a heterotrimeric receptor which consists of type I 
and II receptor to form a TGF-β receptor complex (Heldin and Moustakas, 2016). Upon 
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activation of the receptor complex, TGF-β functions within the cell through the action of the 
Smad family of transcription factors (Miyazono et al., 2000). TGF-β receptor complex 
activation promotes phosphorylation of receptor activated Smads (Smad 2 and 3) by TGF-β 
receptor I kinase which further bind to Smad4 and translocate to nucleus (Figure 5.1) 
(Verrecchia and Mauviel, 2002).  Recent experiments using microarrays have compared gene 
expression profiles of fibroblasts obtained from Smad3-/- and Smad3+/+ mice. Results showed 
that TGF-β was unable to induce transcription in Smad3-/- mice (Yang et al., 2003) 
suggesting that phosphorylation of Smad3 is indispensable for effective functioning of the 
TGF-β signalling pathway.   
 
This chapter aims to explore the effect of fluid flow and TGF-β1 mediated signals in 
modifying the phenotype of fibroblasts from different tissue sources. 
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5.2: Fluid flow enhances gene expression of α-SMA and Collagen 
IA in Dermal and Oral Fibroblasts. 
5.2.1 Methods 
 
Primary dermal fibroblasts (NHDFC) and normal oral fibroblasts (NOF) were treated with 
fluid flow (150 μL/min) as described in section 2.10 for 24 h and RNA was extracted as 
described in section 2.17. RNA was extracted from three coverslips per condition and the 
entire experiment was conducted three times on plain glass and Collagen coated Thermonox 
coverslips. All three experiments were subjected to quantitative PCR analysis of α-SMA and 
COL1A1 as described in section 2.19. For immunofluorescence detection of α-SMA protein, 
coverslips containing dermal fibroblasts subjected to static and fluid flow conditions with and 
without TGF-β1 were immunolabelled with α-smooth muscle actin (α-SMA) antibody 
(Sigma) as described in section 2.12.  
 
5.2.2 Results 
 
TGF-β1 supplemented dermal fibroblasts treated in static conditions showed elevated levels 
of α-SMA and Col IA1 gene expression.  Interestingly, fluid flow (150 µl/min) also showed 
an increased gene expression of α-SMA in dermal fibroblasts grown on glass and collagen 
type I coated Thermonox surfaces (Figure 5.2 a and c). Similarly, COL1A1expression was 
also increased in fluid flow treated (150 μL/min) dermal fibroblasts grown on glass and 
collagen type I coated Thermonox surfaces (Figure 5.3 a and c). However, when TGF-β1 
supplemented fibroblasts were subjected to flow treatment, gene expression of both α-SMA 
and COL1A1were reduced. 
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Likewise in oral fibroblasts, TGF-β1 supplementation in static conditions increases levels of 
α-SMA and COL1A1 gene expression. Intriguingly, fluid flow (150 µl/min) also showed an 
increased gene expression of α-SMA in oral fibroblasts grown on glass and collagen type I 
coated Thermonox surfaces (Figure 5.2 b and d). Concurrently, Col IA1 expression was also 
increased in fluid flow treated dermal fibroblasts grown on glass and collagen type I coated 
Thermonox surfaces (Figure 5.3 b and d). TGF-β1 supplementation in oral fibroblasts 
subjected to flow treatment reduced gene expression of both α-SMA and COL1A1. Fold 
changes associated with changes in α-SMA and COL1A1 gene expression under flow 
treatment are show in table 5.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 5.1:  Fold changes in the gene expression of α- SMA and Coll IA1 in fluid flow (150 μL/min) treated 
dermal and oral fibroblasts grown on glass and collagen coated Thermonox surfaces compared to static controls 
(n=3). 
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Figure 5.2: Changes in α-SMA gene expression of fibroblasts under flow (150 μL/min) for 24 h. Dermal 
fibroblasts cultured on glass coverslips (a) and collagen type I coated Thermonox coverslips (c), oral fibroblasts 
cultured on glass coverslips (b) and collagen type I coated Thermonox coverslips (d), (n=3) (* represents p < 
0.05). Error bars represent mean ±SD.  FC relative to EC represents fold change relative to endogenous control. 
(S= Static, F= Flow, ST= Static+TGF-β1 and FT= Flow+TGF-β1, vs= versus). 
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Figure 5.3: Changes in Collagen I A1 (COL1A1) gene expression of fibroblasts under flow (150 μL/min) for 24 
h. Dermal fibroblasts cultured on glass coverslips (a) and collagen type I coated Thermonox coverslips (c), oral 
fibroblasts cultured on glass coverslips (b) and collagen type I coated Thermonox coverslips (d), (n=3) (* 
represents p < 0.05, *** represents p< 0.001). Error bars represent mean ±SD. FC relative to EC represents fold 
change relative to endogenous control. (S= Static, F= Flow, ST= Static+TGF-β1 and FT= Flow+TGF-β1, vs= 
versus). 
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Immunofluorescence studies revealed intense staining of α-SMA protein fibres in TGF-β1 
stimulated dermal fibroblasts grown in static conditions. As observed in gene expression 
studies, fluid flow also increases staining intensity of α-SMA protein fibres in dermal 
fibroblasts (Figure 5.4). However, the staining intensity decreased in TGF-β1 supplemented 
and flow treated dermal fibroblasts. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4: Expression of α- smooth muscle actin in dermal fibroblasts subjected to fluid flow (150 μL/min) and 
TGF-β1 treatment for 24h. All images were captured using 100X magnification lens using the same exposure 
time. (Scale bar =10 microns). 
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5.3: Phosphorylation of Smad3 modulates fibroblast activation by 
fluid flow. 
5.3.1 Methods 
 
Primary dermal fibroblasts (NHDFC) were treated with fluid flow as described in section 
2.10 for 2 h and immunolabelled with anti-Smad3 (phospho S423 + S425) antibody (Abcam) 
as described in section 2.14. Slides were viewed under a 100X magnification lens (oil 
immersion) in a fluorescent microscope. (Zeiss Axioplan2, Imaging with software proplus 
7.0.1). Phosphorylated Smad3 protein was also detected by treating dermal fibroblasts with 
fluid flow as described in section 2.10 for 2 h, extracting the protein and performing a 
western blot as explained in section 2.21. Protein concentration was quantified by Image J 
software and expression change relative to β-actin control and was plotted using graph pad 
software. 
 
5.3.2 Results 
 
Immunofluorescence studies revealed that in dermal fibroblasts treated in static conditions 
there is little translocation of phosphorylated Smad3 protein to the nucleus. In TGF-β1 
supplemented static conditions, expression of phosphorylated Smad3 was observed in the 
nucleus. We observed similar intensity of phosphorylated Smad3 positive nuclei in fluid flow 
(150 μL/min) treated fibroblasts. When fibroblasts were supplemented with TGF-β1 and 
subjected to fluid flow, all cells displayed phosphorylated Smad3 positive nuclei with intense 
staining (Figure 5.5 a).  
 
Western blots (Figure 5.5 b) and quantification by Image J (Figure 5.5 c) revealed that that 
fluid flow increased the level of phosphorylated Smad3 from 15% in static to 44.7% relative 
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to the β-actin control in comparison to static treatment. When TGF-β1 supplemented 
fibroblasts were subjected to fluid flow, phosphorylated Smad3 increased 98.9% of the β-
actin control which was similar to levels seen in fibroblasts treated with TGF-β1 in static 
conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5:  Phospho Smad3 expression in dermal fibroblasts subjected to flow (150 μL/min) for 2h.(n=3) a) 
nuclear localization of phospho-Smad3 in stained dermal fibroblasts subjected to fluid flow and TGF-β1 
supplementation b) Expression of phospho-Smad3 protein relative to β-actin expression in dermal fibroblasts. 
All images were captured at 100X magnification lens using the same exposure time. (Scale bar =10 microns). C) 
Quantification of phospho-Smad3 protein blots by image J. 
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5.4: Fluid flow increases expression of TGF-β1 in dermal 
fibroblasts. 
5.4.1 Methods 
 
Primary dermal fibroblasts (NHDFC) were treated with fluid flow as described in section 
2.10 for 24 h and immunolabelled with TGF- β1 antibody (Lifespan Biosciences) as 
explained in section 2.15. Slides were viewed under 100X magnification lens (oil immersion) 
in a fluorescent microscope. (Zeiss Axioplan2, Imaging with software proplus 7.0.1).  
Cell associated and secreted TGF- β1 was determined in dermal fibroblasts subjected to fluid 
flow treatment for 24 h. using a Quantikine ELISA kit (Abcam). The assay was performed as 
described in section 2.22. 
 
5.4.2 Results 
 
Dermal fibroblasts subjected to flow treatment revealed intense staining of TGF-β1 in the 
perinuclear region in comparison to the fibroblasts treated in static conditions. (Figure 5.6 a). 
Secreted TGF-β1 in circulating medium (Figure 5.6 b) and cell associated TGF-β1 (Figure 
5.6 c) were elevated in comparison to statics with secreted TGF-β1 being significantly (p< 
0.01) higher under flow.  
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Figure 5.6: Expression of transforming growth factor β1 in dermal fibroblasts subjected to flow (150 μl/min) for 
24h. Immunofluorescence detection of TGF-β1 in a) dermal fibroblasts treated in static conditions and flow 
(n=3). All images were captured using 100X magnification lens using the same exposure time. (Scale bar =10 
microns). b) Secreted TGF-β1 protein expression in dermal fibroblasts subjected to fluid flow at 150 µl/min 
(n=3) (* represents p < 0.05), c) Protein expression of cellular TGF-β1 in dermal fibroblasts subjected to fluid 
flow at 150 µl/min (n=2). 
 
5.5: Fluid flow associated fibroblast differentiation is transient. 
5.5.1 Methods 
 
Primary dermal fibroblasts (NHDFC) and normal oral fibroblasts (NOF) were treated with 
fluid flow (150 μL/min) as described in section 2.10 for 24 h and allowed to remain in static 
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conditions for 24h. following which α-SMA expression was studied by immunofluorescence 
staining of the coverslips with α-smooth muscle actin (α-SMA) antibody (Sigma) as 
described in section 2.12.  
5.5.2 Results 
 
In line with previous observations, fluid flow (150µl/min) treatment for 24h. increases 
expression of α-SMA positive protein fibres. Interestingly, when fluid flow differentiated 
fibroblasts were allowed to remain in static conditions for 24h., expression of α-SMA 
positive protein fibres decreased (Figure 5.7). 
 
 
 
 
 
 
 
 
 
Figure 5.7: Reversal of α- smooth muscle actin (αSMA) expression in dermal fibroblasts subjected to fluid flow 
(150 μL/min) for 24h. followed by static treatment for 24h. All images were captured using 100X magnification 
lens using the same exposure time. (Scale bar =10 microns). 
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5.6: Discussion: 
5.6.1: Fluid flow enhances expression of α-SMA and Collagen IA 
in Dermal and Oral Fibroblasts. 
As discussed in the previous sections, myofibroblasts are a variant form of fibroblasts that 
acquire a smooth muscle phenotype. During wound healing, they contract by using smooth 
muscle type actin-myosin complex and promote wound contracture. They have been shown 
to originate from bone marrow derived circulating cells known as fibrocytes (Abe et al., 
2001), stromal cells from epithelial tumours (Ishii et al., 2003, Kalluri and Zeisberg, 2006), 
and epithelial mesenchymal transition (EMT) (Potenta et al., 2008). Hence injured tissue 
attracts myofibroblasts from different sources to meet the high demands of cells during 
wound healing activity. 
 
In a tissue, normal fibroblasts lie embedded within the fibrillar extracellular matrix (ECM) of 
connective tissue, which consists largely of type I collagen and fibronectin (Baum and Duffy 
2011). Fibroblasts interact with their surrounding microenvironment through integrins such 
as the α1β1 integrin. Typically, fibroblasts appear as fusiform cells with a prominent actin 
cytoskeleton and vimentin intermediate filaments. When these fibroblasts are challenged with 
mechanical stress such as injury or aberrant fluid flow, mechanoreceptors on the cell surface 
invoke a variety of cellular responses to instruct the cell to differentiate to myofibroblasts and 
acquire contractile properties (Duscher, Maan et al. 2014). α-smooth muscle actin (α-SMA) is  
an isoform typical of smooth muscle cells (SMC) (Skalli et al., 1989) and a hallmark of 
myofibroblasts (Skalli et al., 1986).  Expression of α-SMA in stress fibers confers a two fold 
increase in contractile activity of myofibroblasts compared to α-SMA negative fibroblasts 
(Hinz et al., 2001).  Although the detection of fibroblasts can be challenging because most 
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known markers are not specific to fibroblasts, fibroblast-specific protein 1 (FSP1), a member 
of the family of S100 Ca2+ binding proteins, however specifically detects fibroblasts in 
normal tissues. 
 
Mechanotransduction is a process wherein cells convert mechanical signals into biochemical 
signals which mediate cellular responses. Myofibroblasts employ actin based motors to 
generate contractile forces and mediate tissue remodelling by traction (Tomasek et al., 2002). 
Mechanical force induced SMA uses a feed-forward amplification loop involving a priori 
SMA in focal adhesions, binding of p38 MAP kinase to SMA filaments, activation of Rho 
and binding of serum response factor to the CArG-B box of the SMA promoter (Wang et al., 
2006a). Therefore, SMA acts a mechanotransductor which receives messages from 
mechanosensors in focal adhesions and transmits these signals to downstream kinases. 
 
Our results complement previous findings that TGF-β1 is a potent activator of myofibroblasts 
and it causes changes in the expression of alpha-smooth muscle actin (alpha-SMA) (Honda et 
al., 2010) and Collagen IA (Cutroneo et al., 2007, Pan et al., 2013). 
 
Results obtained from qPCR based expression analysis of cells cultured on glass, Thermonox 
cover slips, when subjected to flow conditions in stimulated and unstimulated cultures show 
significantly increased expression of α-SMA and Collagen IA in both oral and dermal 
fibroblasts when subjected to flow. The results showed similar patterns of increased gene 
expression in glass and collagen coated Thermonox cover slips subjected to flow. However, 
in both dermal and oral fibroblasts, when cells were stimulated with TGF-β1 and subjected to 
flow, the expression of α-SMA decreased due to unknown reasons. It is possible that the 
combinatorial effect of TGF-β1 and flow mediated expression of α-SMA switches on 
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alternative biochemical processes such as membrane trafficking of receptors (Chen, 2009), 
lysosome mediated endocytosis of receptor bound TGF-β ligands etc. In our efforts to 
address possible mechanisms involved in downregulation of α-SMA and Col IA1 expression 
in TGF-β1 stimulated fibroblasts treated by fluid flow, endocytosis related experiments were 
performed in the sections described further. 
 
One study reported that in human lung fibroblasts, TGF-β1 treatment induces expression of 
both α-SMA and p38 MAP kinase.  The MAP Kinase pathway is known to play a crucial role 
stress induced senescence (Debacq-Chainiaux et al., 2010, Maruyama et al., 2009).  
Surprisingly, they also showed that TGF-β1 induced α-SMA can be suppressed by p38 kinase 
inhibitor (SB203580), Erk inhibitor (PD98059) and the AP-1 inhibitor curcumin suggesting 
that molecules such as p38 kinase, Erk, and AP-1 can be responsible for the α-SMA 
expression induced by TGF-β1 in human fetal lung fibroblasts (Hu et al., 2006).  This 
evidence suggests that apart from signalling processes such as endocytosis, receptor 
regulation and membrane trafficking of receptors TGF-β1 induced α-SMA expression is 
influenced by other regulatory pathways as well. 
 
5.6.2: Dermal fibroblasts are activated by flow in a phospho-
Smad3 dependant manner. 
Expression of α-SMA in myofibroblasts and quiescent fibroblasts is induced by TGFβ-1 
(Desmouliere et al., 1993). TGFβ-1 is a well-studied factor known to play active roles in 
recruitment of fibroblasts, conferring smooth muscle phenotype to myofibroblasts (Honda et 
al., 2010), induction of EMT and metastasis (Siegel and Massague, 2003). TGFβ signalling 
involves Smads, and Smad3 in particular, is the principal determinant of EMT, a process 
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which mediates epithelial to mesenchymal transition in pathological conditions like cancer 
(Mani et al., 2008). 
 
In order to begin to examine the signalling mechanisms underlying our observation that fluid 
flow can induce fibroblast differentiation, Smad3 phosphorylation was analysed. Smad3 is a 
transcription factor, which remains localised to the cytoplasm in un-stimulated cells. Upon 
activation of TGF-β receptors, Smad3 is phosphorylated by TGFβR1, Alk4 and Alk5 (Lin et 
al. 2009) and translocates to the nucleus. Nuclear localization of phosphorylated Smad3 in 
dermal fibroblasts subjected to TGF-β1 stimulation and fluid flow suggests activation of the 
TGF-β pathway even within 2 h of flow treatment. Contrastingly, fibroblasts treated with 
TGF-β1 and fluid flow also showed nuclear localization of phosphorylated Smad3. It is likely 
that Smad3 is phosphorylated transiently due to elevated levels of TGF-β1 in the circulating 
medium even within 2 h flow and is dephosphorylated with time due to caveolin mediated 
membrane trafficking of TGF-β1 bound receptor complex into the nucleus. 
 
Caveolins coat membrane bound pits that contribute to receptor mediated endocytosis of 
ligands such as transferrin and low density lipoprotein (Marsh and McMahon, 1999). They 
exist in three isoforms namely caveolin-1 (Cav-1), caveolin-2 (Cav-2), and caveolin-3 (Cav-
3). TGF-β1 inhibits proliferation of Cav-2 knockout endothelial cells (ECs) (L Xie, 2011) via 
suppression of Alk5-Smad2/3 pathway. This inhibition manifests itself as a reduced 
magnitude and length of TGF-β-induced Smad2/3 phosphorylation in Cav-2-positive ECs.  
Subsequent reports showed that N-terminal tyrosine phosphorylation is an essential molecular 
event which allows Cav2 to inhibit TGF-β-induced stimulation of Smad3 phosphorylation 
(Abel et al., 2012) thus making it plausible that fluid flow treated dermal fibroblasts enhance 
the expression of caveolins and TGF-β1 supplementation could reduce the length and 
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magnitude of SMAD3 phosphorylation after 2h., thus reducing the expression of α-SMA 
after 24h. 
 
5.6.3: Transient activation of dermal fibroblasts is regulated by 
TGF-β1. 
Our observations from ELISA experiments have shown that TGF-β1 can be detected in cell 
associated fractions and is also secreted by the cell into the circulating medium. This prompts 
conclusion that fluid flow mediated activation of fibroblasts is controlled by the TGF-β 
pathway by release of TGF-β1 which may induce an autocrine and paracrine signalling effect. 
Previous research by others  reveal that interstitial fluid flow can activate dermal fibroblasts 
by increasing expression of TGF-β1 when subjected to fluid flow at rate of 120µl/min (Ng et 
al., 2005). The group demonstrated that such low levels of fluid flow stimulated autocrine 
upregulation of TGF-β1 which in turn induced fibroblast to myofibroblast transition and 
collagen alignment in vitro and that these effects could be eliminated with TGF-β1 blocking 
antibodies. These findings suggest that even in the absence of TGF-β1, factors secreted by 
inflammatory cells and epithelial cells, interstitial fluid flow can induce fibroblast activation 
and sustain differentiation.  Results reveal that similar levels of fluid flow (150 µl/min) can 
invoke TGF-β1 expression in fibroblasts of both dermal and oral origin suggesting that these 
mechanical signals evoke similar differentiation responses irrespective of tissue origin.  
 
Immunofluorescence images of flow activated fibroblasts validate our findings further. 
Observations in the current study show that TGF-β1 is intensely stained in the perinuclear 
region only in fibroblasts under flow when compared to fibroblasts in static conditions. It 
highly likely that 24 h. since induction of flow, dermal fibroblasts adapt themselves to an 
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alternate signalling mechanism which may bring TGF-β1 bound receptor complexes toward 
the nucleus due to mechanisms such as endocytosis and membrane trafficking (Chen, 2009) 
as described in Chapter 6. A recent study has shown that TGF-β displays concentration 
dependant switching of molecular signalling and biological specificity in podocytes (Wu et 
al., 2005) and that lower concentrations of  TGF-β1 induced tubulogenesis in epithelial cells 
(Montesano et al., 2007). These reports suggest that the combined effect of TGF-β1 
supplementation and fluid flow induced release of TGF-β1 leads to supra physiological 
concentration which may cause an inhibitory effect in expression of α-SMA. 
 
Intriguingly, when fluid flow activated fibroblasts were allowed to remain in static conditions 
for 24h., these cells reverted to a resting state phenotype. This suggests that fluid flow 
mediated fibroblast activation is regulated transiently by TGF-β pathway and is influenced by 
other mechanisms that enable reversal to native state phenotype upon withdrawal of the 
mechanical signal.  Prostaglandin E2 (PGE2) is one such molecule which unambiguously 
demonstrates reversal of established fibroblast differentiation to normal fibroblasts (Garrison 
et al., 2013). Fetal and adult lung fibroblasts were first stimulated with TGF-β1 for 24h. to 
differentiate into myofibroblasts. Cells were then treated without or with PGE2 for various 
intervals and α-SMA expression was assessed. Findings showed that in the absence of PGE2 
treatment, TGF-β1 induced α-SMA expression was stable for up to 8 days. Contrastingly, 
PGE2 treatment resulted in dose-dependent decrease in α-SMA and collagen I expression 
within 2 days post treatment and persisted for 8 days in culture. Surprisingly, when TGF-β1 
was reintroduced 2 days after addition of PGE2, fibroblasts started to re-express α-SMA, 
indicating differentiation to myofibroblasts.  
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Chapter 6 - Caveolin mediated 
membrane trafficking of TGFβ 
receptor regulates fluid flow 
activated fibroblasts. 
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6.1: Introduction  
Cells sense and communicate with the environment by interacting with ligands and activating 
the signalling receptors at the surface via processes such as endocytosis. The term 
‘endocytosis’ was first coined by Christian deDuve in 1963 to define an energy dependant 
process wherein a portion of the cellular plasma membrane ingests macromolecules from the 
surrounding medium and forms a vesicle known as an Endosome. 
 
Early Endosomes (EE) are the first endocytic compartment that receives incoming cargo and 
are often located in the cellular periphery.  They have a mildly acid pH and appear as tubule-
vesicular structures.  They are composed of regions of thin tubular extensions and large 
vesicles (Gruenberg, 2001). The ingested receptor-ligand complex is dissociated in the acidic 
lumen of these endosomes and many of the receptors recycle to the cell surface. Some of 
these endosomes form aggregates known as multivesicular bodies (MVB) or endosomal 
carrier vesicles (ECV). The pH in the lumen of these multivesicular bodies ranges from 5.5- 
6.5. The primary function of the EE is breakdown of cellular waste, fats, proteins and other 
macromolecules into simple compounds and the simple compounds are later released into the 
cytoplasm. Interstingly, TGF-β receptors may also enter cells via cholesterol-rich membrane 
microdomain lipid rafts/caveolae and are found in CAV1 positive vesicles (Chen, 2009). A 
study reports that TGF-β receptors localize to the ciliary tip and endocytic vesicles at the 
ciliary base in fibroblasts and TGF-β1 supplementation increases receptor localization and 
activation of SMAD2/3 and ERK1/2 at the ciliary base (Clement et al., 2013). 
 
Caveolae are a type of membrane raft made of flask shaped invaginations of diameter ranging 
from 60-80 nm. Of the three variants as described in chapter 1, caveolin-1 and caveolin-2 are 
found in non-muscle cells whereas caveolin-3 is predominantly expressed in muscle. 
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Caveolin-1 is shown to be important in membrane raft dependant endocytosis via its 
interactions with the actin cytoskeleton. Caveolin dependant endocytosis plays a role in 
biological processes like uptake of viruses, nutrients and cell membrane receptors. Studies 
have shown that mice deficient in caveolin IA harbour significant vascular defects, and 
increased deposition of contractile proteins in the lungs suggesting that loss of caveolin-1 
may promote fibrosis in lungs.  These molecules have been implicated in membrane 
compartmentalization wherein proteins and lipids accumulate in these membrane 
microdomains and transmit specific signalling cascades (Boscher and Nabi, 2012). Caveolin-
1 is required for signaling and membrane targeting of EphB1 receptor tyrosine kinases which 
are key players during the development of the embryonic vasculature (Vihanto et al., 2006). 
Specific components of the TGF-β cascade are associated with caveolin-1 in caveolae with 
Cav-1 interacting with the TGF-β receptor type I (Razani et al., 2001) and caveolin I 
mediated TGF-β receptor internalization contributes to the pathogenesis of systemic sclerosis 
and idiopathic pulmonary fibrosis. 
 
Whilst it is increasingly evident that endocytosis casts an effect on the trafficking of TGF-β 
receptors and that both membrane-raft and caveolin mediated endocytosis  regulate TGF-β 
signalling (Di Guglielmo et al., 2003a), whether this process is involved in negative 
regulation of the signalling in TGF-β1 supplemented fibroblasts under flow has not been 
previously studied. Hence the expression of endocytosis associated markers such as early 
endosomal antigen (EEA-1) and caveolin-1A (CAV-1A) by immunofluorescence were 
studied. 
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6.2: Fluid flow alters the localization of caveolin-1 in dermal 
fibroblasts. 
6.2.1: Methods 
  
Primary dermal fibroblasts (NHDFC) were treated with fluid flow as described in section 
2.10 for 2 h. In order to detect cytoplasmic expression of caveolin, three coverslips were 
permeabiilised with 0.1% Triton X-100 in PBS whereas the other three coverslips were not 
permeabilised to detect surface expression. Cells were immunolabelled with rabbit polyclonal 
anti-caveolin-1 (Abcam) as described in section 2.14.  Mounted slides were viewed under 
100X magnification lens (oil immersion) in a fluorescent microscope. (Zeiss Axioplan2, 
Imaging with software proplus 7.0.1).  
 
6.2.2: Results 
 
To assess whether the decrease in the activation response in TGF- β1-stimulated fibroblasts 
subjected to fluid flow was mediated by changes in endocytosis (Chen, 2009), both 
membrane bound and cytoplasmic protein expression of caveolin-1A under flow were 
detected. Fibroblasts in static culture conditions had intense staining for caveolin-1A on the 
cell surface (Figure 6.2a) and lesser cytoplasmic expression (Figure 6.2b). Cytoplasmic 
expression of caveolin 1A was increased in fibroblasts subjected to flow in both TGF- β1 
stimulated and unstimulated conditions suggesting that under the influence of fluid flow, 
membrane bound caveolin 1A was internalised into the cell.  
 
 
 
146 | P a g e  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1: Changes in expression of caveolin 1A in dermal fibroblasts subjected to fluid flow (150µl/min) for 
2h. a) Cell surface protein expression of caveolin 1A (green) in unpermeabilised dermal fibroblasts and b) 
cytoplasmic expression of caveolin 1A protein in permeabilised fibroblasts. All images were captured using 
100X magnification lens using the same exposure time. (Scale bar =10 microns). 
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6.3: Fluid flows promotes endocytosis and translocates the TGF-β 
receptor to the nucleus of dermal fibroblasts. 
6.3.1: Methods 
  
Primary dermal fibroblasts (NHDFC) were treated with fluid flow as described in section 
2.10 for 2 h. and immunolabelled with rabbit polyclonal transforming growth factor β 
receptor type II (TGFβRII)) (Santa Cruz Biotechnology) and mouse monoclonal early 
endosomal antigen-1 (EEA-1) (B.D Biosciences) as explained in section 2.14. Mounted slides 
were viewed under 100X magnification lens (oil immersion) in a fluorescent microscope. 
(Zeiss Axioplan2, Imaging with software proplus 7.0.1).  
 
6.3.2: Results 
 
Fluid flow treated fibroblasts were double immunolabelled to simultaneously detect early 
endosomal antigen-1 (EEA-1) a marker of endosomal vesicle, and transforming growth factor 
beta receptor type II (TGFβRII). Little expression of EEA-1 (green colour) and TGF-βRII 
(red colour) was detected in fibroblasts in basal static conditions whereas TGF-β1 stimulation 
in static cultures resulted in intense staining of EEA-1 (Figure 6.2). Fluid flow treatment 
triggered not only a similar increase in expression of EEA-1 but also promoted internalisation 
and nuclear translocation of TGF-βRII (Figure 6.2). Similarly, the combination of TGF- β1 
stimulation and fluid flow also induced nuclear translocation of TGF-βRII (Figure 6.2). 
 
 
 
 
 (a) (b) (a) (b) 
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Figure 6.2: Expression of transforming growth factor β receptor type II and early endosomal antigen-1 in dermal 
fibroblasts subjected to flow (150 μL/min) for 2 h.  Cells are stained with (a) EEA-1 (green), (b) TGF-βRII 
(red), and  (c) DAPI (blue) and (d) merged images (red, blue, green) in fibroblasts treated in static conditions, 
static conditions stimulated with TGF-β1, fluid flow and fluid flow stimulated with TGF-β1. All images were 
captured using 100X magnification lens and are representative images from experiment of n=3. 
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6.4: Fluid flows enhances endocytosis in dermal fibroblasts. 
6.4.1 Methods 
 
Primary dermal fibroblasts (NHDFC) were treated with fluid flow as described in section 
2.10 for 2 h. and were stained by pH RODO dextran (70µg/ml) (Molecular Probes) in cell 
imaging buffer as described in section 2.16. Mounted slides were viewed under 100X 
magnification lens (oil immersion) in a fluorescent microscope. (Zeiss Axioplan2, Imaging 
with software proplus 7.0.1).  
 
6.4.2 Results 
 
Little staining of pH RODO dextran was observed in static conditions in both unstimulated 
and TGF-β1 stimulated fibroblasts. However, findings revealed dramatic increase in pH 
RODO dextran staining (Pink colour) in both unstimulated and TGF-β1 stimulated fibroblasts 
which were subjected to flow treatment suggesting that fluid flow increased endocytosis of 
pH RODO Dextran into endosomes due to endocytosis (Figure 6.3). 
 
 
 
 
 
 
 
Figure 6.3:  Staining of endosomal compartment by pH RODO dextran in dermal fibroblasts subjected to static 
treatment ± TGF-β1 and fluid flow ±TGF-β1 at 150 µl/min. All images were captured using 100X magnification 
lens and are representative images from experiment of n=3. 
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6.5: Discussion. 
Various studies in the literature show that receptor mediated endocytosis exerts positive and 
negative effects on activation of signalling receptors such as G- protein coupled receptors 
(Sorkin and von Zastrow, 2009). The TGF-β receptors are no exception in that they are 
sequestered to the vesicular compartments undergoing both clathrin mediated (Chen, 2009) as 
well as caveolin mediated endocytosis (He et al., 2015). In this chapter, efforts were made to 
study the effect of fluid flow in modulating the endocytic response of TGFβ Receptor II 
(TGFβRII) in TGF-β1 stimulated fibroblasts as a possible explanation of the downregulation 
in response to TGFβ under flow conditions (Chapter 5). 
 
6.5.1: Fluid flow enhances the expression of caveolin-1 in dermal 
fibroblasts. 
As described in the previous pages, caveolins form a crucial component of the endocytic 
machinery and exist as three separate members.  Recent studies have shown that caveolin-1 is 
a modulator of fibroblast activation and serves as a biomarker for tumours such as gastric 
cancer (Shen et al., 2015). Findings also showed that CAV-1 was a key regulator of paracrine 
activation in gastric cancers. Contrastingly, other studies showed that caveolin-1 null 
mammary stromal fibroblasts share characteristics with cancer associated fibroblasts (CAF) 
from breast cancer patients (Sotgia et al., 2009) and that a loss of CAV-1 expression in CAFs  
is a predictor of poor prognosis in breast cancer (Simpkins et al., 2012). Apart from its role in 
promoting tumourigenesis, caveolin-1 is also known to exert an antifibrotic effect in diseases 
such as lung fibrosis (Wang et al., 2006b), scleroderma (Tourkina et al., 2008), keloids 
(Zhang et al., 2011a) and cardiac fibrosis (Miyasato et al., 2011). It was observed that in all 
these cases, reintroduction of caveolin-1 antagonised the effect of TGF-β signalling by 
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decreasing expression of Collagen 1AI and fibronectin. Consistent with these observations, 
several other findings also reported that caveolin-1 is a negative regulator of TGF-β1 
signalling in urethral smooth muscle cells (Stehr et al., 2004), leucocytes (Tourkina et al., 
2010), and hepatocytes (Mayoral et al., 2010). Caveolins were initially detected at the inner 
membrane surface of fibroblast Caveolae (Rothberg et al., 1992) and the Golgi apparatus 
(Dupree et al., 1993) using immunogold cytochemistry. Intense expression of caveolin-1A on 
the cellular surface of un-stimulated fibroblasts in static conditions confirm that these 
molecules are membrane bound in conditions devoid of physical forces such as interstitial 
fluid flow.  However, intense cytoplasmic staining of caveolin-1A in both unstimulated and 
TGF-β1 stimulated fibroblasts suggest that fluid flow treatment for a short period of 2 h can 
stimulate translocation of these membrane bound molecules to the cytoplasm. Cytoplasmic 
translocation of caveolin-1 is likely to result in endocytic trafficking of TGF-β1 bound 
receptor complexes that are then engulfed into caveolar vesicles. This has been observed in 
previous studies which showed internalisation of TGF-Β receptor type I (TGF-βRI) into  
caveolin-1 and early endosomal antigen-1 (EEA-1) double positive vesicles (He et al., 2015). 
Our findings of cytoplasmic translocation of caveolin-1 were strengthened by another study 
which showed that mechanical stretch induces translocation of caveolin from caveolae to 
non-caveolar sites in vascular smooth muscle cells (Kawabe et al., 2004). The group showed 
that this translocation is crucial for mechanical stretch induced activation of the ERK 
signalling cascade, an important mitogenic pathway in vascular smooth muscle cells. 
Subsequently it was showed that soluble caveolin remains embedded in a lipid particle and 
can travel to the endoplasmic reticulum, mitochondria and various other locations in the 
cytosol (Li et al., 2001). Our findings suggest that previous studies describing caveolins as 
membrane bound molecules (Parton and Simons 2007) must consider incorporating the 
physiological fluid flow component in studies.  Notably, if exposure of fibroblasts to fluid 
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flow for time periods as short as 2h. can induce cytoplasmic translocation of caveolin-1A,  
then it is highly likely that longer exposure to flow for over 24h. could possibly translocate 
all of the caveolins to non-caveolar locations as shown in previous studies (Kawabe et al., 
2004), thus carrying vesicle bound TGF-β receptors along with them to either non- caveolar 
locations or recycling them back to the cellular surface. 
 
6.5.2: Fluid flow promotes endocytosis and translocates the TGF-
β receptor to the nucleus of dermal fibroblasts. 
The TGF-β receptors are known to be constantly undergoing changes such as activation and 
engulfment into lipid vesicles either by clathrin-dependent or caveolin-dependent endocytosis 
(Di Guglielmo et al., 2003b, He et al., 2015). Notably in this study, genes associated with 
endocytosis were modified by fluid flow in fibroblasts. Since it is know that clathrin–
dependent trafficking of TGF-β receptors facilitates TGF-β signalling whereas caveolin- 
dependent internalisation of the receptors exerts an inhibitory effect (Anders et al., 1998, Di 
Guglielmo et al., 2003b), whether reduced expression of α-SMA in TGF-β1 stimulated 
fibroblasts subjected to fluid flow was explored (Figure 5.2) was due to caveolin mediated 
internalisation of TGFβ receptors. In line with previous studies that show that fluid flow 
induces endocytosis in the proximal kidney tubule (Raghavan and Weisz, 2015, Raghavan et 
al., 2014), observations show nuclear and cytoplasmic staining of early endosomal antigen 
(EEA-1) in fibroblasts subjected to fluid flow and double immunolabelled for EEA-1 and 
TGFβRII.  Interestingly, staining intensity of both nuclear and cytoplasmic EEA-1 was high 
in TGF-β1 stimulated cultures subjected to fluid flow for 2h (Figure 6.2).   
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In the unstimulated resting state, TGF-β receptors exist as monomers on the membrane of 
cells. Upon binding of TGF-β1, the receptors undergo dimerization (Zhang et al., 2009) and 
the TGF-β co-receptor, betaglycan presents the ligands to TGFβRII (Lopez-Casillas et al., 
1993). The ligand bound TGFβRII phosphorylates the GS domain of TGFβRI, thus 
promoting its interaction with Smad 2/3 and initiation of the signalling cascade (Kang et al., 
2009). Fibroblasts that were stained for both EEA-1 and TGFβRII not only reveal that flow 
promotes endocytosis but also nuclear translocation of TGFβRII (Figure 6.2).  Notably, 
nuclear staining of translocated TGFβRII was notably high in TGF-β1 stimulated cultures 
subjected to flow. Recent reports have shown that TGFβRI can be cleaved at residue G120 by 
TNF-α converting enzyme (TACE) and the released intracellular domain enters the nucleus 
to associate with p300 and regulate the expression of genes such as Snail and MMP2 (Mu et 
al., 2011). Subsequent papers showed that nuclear transport of TGFβRI is ligand inducible 
and requires cellular transformation as is observed in breast cancer cells (Chandra et al., 
2012) . We report here that TGFβRII can translocate to the nucleus under the influence of 
TGF-β1 stimulation and low levels of fluid flow. Our findings suggests that even short-term 
TGF-β1 stimulation and fluid flow treatment for 2h. can augment caveolin mediated 
endocytic trafficking of the TGFβRII to the nucleus, thus antagonising the TGF-β pathway 
and expression of α-SMA.  
 
6.5.3: Fluid flows enhances endocytosis in dermal fibroblasts. 
One of the characteristic properties of the endosome is its acidic nature. Apart from 
permitting the selective function of lysosomal enzymes, the acidic profile plays other vital 
roles such as dissociating the ligand-receptor complexes (Brown et al., 1983). For example, 
reports have shown that binding of epidermal growth factor is highly pH sensitive that the 
receptor bound complex dissociates at a pH of 6 (Nunez et al., 1993).  This high sensitivity to 
154 | P a g e  
 
pH is generally the rule of ligand dissociation of receptor ligand complexes during membrane 
trafficking. The trafficking of transferrin is another example which uses the unique pH 
sensitive membrane trafficking mechanism to achieve its biological function of delivering 
iron to intracellular sites. Here, the iron-transferrin complex binds to the cell surface receptor 
and is internalised to the acidic endosomes. Due to the sudden decrease in pH the iron 
dissociates but the receptor complex remains intact and rapidly returns to the cell surface. At 
the cell surface, the pH becomes neutral. This sudden change dissociates the apotransferrin 
complex (May et al., 1984).   
 
pH RODO Dextran is a an alternative to fluorescent conjugates used for live cell imaging of 
endocytosis. It possesses a pH sensitive fluorescence emission which emits fluorescence only 
in an acidic profile. Essentially, it is non-fluorescent in the extracellular compartment. 
However upon internalization, the acidic environment emits a bright red signal from the 
dextran conjugate. It emits little signal at neutral pH and hence pH RODO dextran prevents 
detection of non-internalised and non-specific binding of conjugates. Our findings reveal 
little florescence from the dextran conjugates in static conditions. On the other hand, 
fluorescence signals were intensely emitted by fibroblasts treated by flow suggesting that 
flow enhances overall endocytosis and internalisation of ligand bound complexes and that 
flow induced endocytosis is independent of the highly complex fibroblast activation process. 
Recent studies which investigated the effect of fluid shear stresses on cellular uptake and 
endocytosis of nanoparticles in a biomimetic microfluidic system showed that under the 
influence of fluid flow, cancer cells exhibited higher cellular uptake of positively charged 
amino modified polystyrene nanoparticles which were delivered to cells in both static and 
dynamic conditions (Kang et al., 2016).  These findings suggest that biomimetic dynamic 
conditions stimulated specific endocytosis and cellular uptake. 
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It is also possible that there are other relevant processes which use the endosomal 
environment to stimulate a chemical signal involved in receptor activation. For example, it 
has been shown in the past that the epidermal growth factor has to be continually present for 
a minimum of 8-10 h. to obtain a mitogenic reponse after 20 h. (Jorissen et al., 2003). 
Subsequently, it was shown that the biological effect of epidermal growth factor can be 
blocked by compounds such as methylamine and dansylcadaverine which can neutralise the 
endosomal system (Haigler et al., 1980). In line with these findings, it may be possible that 
treatment of fibroblasts with components that neutralise the endosomal system may influence 
the activation of fibroblasts. Whether endocytosis is vital for fluid flow mediated fibroblast 
activation is an area which requires further exploration. 
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Chapter 7- Fluid flow mediated 
fibroblast activation is buffered by 
TGF-β pathway associated molecules. 
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7.1: Introduction  
The TGF-β superfamily is composed of a numerous signalling molecules interacting with 
other signalling pathways, thus contributing versatility to its response to various biological 
processes. In this study we explored flow mediated effects on some of the widely described 
molecules: activin A, follistatin and CD109. 
 
Activin A’s role as a proliferative and a differentiation factor was first studied in human lung 
fibroblasts (Ohga et al., 1996b). Findings revealed that activin A showed maximal effect on 
cellular proliferation of lung fibroblasts at levels as low as 10-11 M. Activin A also stimulated 
differentiation of human lung fibroblast to myofibroblast phenotype (Ohga et al., 1996a). 
Notably, the proliferative effect of activin A was abolished by follistatin, an activin binding 
protein. Activin A is also a crucial regulator of fibrosis in cardiac fibroblasts and that 
Angiotensin II enhanced expression of activin A was reversed by follistatin (Hu et al., 2016). 
Interestingly, follistatin could reverse activin A mediated responses such as cellular 
proliferation, differentiation, collagen type I expression and activin A activated pathways 
such as ERK1/2 and p38-MAP kinase pathways (Hu et al., 2016).  Hashimoto et.al (1997) 
reported that the binding of activin to follistatin-288 (FS-288) is an irreversible process since 
the follistatin-activin complexes are rapidly endocytosed or degraded by lysosomal enzymes 
(Hashimoto et al., 1997).  Reports have shown that follistatin  can block the mesoderm 
inducing property of activins with other studies showing that it can also bind to bone 
morphogenic proteins (BMP-4 and 7) (Fainsod et al., 1997). The activin A–follistatin 
signalling system (Figure 7.1) is also a crucial determinant of extracellular matrix 
mineralization. Activin A induced inhibition of mineralization in osteoblast cultures was 
reversed by follistatin treatment (Eijken et al., 2007).  
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Exosomes are membrane vesicles released by epithelial cells, mesenchymal stem cells and 
tumour cells (Verma et al., 2015) and are known to contribute in cell-cell communication by 
removing dispensable proteins and cellular debris (Pan and Johnstone, 1983). These vesicles 
retain mRNAs, proteins and microRNAs and are released from the cells into the culture 
medium. CD 109 (cluster of differentiation 109) is a glycosylphosphatidylinositol anchored 
protein and is a crucial component of the exosomal factory. Recent findings revealed that 
membrane bound CD109 binds to TGF-β1 and promotes TGF-β receptor degradation via 
Smad7/Smurf2 mediated mechanism. Studies using the HEK293 human embryonic kidney 
cell line revealed that release of CD109 in the circulating medium is vital in the inhibition of 
TGF-β signalling (Sakakura et al., 2016). 
 
Based on the available body of literature, it could be hypothesized that these molecules could 
contribute to fluid flow induced fibroblast differentiation. Hence studies were focussed on 
activins, antagonists of activins and TGF-β binding proteins that are known to exert both 
positive and negative regulatory effects on the signalling cascade. 
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Figure 7.1: Activin A associated signalling mechanism. (Red dotted line indicates follistatin mediated 
antagonism of the pathway). 
 
7.2: Fluid flow mediated activation of fibroblasts is modulated by 
activin A.  
Although previous studies have shown that one of the widely described functions of activins 
are to invoke differentiation in fibroblasts, it is not clear yet whether these molecules 
contribute to fluid flow induced fibroblast activation. Our microarray analysis revealed that 
activin A is one of the top 20 genes associated with the TGF-β pathway increased under fluid 
flow, suggesting that activin A may play a role in fluid flow-mediated fibroblast activation 
and buffering of responses to TGF-β1. In this chapter, the gene and protein expression of 
activin A in unstimulated and TGF-β1 stimulated fibroblasts subjected to fluid flow were 
studied. 
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7.2.1: Methods  
 
Primary dermal fibroblasts (NHDFC) were treated with fluid flow as described in section 
2.10 for 24 h and RNA was extracted as described in section 2.17. Experiments were 
performed three times and all replicates were subjected to analysis by quantitative PCR of 
activin A (INHBA) as described in section 2.19.  Both cellular and secreted activin A were 
studied by subjecting dermal fibroblasts to flow treatment as above and performing ELISA as 
described in section 2.23. 
 
7.2.2: Results 
 
TGF-β1 supplemented dermal fibroblasts treated in static conditions showed elevated levels 
of activin A gene expression.  Interestingly, activin A transcript levels were increased by 2.5 
fold in dermal fibroblasts subjected to fluid flow for 24 h (Figure 7.2A). This was reduced to 
0.8 fold in TGF-β1 stimulated fibroblasts subjected to fluid flow as compared to those under 
fluid flow only.  
 
Concurrently, both cell-associated (Figure 7.2B) and secreted (Figure 7.2C) activin A protein 
were also measured by ELISA in cell lysates and conditioned medium. Results revealed that 
activin A was significantly (p< 0.01) increased in the conditioned culture medium and in cell 
extracts of fibroblasts subjected to flow. TGF-β1 stimulated fibroblasts in static and fluid 
flow conditions also showed elevated levels of cell-associated, but not secreted, activin A. 
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Figure 7.2: Expression of activin A in dermal fibroblasts subjected to fluid flow (150 μl/min) treatment for 24h. 
a) Gene expression of activin A with fold change relative to endogenous control in dermal fibroblasts subjected 
to flow (n=3) (* represents p < 0.05), b) Protein expression of cell associated A (n=3) (*** represents p < 
0.0001) and c) Protein expression of secreted activin A in dermal fibroblasts subjected to fluid flow (n=3) (*** 
represents p < 0.0001).  FC relative to EC represents fold change relative to endogenous control. (S= Static, F= 
Flow, ST= Static+TGF-β1 and FT= Flow+TGF-β1, vs= versus). 
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7.3: Fibroblast activation is attenuated by inhibition of activin A. 
Follistatins are activin binding proteins and inhibit the cellular effects mediated by Activin.  
The role of activins in modulating fluid flow mediated responses was tested by treating 
fibroblasts with follistatins.  
 
7.3.1: Methods  
 
For immunofluorescence detection of α-SMA, dermal fibroblasts (NHDFC) grown on glass 
coverslips were subjected to following treatments in static conditions: TGF-β (10ng/ml), 
activin A (1ng/ml) and flow (150µl/min). follistatin (1ng/ml) inhibited cultures were also 
subjected to the same treatment as stated above for 24h. Post treatment, coverslips were 
immunolabelled with α-smooth muscle actin (α-SMA) (Sigma) antibody as described in 
section 2.12. Experiment was performed three times and staining intensity was quantified by 
Image J. 
 
7.3.2: Results 
 
To study whether activation of fibroblasts is regulated by activin A, dermal fibroblasts were 
treated with 1 ng/ml activin A and α-SMA protein was detected by immunofluorescence.  
Activin A stimulation in static conditions increased α-SMA expression (Figure 7.3a) to a 
similar level observed in fibroblasts stimulated with TGF-β1.  When activin A stimulated 
fibroblasts were treated with 1 ng/ml follistatin-288 (activin A antagonist), protein expression 
of α-SMA decreased in comparison to cells treated with activin A alone. We also observed 
that follistatin treatment in TGF-β1 treated cells reduces the expression of α-SMA.  
Quantification of staining intensity by Image J analysis software also revealed that follistatin 
decreases α-SMA expression in both TGF-β1 and activin A stimulated cultures (Figure 7.3 
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b&c).  Notably, it was observed that follistatin treatment caused very little decrease in α-
SMA protein in flow activated cultures. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3:  Protein expression of α-SMA protein in dermal fibroblasts subjected to fluid flow (150 μl/min), 
follistatin-288, TGF-β1 and activin A treatment for 24h. (n=3) Top panel: TGF-β1, activin A, fluid flow and 
Bottom panel: follistatin, TGF-β1 treated with follistatin, activin A treated with follistatin, Fluid flow treated 
with follistatin. b) Image J based quantification of α-SMA protein in dermal fibroblasts subjected to fluid flow 
(150 μl/min) for 24h (n=3), treated with minimal medium, TGF-β1, follistatin (Fol), activin A (A) and activin A 
with follistatin (AFol), TGF-β1 (T), TGF-β1 with follistatin (1 ng/ml) (TFol), flow (F) and flow with follistatin 
(FFol). (Scale bar =10 microns). 
(c) 
(a) 
(b) 
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7.4: Fluid flow regulates gene expression of CD109 in fibroblasts. 
Although studies have shown that CD109 is a TGF-β binding protein known to negatively 
regulate the TGF-β signalling pathway, little is known of its role in flow mediated fibroblast 
differentiation. It is hypothesized that CD109 may contribute to negative regulation of the 
TGF-β pathway in TGF-β1 supplemented fibroblasts subjected to fluid flow. 
 
7.4.1: Methods 
  
Dermal fibroblasts (NHDFC) seeded on glass coverslips were treated with fluid flow as 
described in section 2.10 for 24 h and RNA was extracted as described in section 2.17. 
Experiments were performed three times and all the replicates were subjected to quantitative 
PCR analysis of CD109 as described in section 2.19.   
 
7.4.2: Results 
 
Gene expression of CD109 was studied by quantitative PCR analysis of cDNA samples 
obtained from dermal fibroblasts subjected to flow in both TGF-β1 stimulated and 
unstimulated conditions. CD109 was significantly (p < 0.01) decreased by 0.5 fold in dermal 
fibroblasts treated by fluid flow.  Interestingly, TGF- β1 stimulation under flow induces a 
significant (p< 0.03) increase in CD109 gene expression by 0.5 fold (Figure 7.4). Findings 
suggest that flow treatment in TGF- β1 supplemented cultures enhances expression of 
CD109, the TGF-β co-receptor and antagonises the fluid flow mediated activation of TGF-β 
pathway. 
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Figure 7.4: Gene expression of CD109 with fold change relative to endogenous control in dermal fibroblasts 
subjected to flow (150 μL/min) (p < 0.05) (n=3). FC relative to EC represents fold change relative to 
endogenous control. 
 
7.4: Discussion 
7.4.1: TGF-β1 regulates fluid flow mediated activation of 
fibroblasts via activin A. 
Activin A is a known member of TGF-β superfamily and is neutralised by binding of two 
follistatin molecules (Thompson et al., 2005).  The first evidence of activin’s role in 
modulating fibroblast activity came from studies which showed that human lung fibroblasts 
proliferated in the presence of low levels of activin A (Ohga et al., 1996b).  Another study 
showed that activin A promotes proliferation of fibroblast- like synoviocytes (Ota et al., 
2003). Subsequently, it was shown that activin A is a potent activator of renal interstitial 
fibroblasts (Yamashita et al., 2004). Their findings revealed that activin A promoted cell 
proliferation, enhanced expression of type I collagen mRNA and α-SMA expression in rat 
kidney fibroblast cells. Recently, activin A was shown to promote profibrotic responses in 
interstitial fibroblasts during renal fibrosis and administration of recombinant follistatin 
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alleviated the profibrotic response (Maeshima et al., 2014a). Epithelium derived activin A is 
known to increase tumour promoting properties in mammary fibroblasts in a Cox-2 
dependent manner differentiating these fibroblasts to a cancer associated fibroblast like 
phenotype (Fordyce et al., 2012). Whilst, literature suggests that activin A is mediator of 
fibroblast activation, whether supplementation of recombinant activin A is capable of 
differentiating normal fibroblasts to a myofibroblast like phenotype remains to be established. 
Findings report here that recombinant activin A can activate dermal fibroblasts by increasing 
α- SMA protein expression, thereby promoting differentiation to a myofibroblast like 
phenotype in static conditions.  
 
To observe whether fluid flow mediated fibroblast activation is regulated by activin A, gene 
and protein expression of activin A was studied in TGF-β1 stimulated and un-stimulated 
dermal fibroblasts in both static and fluid flow conditions. In line with gene expression 
profile of α-SMA and Collagen IA1, activin A is also increased under flow. However, TGF-
β1 supplementation decreases its expression under flow treatment. These findings suggest 
that fluid flow mediated activation of fibroblasts is modulated by activin A and are regulated 
by processes discussed in chapter 6. 
 
Our findings also showed that secreted activin A is detected in high levels only in 
conditioned medium of fibroblasts subjected to flow treatment whereas cell associated activin 
A is high in TGF-β1 stimulated fibroblasts in static conditions and in fibroblasts treated with 
fluid flow in both TGF-β1 stimulated and un-stimulated conditions. This suggests that TGF-
β1 supplementation regulates release of ectopic activin A under the influence of fluid flow.  It 
is possible that secreted activin A competitively binds to TGF-β receptor type II and is then 
internalised into the nucleus. Our findings correlate with a recent paper which shows that 
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activin A can competitively bind to TGF-β receptor type 2 and BMP receptor type 2 to 
antagonise the signalling pathway (Aykul and Martinez-Hackert 2016) and undergo 
proteolytic degradation.  
 
Fumagalli et al. 2007 have shown that in tissue sections of hypertrophic scars, there were 
high numbers of α-SMA(+) myofibroblasts which co-express activin A. Furthermore, 
treatment of fibroblasts with activin A induced Akt phosphorylation, promoted cell 
proliferation, and enhanced α-SMA and type I collagen expression. Follistatin reduced 
proliferation and suppressed activin-induced collagen expression suggesting that inhibition of 
activin A can potentially attenuate α-SMA expression (Fumagalli et al., 2007).  
 
7.4.2: TGF-β & activin A induced response is inhibited by 
follistatin. 
Follistatin is an extracellular regulatory protein of activin A and exerts isoform specific 
inhibitory effects on the biological activity of activin A and other members of the TGF-β 
superfamily. It is a secreted protein which binds to activins with high affinity and promotes 
binding to high affinity trans-membrane receptors. A number of studies have shown that 
expression of follistatins can reduce activin A mediated proliferation of fibroblast- like 
synoviocytes (Ota et al., 2003), modifies inflammatory cytokine cascade (de Kretser et al., 
2012), prevent renal fibrosis in vivo (Maeshima et al., 2014b), is inversely proportional to 
expression of activin A (Forrester et al., 2013)  and is highly expressed in all fibroblast strains 
with similar expression profile regardless of donor species (human or animals) (Kawakami et 
al., 2001). Since expression of activin A is observed in almost all tissues and of all the 
isoforms, follistatin 288 (FS-288) is known to show high cell surface binding and ligand 
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binding affinity to activin A (Sidis et al., 2006). Hence it was decided that FS-288 is used for 
study purposes. 
 
Findings from our immunofluorescence studies showed that F-288 inhibition in both activin 
A treated and TGF-β1 stimulated dermal fibroblasts decreased α- SMA protein expression 
suggesting that a) activin A by itself is capable of differentiating fibroblasts to a pro- 
myofibroblast like phenotype and b) this biological effect can be inhibited by recombinant 
follistatin 288.  Previous, reports show that cell associated FS-288 accelerates uptake of 
activin A, into cells which is then degraded by lysosomal enzymes (Hashimoto et al., 1997). 
Our findings strengthen previous research on the role of follistatin in modulating the response 
of activin A mediated fibroblast differentiation. It is possible that the under the influence of 
TGF-β1, fluid flow enhances expression and release of follistatins which may in turn bind to 
cell associated activin A leading to endocytic degradation.   
 
Follistatin-like 3 (FSTL-3), FLRG, and FSRP are another group of proteins which show 
similarity with the biochemical, molecular and biosynthetic functions of follistatins. These 
proteins are known to neutralize ligands of the TGF-β superfamily such as activin A and bind 
to Myostatin with a 3-5 fold lower affinity (Schneyer et al., 1994, Tortoriello et al., 2001, 
Sidis et al., 2006).  FSTL-3 is a potent inhibitor of activin signalling, negates the 
cardioprotective role of activin A in cardiomyocytes and is known to regulate stress induced 
hypertrophy via Smad7 signalling (Shimano et al., 2011).  Subsequent studies showed that  
expression of FSTL-3 is indispensable for regulation of paracrine fibroblast activation by 
cardiomycocytes (Panse et al., 2012).  Based on our microarray analysis which shows that 
Smad7 is upregulated by 4 fold, there exists a possibility that TGF-β1 stimulation under flow 
enhances expression of both isoforms of FST and FSTL-3 in fibroblasts and that the 
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cumulative effect of both FST and FSTL-3 augments binding to activin A promoting its 
degradation by endosomal enzymes. 
 
7.4.3: Fluid flow mediated activation of fibroblasts regulates gene 
expression of CD109.  
CD109 is a glycosylphosphatidylinositol- anchored protein first identified in primitive 
hematopoietic stem and progenitor cells (Sutherland et al., 1991). It is a membrane anchored 
protein and a member of α-2 macroglobulin family of thioester containing proteins (Lin et al., 
2002). Expression of CD109 was found to be high in NIH3T3 cells with multiple endocrine 
neoplasia 2B mutation (Watanabe et al., 2002) and in some tumour cell lines such as 
squamous cell carcinoma and glioblastomas. Hence it is considered as an important 
molecular target for development of novel therapeutics for malignant tumours such as 
squamous cell carcinoma (Hashimoto et al., 2004). CD109 functions as a TGF-β co receptor 
and an inhibitor of TGF-β pathway in keratinocytes (Finnson et al., 2006) and is known to 
enhance binding of TGF-β to its receptors, promote TGF-β bound receptor internalization via 
the Caveolin pathway in a ligand dependant manner (Bizet, Liu et al. 2011) and attenuate 
ECM production in skin fibroblasts (Man, Finnson et al. 2012).  
 
Our results reveal that gene expression of CD109 (TGF-β co-receptor) is reduced under flow 
and TGF- β1 supplementation under flow returns levels to that of statics suggesting that 
CD109 may antagonise the TGF-β pathway and function as an attenuator of extracellular 
matrix production as is observed previously in scleroderma skin fibroblasts (Man et al., 
2012). Observations from studies of endocytosis suggest that TGF-β1 supplementation in the 
presence of fluid flow enhances expression of CD109. It is possible that CD109 binds to 
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excess TGF- β1 and enhances caveolin mediated endocytosis of TGF- β1 and negatively 
regulate the TGF- β pathway (Bizet et al., 2011).  
 
Findings prompt to conclude the negative regulation of the TGF- β pathway as is observed in 
TGF- β1 supplemented cultures subjected to fluid flow which may be due to the combined 
effect of multiple processes. Two such proposed mechanisms are a) release of follistatins or 
follistatin like proteins which bind to activin A and enhance lysosomal degradation and b) 
release of CD109 which binds to TGF- β1 and promotes caveolin mediated internalization of 
the TGF- β receptor into endosomes.  Since effects observed when normal fibroblasts were 
subjected to fluid flow are dramatically different to those under flow in TGF-β1 stimulated 
conditions, suggests that this may be a novel mechanism which regulates the homeostatic 
balance of fibroblasts during abnormal conditions such as wound healing and cancer. 
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Chapter 8 – Fluid flow modulates 
cellular growth arrest in fibroblasts. 
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8.1: Introduction.  
Cellular growth is directed by the cell cycle which has a number of checkpoints to allow the 
cell to decide whether to continue dividing or stop. The cell cycle commences with G1 phase 
when the cell prepares to duplicate itself. It remains active in the S phase by DNA replication. 
Damage to the newly formed DNA are repaired prior to the G2 checkpoint before the cell 
proceeds to the mitotic M phase where cell division occurs. Cells now return to the G1 phase 
to continue the process or halt. Cellular checkpoints are influenced by environmental factors 
such as mechanical forces, radiation and drugs which could either arrest cellular growth, 
initiate apoptosis or allow the cell to remain in a state of quietness or inactivity (Huselstein et 
al., 2006, Mundt AJ, 2003, Shiff et al., 1996).  
 
Quiescence is a cell cycle state in which cells do not proliferate. Instead, they retain the 
ability to proliferate but can remain quiescent for long intervals (Campisi and d'Adda di 
Fagagna, 2007). Such growth arrest can be caused by withdrawal of serum growth factors. 
Absence of growth leads to low metabolism, very little protein synthesis and cellular 
functions. Cells in a quiescent state invoke a program which protects them from programmed 
cell death, differentiation and oxidative stress (Naderi et al., 2003, Coller et al., 2006, Sang 
and Coller, 2009). Such programming in tumour cells allows them to survive from apoptosis 
induced by anti-cancer agents. Nevertheless, in the case of long-lived cells such a protected 
state may be beneficial.  These cells use lysosomal and autophagy associated pathways for 
protein degradation and protein turnover (Ciechanover, 2005). 
 
On the other hand, senescence can also be defined as cellular aging wherein DNA damage 
harbouring cells or aging cells are maintained in a cellular state which is irreversible and 
permanent (Fridlyanskaya et al., 2015, Dimri et al., 1995). It is characterised by growth arrest 
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usually at G1 and sometimes in G2 phases of the cell cycle. Senescence is broadly classified 
into two types: replicative senescence occurring due to long-term cultivation of cells in 
culture resulting in loss of telomeric DNA (Hodes, 1999) and stress induced premature 
senescence (SIPS) which results due to the effects of radiation, osmotic stress, mechanical 
stress and drugs which inhibits cell division (Cmielova et al., 2012). Senescent fibroblasts 
show variations in gene expression of cell cycle modulators and cyclin dependent kinase 
inhibitors such as p21 Waf-1 and p16 Ink4 A (Jackson and Pereira-Smith, 2006). Initially 
discovered as the terminal replicative stage in mitotic cells, senescence was linked to loss of 
telomeres (Hayflick, 1965). Later, studies showed that senescence need not be associated 
with telometric attrition and cell division, particularly in fibroblasts which reach confluency 
in static cell culture (Munro et al., 2001). Classical studies have shown that activated 
fibroblasts maintain their phenotype in static cell culture even when they are isolated from the 
tissue of origin suggesting that they maintain their phenotype by a mechanism which is 
irreversible and permanent as is observed during senescence. Senescent cancer associated 
fibroblasts develop a secretory phenotype known as senescence associated secretory 
phenotype (SASP) (Coppe et al., 2010) and regulate tumour cell adhesion and invasion via 
TGF-β dependent pathways (Hassona et al., 2015, Calon et al., 2014). TGF-β1 induces 
senescence of bone marrow mesenchymal stem cells by increasing senescence-associated-β 
galactosidase (SA-β Gal) activity and p16/INK4 expression (Wu et al., 2014). Co-culture of 
senescent fibroblasts from tissues of different origin such as prostate or lung with non-
malignant epithelial counterparts promotes cell growth, migration and invasion showing that 
that senescent fibroblasts contribute to augment growth of tumours of epithelial origin 
(Krtolica et al., 2001). Interestingly, numerous reports showed that genotoxic stress can also 
invoke senescence of cells (Matos et al., 2015).  Recent reports show that differentially 
expressed micro RNAs such as miR-210 and miR-146a are involved in both fibroblast 
174 | P a g e  
 
activation and senescence (Yao et al., 2011, Bhaumik et al., 2009). Research has also reveal 
widespread changes in miRNA expression of both cancer associated fibroblasts and senescent 
fibroblasts (Prime et al., 2016). This compelling evidence suggests that there are common 
links between fibroblast activation and senescence and it is therefore possible that fluid flow 
induced fibroblast differentiation is associated with a cell cycle arrest which may result from 
senescence or quiescence. 
 
8.2: Fluid flow alters gene expression of p16 INK4a in dermal 
fibroblasts. 
8.2.1: Methods 
 
Primary dermal fibroblasts (NHDFC) were treated with fluid flow as described in section 
2.10 for 24 h. and RNA was extracted as described in section 2.17. Experiments were 
performed three times and all the replicates were subjected to quantitative PCR analysis of 
p16 expression.  
 
8.2.2 Results 
 
TGF-β1 treated dermal fibroblasts seeded on glass coverslips revealed an increased 
expression of p16 INK4a (Figure 8.1a) in static conditions. Interestingly, flow treatment 
decreases the expression of p16 INK4a.  Similarly, when TGF-β1 supplemented fibroblasts 
were treated by fluid flow, gene expression of p16 INK4a decreased significantly in 
comparison to fibroblasts stimulated with TGF- β1 in static conditions. Contrastingly, flow 
treated dermal fibroblasts seeded on collagen IA coated Thermonox coverslips revealed an 
increased expression of p16 INK4a (Figure 8.1b).  Nevertheless, TGF-β1 supplementation 
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significantly reduces p16 INK4a expression under flow than static in fibroblasts seeded on 
both glass and collagen coated Thermonox coverslips. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.1: Changes in gene expression of p16 in dermal fibroblasts under flow (150 μL/min) for 24 h. Dermal 
fibroblasts cultured on (a) glass coverslips and (b) collagen type I coated Thermonox coverslips. FC relative to 
EC represents fold change relative to endogenous control. (S= Static, F= Flow, ST= Static+TGF-β1 and FT= 
Flow+TGF-β1, vs= versus). 
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8.3 Fluid flow modulates gene expression of p21Waf-1 in dermal 
fibroblasts. 
8.3.1: Methods 
 
Primary dermal fibroblasts (NHDFC) were treated with fluid flow as described in section 
2.10 for 24 h and RNA was extracted as described in section 2.17. Experiments were 
performed three times and all the replicates were subjected to quantitative PCR analysis of 
p21 Waf-1 gene expression as described in section 2.19.   
 
8.3.2 Results 
 
TGF-β1 treatment in static conditions decreases expression of p21 Waf-1 in dermal fibroblasts 
that were seeded on glass coverslips. Interestingly, flow treatment enhances the expression of 
p21 Waf-1 in both TGF-β1 supplemented and fibroblasts (Figure 8.2). In line with data obtained 
from fibroblasts on glass coverslips, static fibroblasts seeded on collagen IA coated 
Thermonox coverslips showed a decrease in gene expression of p21 Waf-1 whereas flow 
treatment increases the expression in both TGF-β1 supplemented and untreated fibroblasts. 
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Figure 8.2: Changes in gene expression of p21Waf-1 in dermal fibroblasts under flow (150 μL/min) for 24 h. (a) 
Dermal fibroblasts cultured on glass coverslips and (b) collagen type I coated Thermonox coverslips. FC relative 
to EC represents fold change relative to endogenous control. (S= Static, F= Flow, ST= Static+TGF-β1 and FT= 
Flow+TGF-β1, vs= versus). 
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8.4: Fluid flow decreases senescence in dermal fibroblasts. 
8.4.1: Methods 
 
Primary dermal fibroblasts (NHDFC) were treated with fluid flow as described in section 
2.10 for 24 h and coverslips were stained for detecting SA β Galactosidase activity using the 
X-Gal staining kit (Abcam) as explained in section 2.15.  
 
8.4.2 Results 
 
Senescence associated-β galactosidase (SA-β Gal) activity was detected as a blue colour in a 
few dermal fibroblasts grown on glass coverslips in static conditions. TGF-β1 
supplementation in static conditions revealed very little β galactosidase activity in fibroblasts. 
However, flow treated fibroblasts display little activity of SA-β Gal in both TGF-β1 
supplemented and untreated conditions (Figure 8.3). In addition, flow treated fibroblasts 
display changes in shape in comparison to those in static conditions. 
 
 
 
 
 
 
 
 
 
Figure 8.3: SA-β-Galactosidase staining of dermal fibroblasts on glass coverslips under flow (150 μL/min) for 
24 h. All images were captured using 10X magnification lens at the same exposure time. Representative images 
from three independent experiments. 
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8.5: Discussion  
Compelling evidence has shown that normal human fibroblasts gradually lose their 
proliferative capacity to undergo senescence whereas other studies show that fibroblasts 
undergo stress induced senescence as an adaptive mechanism to environmental factors and 
mechanical stresses (Prime et al., 2016). Whilst it is understood that experiments involving 
senescence and quiescence should be pursued over prolonged exposure times to gain a deeper 
understanding, in this chapter efforts were focussed to understand if fluid flow invokes stress 
induced proliferative senescence in dermal fibroblasts during shorter incubation periods of 
about 24h. 
 
8.5.1: Fluid flow alters the expression of p16 INK4a in dermal 
fibroblasts. 
Whilst senescence is reflected by changes in the phenotypic profile of various organelles, 
cyclin-dependent kinase inhibitors such as p21 Waf-1 and p16 INK4a and p53 pathways are the 
known molecular mechanisms that mediate senescence (Kabir et al., 2016). Transition from 
G1 to S phase is controlled by the p16-Rb pathway, binding of p16 INK4a to CDK4/6 
prevents phosphorylation of Rb and transcription E2F1 genes that are crucial for G1 to S 
transition. Studies have also reported that premature senescence could be induced by Rb-p16-
19 Arf proteins in the presence of E2F activation in a mouse pituitary tumour model 
(Lazzerini Denchi et al., 2005). Despite that, cellular proliferation was invoked by E2F and 
cells underwent senescence through formation of repressor complexes between Rb family 
members and E2F in the nucleus (Rowland and Bernards, 2006). Rb is therefore a crucial 
tumour suppressor gene and its inactivation by p16 INK4a promotes proliferation of the 
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reprogrammed cells (Li et al., 2009). Although there exists a feedback loop mechanism 
between p16 INK4a and Rb wherein phosphorylation of Rb results in increased inhibition of 
CDK4/6 by p16 INK4a, various reports have shown that levels of p16 INK4a do not vary 
appreciably during cell cycle (Li et al., 1994, Hara et al., 1996). However, during aging and 
in conditions of exposure to DNA damaging agents, expression of p16 INK4a is increased 
resulting in senescence (Meng et al., 2003, Wang et al., 2006c).  Finally, reports have shown 
that the p16/Rb pathway activates protein kinase C delta (PKC delta) via induction of reactive 
oxygen species (ROS) leading to an irreversible cell cycle arrest (Takahashi et al., 2006). Our 
findings show that gene expression of p16 INK4a is altered under flow. In fibroblasts grown 
on glass surfaces, flow treatment reduces the expression of p16 INK4a whereas those 
fibroblasts grown on collagen coated Thermonox coverslips reveal an increase in expression 
of p16 INK4a. These findings seem to suggest that in an in vivo like condition where cells 
experience fluid flow, matrix proteins such as collagen IA1 influence the gene expression of 
p16 INK4a and may contribute to premature cellular aging.  Regardless of the surface 
treatment when TGF-β1 treated fibroblasts are exposed to fluid flow, expression of p16 
INK4a is decreased suggesting that a) despite the presence of endocytosis and ligand 
trafficking, TGF-β1 can reduce the expression of p16 INK4a under fluid flow and b) The 
influence of matrix proteins such as collagen I A1 can be antagonised by TGF-β1. It is 
reported that senescent cells which do not express p16 INK4a can resume growth after 
genetic interventions that inactivate the p53 tumor suppressor (Beausejour et al., 2003) 
suggesting that fibroblasts which show reduced expression of p16 INK4a under flow can 
potentially resume proliferation and regain expression of p16 INK4a upon withdrawal of 
flow. 
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Apart from the p16/Rb pathway, the p38 MAP Kinase pathway is known to play a role in 
premature senescence via the Ets family of transcription factors (Lin et al., 1998, Foos et al., 
1998, Freund et al., 2011). Studies have shown using reporter assays that these transcription 
factors (Ets 1 and Ets 2) enhance transcription of p16 INK4a gene and transcriptional 
repression of p16 INK4a could be prevented by mutating the binding site of Ets 1 (Ohtani et 
al., 2001). Data obtained from microarray based global gene expression analysis of 
fibroblasts subjected to two different flow rates reveal that alterations are observed in the 
MAP kinase pathway (Chapter 4).  This finding suggests that flow mediated stresses causes 
variations in the MAP kinase which may contribute to p16 INK4A induced premature 
senescence in flow activated fibroblasts cultured on collagen coated Thermonox coverslips. 
 
Despite evidence that senescence is associated with changes in both p16 INK4a and p21 Waf-1, 
numerous studies have shown that p16 INK4a is not commonly expressed by quiescent or 
terminally differentiated cells (Hara et al., 1996, Stein et al., 1999). These reports call in to 
question observations on differential expression of p16 INK4a in plain glass and collagen 
coated Thermonox coverslips. In line with observations that flow induced fibroblast 
activation is transient and reversed upon withdrawal of flow (Section 5.5), suggests that the 
observed effects are the result of a short term cell cycle arrested state which may be reversed 
and may be an indicator of a quiescent phenotype rather than that of senescence. 
 
8.5.2: Fluid flow alters the expression of p21Waf-1 in dermal 
fibroblasts. 
Cellular quiescence is defined as a reversible non-proliferative state. In contrast to terminally 
differentiated cells which are senescent and irreversibly arrested, quiescent cells can re-enter 
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the proliferative cell cycle in response to growth signals. Quiescence protects cells against 
stresses and toxicities in long lived cells such as stem cells (Cheung and Rando, 2013). 
Studies on quiescent fibroblasts show that whilst these cells are viable, they are protected 
from proteasome inhibition mediated toxicity (Legesse-Miller et al., 2012). In addition to 
down-regulation of proliferation related genes, quiescent cells express a group of cyclin-
dependent kinase inhibitors (CDKs) p21 Waf-1  or p27 that are distinct from cell cycle arrested 
cells (Liu et al., 2007).  In contrast to the senescence pathway, quiescent cells feature high 
levels of Rb-E2F pathway repressors and Cdk inhibitors such as p21 Waf-1 (Cheng et al., 2000) 
and p27 (Coats et al., 1996). Other studies show that down regulation of Cdk inhibitor p21 
Waf-1 can reprogram the cells to re-enter the cell cycle (Nakanishi et al., 1995). The study 
revealed that expression of antisense p21 Waf-1 RNA in G0 arrested cells resulted in induction 
of DNA synthesis and entry of cells into the mitotic phase. These findings suggest that 
p21Waf-1 functions in the G0 and the early G1 phase and a decreased expression of the gene is 
necessary for cell cycle progression. A recent report revealed that the proliferation –
quiescence decision is controlled by a bifurcation in CDK2 activity at mitotic exit and that 
this exit is guarded by p21 Waf-1  expression (Spencer et al., 2013).   
 
In the face of a huge body of literature which shows that the CDK inhibitor p21 Waf-1 can 
induce growth arrest, senescence and quiescence, its involvement as a promoter of quiescence 
still remains debated. Studies conducted by Perucca et.al (2009) provide the first evidence 
showing that high levels of p21Waf-1 protein are essential to enter and maintain the quiescence 
state. Our findings show that gene expression of p21Waf-1 is increased under flow. In 
fibroblasts, flow treatment increases the expression of p21Waf-1 in both TGF-β1 treated as well 
as in untreated cells suggesting that fluid flow may induce a short lived state of quiescence in 
fibroblasts and that this state may be guarded by increasing levels of p21 Waf-1.  Quiescent 
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fibroblasts are known to exhibit high metabolic activity (Lemons et al., 2010). However, 
results in the current study reveal that fluid flow reduces the metabolic activity of fibroblasts 
(Section 3.4). Although this observation contradicts existing literature, it is possible that 
under the influence of fluid flow and high levels of p21, the cellular machinery maintains a 
low metabolic profile and the cellular machinery focusses only on processes involved in 
differentiation such as synthesis of fibrous proteins.  
 
Recent studies have shown that the multi-functional cytokine activin A potently inhibits 
cellular proliferation and tube formation of endothelial cells (HUVECs) by induction of 
p21Waf-1  (Kaneda et al., 2011).  Notably, stable p21Waf-1 knockdown significantly enhanced 
cellular proliferation of HUVECs suggesting that p21Waf-1 induction has a key role in activin 
A mediated growth inhibition of endothelial cells.  Our observations on flow mediated 
increase in expression of cell associated and secreted activin A (Section 7.2) validates 
existing literature. Enhanced expression of p21Waf-1 in both normal and TGF-β1 stimulated 
fibroblasts subjected to flow suggests that fluid flow induces a short term growth arrested 
quiescent state by a) reducing the mitochondrial activity of fibroblasts and b) activin A 
mediated increase in the expression of p21Waf-1 which inhibits cellular proliferation in 
fibroblasts. 
 
8.5.3: Fluid flow decreases senescence in dermal fibroblasts. 
Morphological changes are one of the most evident changes that occurs when cells undergo 
senescence.  Cells increase in volume and often reach double the size of a presenescent cell 
(Hayflick, 1965). Upon senescence, cells switch their phenotype from a matrix producing to a 
matrix degrading phenotype. Production of elastin and collagen are decreased whereas 
increased production of fibronectin and matrix metalloproteinases- 1 and 3 (MMP-1 and 
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MMP-3) (Hornebeck and Maquart, 2003) occurs which regulate the activity of factors in the 
senescence associated secretory phenotype (SASP) and degrade the stromal fibres and the 
extracellular matrix. Senescent fibroblasts secrete pro-inflammatory cytokines such as IL-6 
(Kuilman et al., 2008), IL-1 (Kumar et al., 1992) and numerous epithelial cell growth factors 
and hence adopt a phenotype which resembles a wounding response. Flatter and irregular 
shaped cellular architecture, distinct intracellular actin fibres, enhanced nuclear and nucleolar 
size, multinucleated cells, prominent golgi apparatus, increased number of vacuoles in 
endoplasmic reticulum and cytoplasm and large lysosomal bodies are other morphological 
changes which accompany senescence (Cristofalo and Pignolo, 1993).  Bright field images of 
flow treated fibroblasts appear elongated instead of having a flat and irregular shaped 
morphology as is observed in senescence. However immunofluorescence imaging show that 
flow enhances expression of the fibrous protein α-SMA in fibroblasts (section 5.2). These 
observations suggest that fibroblasts treated with flow over a short period of 24h. are not 
senescent. Instead they acquire a growth arrested, presenescent phenotype which is marked 
by low mitochondrial activity and enhanced expression of contractile proteins such as α-SMA 
and Col IA1. 
 
Senescence associated beta galactosidase (SA-β-gal) is a β-galactosidase enzyme which can 
be detected only in cells undergoing induced or replicative senescence (Dimri et al., 1995). 
SA-β-gal could be detected by in-situ staining using a chromogenic substance known as X-
gal which yields a blue precipitate (Miller, 1972).  Since early reports, SA-β-gal activity has 
been widely used as a biomarker for senescence. Its activity was detected at pH 6.0 detected 
in organs of old animals suggesting that ageing tissue accumulates senescent cells and is 
generated by the β-galactosidase that is localised to lysosomes of mammalian cells.  Based on 
indirect physiological experiments, it was initially proposed that increased lysosomal-β-
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galactosidase activity in senescent cells accounts for SA-β-gal activity (Kurz et al., 2000).  
Lee et.al (2006) later showed that GLB1 gene encoded activity of SA-β-gal is typically 
measured only at a pH of 4.5 (Lee et al., 2006). They showed that fibroblasts from patients 
with a defective lysosomal β-galactosidase did not express SA-β-gal even when they 
underwent replicative senescence. In addition, late passage normal fibroblasts that underwent 
senescence but failed to express SA-β-gal. These findings seem to suggest that the increase in 
β-galactosidase activity is an outcome of senescence and that SA-β-gal activity cannot stand 
alone to define a senescent phenotype.  Bright field images of fluid flow treated fibroblasts 
reveal little activity of SA-β-gal compared to static cultures. This observation seemingly 
suggests that fibroblasts do not undergo senescence under the influence of fluid flow. 
 
p16 INK4a and p21Waf-1 are classically characterised as cellular markers of growth arrest. 
However, from the body of existing literature on the overlapping roles of p16 INK4a and 
p21Waf-1, our findings prompt evaluation of other senescence associated markers and analysis 
cell cycle analysis by techniques such as flowcytometry and BrDU based detection of cells in 
S- phase. Nonetheless, results from cumulative experiments on gene expression of p16 
INK4a, p21Waf-1 and SA-β-gal staining suggest that fluid flow induced differentiation of 
fibroblasts is more transient and may induce growth arrest that is reversible in nature.  
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Chapter 9 - Discussion of findings 
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All living cells are constantly exposed to a number of different physical forces such as shear 
stresses, interstitial fluid flow, blood flow and tissue fluid flow due to mobility.  The 
microenvironment of growing tumours and healing wounds are known to experience a highly 
dynamic environment with increased mechanical stiffness due to accumulation and 
reorganisation of the extracellular proteins and interstitial fluid flow (Butcher et al., 2009). 
Whilst 3D tissue culture models are a recent advancement and help towards building realistic 
models incorporating more than one cell type to form a tissue, these models do not easily 
lend themselves to studying the effect of interstitial fluid flow like mechanical signals on 
individual cell types or cells grown in a matrix. Furthermore, studies have shown that the 
oxygen concentrations within the central regions of 3D scaffolds is low in static cultures 
resulting in a gradient of cellular attachment from the periphery towards the centre. The 
introduction of fluid perfusion in bioreactors results in an improved oxygen supply to cells 
(Volkmer et al., 2012, Sugiura et al., 2011, Weyand et al., 2015). Previous studies show that 
oxygen levels in static cultures drop to 0% within 5 days of culture whereas perfusion 
bioreactors prevented cell death by sustaining 4% oxygen levels throughout the study 
(Volkmer et al., 2008).  
 
 The Quasi vivo® bioreactor used in this study is a multi-compartmental modular bioreactor 
(MCmB 2.0) consisting of chambers made of polydimethylsiloxane (PDMS) (Mazzei et al., 
2010). The Quasi vivo® system (QV-500) was developed as a dynamic fluid model and was 
designed initially with assessment of the minimum concentration of oxygen allowed near the 
cell surface with hepatocytes as a reference cell type. Optimal chamber size enabling both 
adequate oxygen diffusion and low shear stress near the cell surface were also studied. 
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Results showed that the total amount of oxygen available is greater in the chambers and that 
the bioreactor chambers can enhance or maintain cell viability and function when the flow 
rates are below 500 µL/min, corresponding to wall shear stresses of 10-5 Pa or less at the cell 
culture surface (Mazzei et al., 2010).  When human umbilical endothelial cells (HUVECs) 
and hepatocytes were grown in connected chambers of the Quasi Vivo®  bioreactor, they 
displayed increased endothelial cell viability, elevated levels of hepatic glucose, albumin and 
urea in hepatocytes (Vozzi et al., 2009). These findings suggest that, unlike the hypoxic 
environments experienced by cells in static culture, the perfusion flow in multi-
compartmental bioreactor supplements the cells with sufficient oxygen levels for improved 
function. Current study shows that fibroblasts from both oral and dermal tissues can 
withstand flow conditions. Further, absence of SA-β Galactosidase positive cells in fluid flow 
treated dermal fibroblasts suggest that the perfused oxygen contributes to decreased 
expression of SA-β Galactosidase in these cells. 
 
Living cells experience shear stresses due to different types of fluid movement such as blood 
flow, interstitial fluid flow and that these are highly dependent on the tissue and pathological 
conditions. It is difficult to determine actual shear stresses and fluid flow velocities 
experienced by cells. Literature shows that average interstitial flow velocities in normal and 
neoplastic tissues is  6 x 10-7 m/s (Chary and Jain, 1989), the flow velocities generated at a 
fluid flow rate of 75 & 150 µl/min were 3 x 10-7 m/s and 5 x 10-7 m/s respectively suggesting 
that flow velocities experience by fibroblasts in this study are comparable those experienced 
tissues in vivo. These values are many orders of magnitude lower than those present in the 
vascular system in vivo. In this thesis, efforts were focussed to model in vivo like interstitial 
fluid movement on fibroblast and study their responses. The study compares the differences 
in cellular response, signalling changes and the effect of growth factor supplementation in 
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fibroblasts subjected to static and dynamic treatment conditions from both dermal and oral 
sources. 
Fibroblasts serve as building blocks of the extracellular matrix in connective tissues. These 
cells secrete different types of Collagen, glycoproteins, Matrix Metalloproteases and fibrous 
proteins such as α-smooth muscle actin. They can differentiate into myofibroblasts when 
stimulated by TGF-β1 (Hinz et al., 2012). Myofibroblasts are a variant form of activated 
fibroblasts that acquire a smooth muscle phenotype and promote wound contracture. During a 
wound healing process, cytokines and chemokines released by epithelial, endothelial and 
mesenchymal cells work in a paracrine manner to stimulate fibroblasts to proliferate and 
migrate into the granulation tissue matrix. Once they embed themselves into the matrix, they 
transform into an activated phenotype which is characterised by enhanced expression of α-
Smooth Muscle Actin (Honda et al., 2010), and Collagen IA1 (Cutroneo et al., 2007, Pan et 
al., 2013).  Upon completion of wound healing, these fibroblasts undergo apoptosis. 
However, in pathological conditions such as cancer which is marked by high levels of 
interstitial fluid flow, angiogenesis and blood vessel formation (Thannickal et al., 2004) and 
systemic sclerosis (Varga and Jimenez, 1995), these fibroblasts remain activated indefinitely.  
Hence activated fibroblasts are often used as a marker for poor prognosis in cancer. Recent 
studies revealed that SMA-positive, myofibroblastic stroma is the strongest predictor of Oral 
Squamous cell carcinoma mortality (Marsh et al., 2011). 
 
Mechanobiology refers to the method by which living cells sense signals from surroundings, 
process these signals; modulate structural and mechanical integrity inside cells and in their 
microenvironment. The extracellular matrix was once thought to solely provide structural 
support to tissue architecture. However, recent literature suggests that ECM also mediates a 
range of cellular activities like migration, myofibroblast differentiation, matrix stiffness and 
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cellular survival. For example studies have shown that myofibroblasts employ actin based 
motors to generate contractile forces and mediate tissue remodelling by traction (Tomasek et 
al., 2002). The aim of this study was to investigate the response of fibroblasts to mechanical 
forces and chemical signals in a physiologically relevant dynamic environment. preliminary 
experiments showed that that interstitial fluid flow can activate fibroblasts when subjected to 
fluid flow at rate of 120µl/min (Ng et al., 2005). Results show that such low levels of shear 
stresses of 3.61x10-6 Pa at a flow rate of 150 µL/min can induce significant changes in the 
global gene expression profile of dermal fibroblasts. The changes in gene expression profile 
was dependant on the fluid flow rate suggesting that fluid flow acts as a mechanotransducer 
invoking various signalling responses in fibroblasts. Go Term and KEGG pathways analysis 
also revealed that the genes altered under fluid flow were associated with the TGF-β pathway 
and biological processes like endocytosis and angiogenesis. Interestingly, when gene 
expression changes were sorted on the basis of p-value (p ≤0.01), gene expression variations 
under flow were all associated to the TGF-Beta pathway. The Transforming growth factor β 
family of ligands includes TGF-β 1-3, Bone Morphogenic Proteins (BMP) and activins 
(Schmierer and Hill, 2007). Surprisingly, changes were observed in activin A (INHBA), 
Smad9, and TGF-β pathway antagonists like Smad7, TGFBRIII (Betaglycan) and CD109 that 
are members of the TGF-β sub family. These findings suggest that the mechanobiology of 
fibroblasts is highly influenced by the components of TGF-β pathway in vivo and their 
responses may be modified by changes in fluid movement as is observed in pathological 
conditions such as fibrosis, EMT as discussed in previous sections. 
 
Activins are proteins known to play a role in cellular proliferation, differentiation, apoptosis 
and wound repair (Chen et al., 2006, Sulyok et al., 2004). Activin A is a potent activator of 
renal interstitial fibroblasts and enhances the expression of both collagen I A and α-smooth 
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muscle actin (Yamashita et al., 2004). Smad9 is a transcriptional regulator otherwise known 
as inhibitory Smad (ISmad) and belongs to the Bone morphogenetic protein (BMP) family. It 
is  known to play a crucial role in phospho-control of TGF-β signalling (Wrighton et al., 
2009). CD109 is cell surface antigen (Lin et al., 2002) observed to be highly expressed in 
cancer (Hashimoto et al., 2004) and known to degrade TGFβ receptors (Bizet et al., 2011) to 
attenuate extracellular matrix production in scleroderma skin fibroblasts (Man et al., 2012). 
Interestingly we observed that although activin A, SMAD9 and CD109 do not display fold 
change of more than 2.0, they were altered under flow suggesting that fluid flow acts as 
mechanical signal inducing variations in genes listed above, which in turn alter the 
functioning of normal fibroblasts. 
 
In accordance with fold changes observed in microarray analysis, TGF-β1 stimulation 
increases expression of α-SMA in fibroblasts of both dermal and oral origin in static 
conditions. Fluid flow also activates fibroblasts of both dermal and oral origin by enhancing 
gene expression of α-SMA and Collagen IA. Contrastingly, TGF-β1 stimulation under flow 
decreases the activation response suggesting that fibroblast mechanobiology is prone to 
chemical alterations in the microenvironment. Although we had used 10 ng/ml of TGF-β1 in 
all our experiments, higher doses may result in a different effect. Our findings correlate to the 
highly heterogeneous profile of fibroblast in tissues in vivo where the microenvironment is 
dynamic in nature. It is possible that levels of TGF-β1 experienced by cells in vivo are much 
higher than those used in this study which may in turn influence the mechanobiology of these 
fibroblasts.  
 
Smad proteins are regulatory proteins that are responsible for not only transducing the signals 
from the membrane into the nucleus, but also initiate downstream responses by directly 
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regulating gene expression. Activated Smads regulate diverse biological functions by 
partnering with transcription factors and translocation to the nucleus. Upon activation of the 
TGF- β receptors within a short time period of 1h., the highly homologous Smad2 and Smad3 
are phosphorylated by the TGF-β receptor in the C-terminal SXS motif and in the linker 
region at Ser208, Ser204, and Thr179 sites and transduce the signal to the nucleus (Wang, 2009).  
Smad3 can also be phosphorylated by Alk4 and Alk5 (Attisano and Wrana, 2002). Our 
studies revealed that protein expression of phosphorylated-Smad3 is elevated by two fold in 
dermal fibroblasts treated by fluid flow for 2h.  Further, we also observed high levels of cell 
associated and secreted TGF-β1 protein in fibroblasts that were subjected to fluid flow but 
not in those treated in static conditions. These results support previous findings from 
microarray data which shows that a) fluid flow stimulates expression of TGF- β1 in dermal 
fibroblasts and b) fluid flow causes variations in the TGF- β pathway. These results prompt 
us to conclude that in the presence of fluid flow TGF- β1 is released into the conditioned 
medium which may in turn cause an autocrine effect leading to activation of fibroblasts.  
 
Homeostasis is maintained by positive and negative feedback mechanisms that respond to 
signals from the microenvironment and restores normalcy to cells. However in most 
pathological conditions like systemic fibrosis, cancer and wound healing this feedback 
mechanism fails and hence a homeostatic imbalance occurs. Studies on mechanobiology of 
fibroblasts in normal and diseased conditions have attracted a lot of research interest in recent 
years. These studies not only help towards understanding the heterogeneous nature of 
fibroblasts but also explain mechanisms involved in regulating ‘tensional homeostasis’ of 
fibroblasts, a term recently coined by Brown (Mouw et al., 2014). The group showed that 
fibroblasts embedded in 3D collagen gels antagonize the effect of external force application 
in an attempt to maintain the original state of the cell as it was before application of external 
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force.  Although ‘tensional homeostasis’ is a ubiquitous concept with no direct evidence of 
cell’s ability to respond to mechanical loading by maintaining tensional homeostasis, recently 
a group set out to look for direct evidence of tensional homeostasis in single fibroblast cells 
using single-cell contraction force microscopy (Marenzana et al., 2006). They reported that 
fibroblasts respond to external loading by a process called ‘tensional buffering’ and respond 
to physical forces. Whether the cell reverts to its original state depends largely on the cell’s 
previous mechanical state and the force applied on it. Although previous studies showed that 
interstitial fluid flow invokes fibroblasts to  differentiate to an activated phenotype with 
alignment of collagen fibres in vitro (Ng et al., 2005), it was not clear if the cell reverts to its 
original resting state when the ‘flow’ is withdrawn. Hence, we explored whether fibroblasts 
respond to fluid flow mediated physical stimuli and whether these signals could be altered to 
revert the fibroblasts to its original state. Findings in this study show that flow-activated 
fibroblasts can revert to a resting state phenotype when allowed to remain in static conditions. 
This transient activation of fibroblast under the influence of fluid flow provides an evidence 
of ‘tensional buffering’ in fibroblasts treated with physical forces. Although we have shown 
that fluid flow mediated activation of fibroblasts is regulated by TGF-β pathway, this 
property of transient activation may be also influenced by other signalling pathways that 
contribute to maintaining cellular homeostasis in normal and diseased tissues. Our findings 
prompt further exploration of flow mediated mechanisms that contradict classical pro-fibrotic 
effects of TGF-β1 in fibroblasts.  
 
In the current study, the effect of other regulatory molecules in driving the molecular events 
involved in fluid flow mediated fibroblast differentiation were also explored. Analysis of 
microarray-based global gene expression variations under flow revealed that caveolins are 
one among the top 20 genes altered under flow. These molecules are membrane bound 
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proteins with a hairpin like structure that remains embedded in the plasma membrane. These 
molecules were initially detected in human prostate cancer (Yang et al., 1999) and contribute 
to cell transformation (Razani et al., 2000). They regulate TGF-β signalling through 
interactions with the TGF-β type I receptor (Razani et al., 2001) and endocytic pathways (Di 
Guglielmo et al., 2003b). Caveolins possess anti-fibrotic properties (Tourkina et al., 2008) 
and are a crucial regulator of lung fibrosis in idiopathic pulmonary fibrosis (Wang et al., 
2006b). Deficiency of caveolins in mice modulates cellular senescence in epithelial cells and 
exerts a protective effect in pulmonary fibrosis (Shivshankar et al., 2012).  They are also 
known to internalise the TGF-β receptor in lipid rafts and degrade the receptors to negatively 
regulate the pathway (Del Galdo et al., 2008) and hence are considered as modulators of 
fibroblast activation and biomarkers of gastric cancers (Shen et al., 2015). Immunostaining 
results revealed high levels of membrane bound caveolin-1A in fibroblasts treated in static 
conditions whereas cytoplasmic protein expression of caveolin-1A is high under the influence 
of fluid flow in both TGF-β1 stimulated and unstimulated conditions suggesting that fluid 
flow internalises membrane bound caveolin 1A into the cytoplasm.  
 
Classical studies have shown that TGFβ receptors are internalized by both lipid raft bound 
(caveolins) and non-lipid raft (endosomal) pathways (Mitchell et al., 2004b, Di Guglielmo et 
al., 2003b) involving caveolin-1 and early endosomal antigen-1 (EEA-1) double positive 
vesicles (He et al., 2015). Further, numerous reports have also shown that the 
SARA/Smad2/3 complex which initiates TGFβ signalling was found to be localized in the 
EEA-1 positive endosome whereas the SMURF/Smad7 complex that initiates degradation of 
TGFβ receptors was localized in caveolin-1 positive lipid rafts (Hayes et al., 2002, Runyan et 
al., 2005). These studies also showed that disruption to localization of SARA to endosomes 
disrupts TGFβ signalling and localization of TGFβ receptor type II in caveolin positive lipid 
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rafts and prevents nuclear translocation of Smad2/3 suggesting that nuclear translocation of 
p-Smad3 would be abrogated in TGF-β1 stimulated fibroblasts treated with flow. However, 
in this study, immunofluorescence images and western blot samples revealed nuclear 
translocation of p-Smad3 in TGF-β1 stimulated fibroblasts treated with flow. There are a 
number of possible explanations for this. Firstly the western blot samples were taken after 2 
hours whereas α-SMA expression was determined after 24 hours. Hence it is possible that 
nuclear translocation of pSmad3 is disrupted over time in TGF-β1 stimulated fibroblasts 
treated with flow.  Secondly, it is possible that other pathways/mediators are involved and 
finally the concurrent translocation of the receptor complex and Smad3 under flow conditions 
may result in a reduced capacity for p-Smad3 binding to promoter regions.  
 
To analyse whether the combined effect of TGF-β1 stimulation and fluid flow internalises the 
TGFβ receptor type II by enhancing endocytosis, fibroblasts were immunolabelled with both 
early endosomal antigen 1A (EEA-1) and TGFβ receptor type II (TGFβRII).  
Immunofluorescence images revealed that TGF-β1 stimulation increases expression of early 
endosomal antigen-1 in dermal fibroblasts under static conditions. When these fibroblasts 
were treated with fluid flow, expression of EEA-1 was not only stimulated but the TGF-β 
receptor type 2 translocated to the nucleus. TGF-β1 stimulation under flow further accelerates 
nuclear localisation of TGF-β receptor type II even within 2h. of flow treatment. This 
indicates that rapid localisation of the TGF-β receptor type II reduces its availability to bind 
to ligands like TGF-β1, TGF-β3 and is unable to form receptor-ligand complex, thus 
negatively regulating the TGF-β signalling mechanism. Therefore, abrogation of α-SMA 
expression in TGF-β1 stimulated fibroblasts under flow may occur due to four possible 
mechanisms: a) TGF-β Receptor type II localizes itself to caveolin-1 and early endosomal 
antigen-1 (EEA-1) double positive vesicles as is shown in previous studies (He et al., 2015) 
196 | P a g e  
 
and is degraded by endocytosis, b) internalization of TGF-β receptor type II into EEA-1 
positive compartments may lead to internalization of  Smad7 containing caveolins resulting 
in nuclear localisation of Smad7 and binding to transcriptional machinery for disruption of 
TGF-β signalling, c) the cumulative effect of other signalling mechanisms, endocytosis of  
TGF-β receptor type II into EEA-1 positive compartment and Smad7 signalling leading to 
disruption of  TGF-β signalling and d) release of endogenous TGF-β1 in fibroblasts during 
TGF-β1 supplemented fluid flow conditions may result in supra physiological levels to 
promote distinct endocytic pathways, accelerated trafficking of the receptor bound ligand, 
and inhibition of the activation response. 
 
Activin A is a member of the TGF-β superfamily and is known to be neutralised by binding 
of two follistatin molecules (Thompson et al., 2005).  Recently, activin A was shown to 
promote profibrotic responses in interstitial fibroblasts during renal fibrosis and 
administration of recombinant follistatin alleviates the profibrotic response (Maeshima et al., 
2014a). Epithelium derived activin A is known to increase tumour promoting properties in 
mammary fibroblasts in a Cox-2 dependent manner by enhancing incorporation of ECM 
components and promoting differentiation of fibroblasts to a cancer associated fibroblast like 
phenotype (Fordyce et al., 2012). Whilst there is a large body of literature demonstrating that 
TGF-β1 induces fibroblast differentiation to a myofibroblast phenotype with increased 
expression of α-SMA rich stress fibres, this study has shown that activin A is a potent 
activator of fibroblasts.  
 
To observe whether fluid flow mediated fibroblast activation is regulated by activin A, gene 
and protein expression of activin A was studied in TGF-β1 stimulated and unstimulated 
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dermal fibroblasts in both static and fluid flow conditions. Results show that gene expression 
of activin A is increased under flow whereas its expression is down regulated in TGF-β1 
stimulated flow conditions. Exogenous activin A is detected in high levels only in 
conditioned medium of fibroblasts subjected to flow treatment whereas endogenous activin A 
is high in TGF-β1 stimulated fibroblasts in both static and flow conditions. This suggests that 
fluid flow regulates release of ectopic activin A and this mechanically induced biological 
release of activin A is negated by TGF-β1 supplementation, possibly because exogenously 
released activin A competitively binds to TGF-β receptor type II and is internalised into the 
nucleus. Our findings correlate with a recent paper which shows that activin A can 
competitively bind to TGF-β receptor type II and BMP receptor type II to antagonise the 
signalling pathway (Aykul and Martinez-Hackert 2016).  
 
Findings from microarray based analysis of global gene expression profile shows that activin 
A is one of the top 20 genes altered under flow. Additionally, protein expression of both cell 
associated and secreted activin A was observed to be increased under flow. To explore 
whether supplementation of recombinant activin A is capable of differentiating normal 
fibroblasts to a myofibroblast like phenotype.  Findings reveal that recombinant activin A can 
activate dermal fibroblasts by increasing α- SMA protein expression, thereby promoting 
differentiation to a myofibroblast like phenotype in static conditions. Follistatin is an 
extracellular regulatory protein of activin A and exerts isoform specific effect on biological 
activity of activin A. Of all the isoforms, follistatin 288 (FS-288) is known to show high cell 
surface binding and ligand binding affinity to activin A (Sidis et al., 2006) and inhibition of 
exogenous and endogenous activin A is regulated differentially by various isoforms. 
Follistatin 288 inhibition in both activin A stimulated dermal fibroblasts and TGF-β1 
stimulated dermal fibroblasts show decreased α- SMA protein expression suggesting that 
198 | P a g e  
 
activin A on its own is capable of differentiating fibroblasts to a pro- myofibroblast like 
phenotype and this biological effect can be negated by recombinant follistatin 288. Our data 
confirms the potent stimulatory effect of TGF-β1 on α-SMA expression and that activin A is 
intimately linked with this pathway by stimulating α-SMA expression. Findings also show 
that both these agonists (TGF-β1 and activin A) are sensitive to inhibition by follistatin. 
Furthermore, TGF-β1 enhances expression of endogenous activin A in dermal fibroblasts. 
 
CD109 is a glycosylphosphatidylinositol- anchored protein and is known to function as a 
TGF-β co receptor and inhibitor of the TGF-β pathway in keratinocytes. Recently it has been 
shown that CD109 can attenuate ECM production in scleroderma skin fibroblasts. CD109  is 
known to enhance binding of TGF-β to its receptors and promote TGF-β bound receptor 
internalization via a caveolin pathway in a ligand dependant manner (Bizet, Liu et al. 2011) 
and attenuate ECM production in skin fibroblasts (Man, Finnson et al. 2012). Our results 
reveal that gene expression of CD109 (TGF-β co-receptor) is increased in TGF-β1 stimulated 
fluid flow conditions in dermal fibroblasts suggesting that supplementation of TGF-β1 in 
dermal fibroblasts followed by fluid flow treatment increases expression of CD109 and 
antagonises the TGF-β pathway. Results on CD109 validate recent studies that show that 
CD109 increases binding of TGF-β1 to its receptor, enhances caveolin mediated endocytosis 
of the TGF-β ligand–receptor complex to negatively regulating the TGF- β pathway (Bizet et 
al., 2011).  
 
Since compelling evidence has shown that cellular activation and senescence are stress 
responses and share common pathways, we decided to explore if fluid flow induces 
senescence in fibroblasts. Our findings show that markers of senescence and growth arrest, 
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p16 INK4a and p21Waf-1 are altered in fibroblasts under flow suggesting that fluid flow 
induced differentiation of fibroblasts is transient and may induce growth arrest that is 
reversible in nature. However, since existing literature on cellular senescence shows that the 
CDK inhibitors p16 INK4a and p21 Waf-1  have overlapping roles in inducing quiescence and 
senescence,  our findings call in to evaluate other markers of senescence and phases of cell 
cycle. Quiescent fibroblasts are known to exhibit high metabolic activity (Lemons et al., 
2010). However, our findings reveal that fluid flow reduces the metabolic activity of 
fibroblasts. Although this observation contradicts existing literature, it is possible that in the 
presence of fluid flow, the cellular machinery focussed its functions on differentiation 
associated processes such as synthesis of fibrous proteins. 
 
In summary, fluid flow acts as a critical regulator in modulating the phenotype of fibroblasts 
from both dermal and oral origin and the combined effect of mechanical signals and pro-
fibrotic signals like TGF- β1 negatively regulates myofibroblast differentiation.  In the 
absence of regulatory signals like TGF- β1, fluid flow promotes fibroblast differentiation into 
a myofibroblast phenotype. This biological effect is a cumulative response of sensor-like 
components such as high levels of ectopic activin A, exogenous and endogenous TGF-β1 and 
low levels of TGF- β antagonists like CD109 that promote the activation response (Figure 
9.1). However in the presence of  pro-fibrotic signals like TGF-β1, fluid flow negatively 
regulates differentiation into a myofibroblast phenotype possibly because ligand bound TGF-
β Receptor type II localizes itself to caveolin-1 and early endosomal antigen-1 (EEA-1) 
double positive vesicles as is shown in previous studies (He et al., 2015) and gets translocated 
to the nucleus for endocytic degradation (Figure 9.2 ).  Although our results prompt thorough 
assessment of endocytic regulation of ligand bound TGFβRII to lipid rafts, our 
200 | P a g e  
 
immunofluorescence results clearly reveal the nuclear localization of TGFβRII in EEA-1 
positive cells in TGF-β1 stimulated fibroblasts subjected to flow. 
 
 
 
 
 
 
 
 
 
 
Figure 9.1: Mechanobiology of fibroblasts subjected to fluid flow. 
 
 
 
 
 
 
 
 
 
Figure 9.2: Mechanobiology of fibroblasts subjected to TGF-β1 supplementation under fluid flow. 
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This study shows that a physiologically relevant fluid flow mediated fibroblast response is 
influenced by the cumulative effect of reduced activin A released into the circulating medium 
and caveolin mediated internalisation of TGF-β1 bound TGFβRII receptor-ligand complex. 
Our findings provide first direct evidence of fluid flow mediated ‘tensional homeostasis’ in 
fibroblasts.   
 
Surprisingly, our findings show that both dermal and oral fibroblasts respond to flow in a 
similar manner by showing increase in gene and protein expression of α- SMA and an 
opposite effect in the presence of TGF-β1. This in particular is an interesting observation 
since most studies to date have shown that fibroblasts from different origin show phenotypic 
differences (Shannon et al., 2006). Our findings suggest that differences in phenotype and 
cellular response of fibroblasts from oral and dermal sources are influenced by other cell 
types and signalling molecules present in the tissue origin. Although this observation 
contradicts our hypothesis that cells from different tissue sources may respond differently, 
results show that factors such as presence of in vivo like fluid movement, cellular 
communication from other cell types and profibrotic molecules contribute to molecular 
pathology of fibrotic responses. Findings in this study also suggest that care should be 
observed in extrapolating results from in-vitro experiments which lack the presence of these 
factors in a physiologically relevant condition.  
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Future work  
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Microarray based global gene expression analysis revealed changes in YAP (Yes associated 
protein) (enrichment score: 1.55), a transcriptional co activator that is sensitive to mechanical 
stress (Szeto et al., 2016) and a regulator of proliferation, differentiation (Piersma et al., 
2015a) and senescence (Xie et al., 2013). Following experimental approaches are planned for 
further studies. 
 
1) Findings have shown that when fluid flow activated fibroblasts are allowed to remain in 
static conditions for 24h., they revert to resting state phenotype with loss of α-SMA protein 
expression. Assessing the effect of both fluid flow and chemical signals such as TGF-β1 in 
inducing changes in expression and localization of YAP1 in fibroblasts will provide a better 
understanding of the nature and magnitude of stress that can invoke a mechanotransduction 
response in fibroblasts. Assessing the effect of different fluid flow rates in inducing nuclear 
translocation and changes in gene expression of YAP1 would further help towards 
establishing minimal shear stress needed to invoke a stress response in fibroblasts. 
 
2) Recent reports have shown that fluid flow induced YAP1 activation promotes cancer cell 
motility (Lee et al., 2017). However, the effect of both fluid flow and chemical signals such 
as TGF-β1 in inducing cellular motility of myofibroblasts remains to be assessed. We aim 
to study this using the Quasi-vivo® bioreactor and by assessing the gene and protein 
expression of YAP1. Cellular motility will assessed by wound scratch assay and migration 
inserts. 
 
3) Experiments stated in points above will be pursued on normal keratinocytes and human 
umbilical vein endothelial cells (HUVECs) to analyse the effect of fluid flow and chemical 
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signals in inducing a stress response in cells of both the epithelial and endothelial 
compartment. The Quasi-vivo® bioreactor provides an advantage wherein multiple cell 
types could be cultured in the chambers and held together in series of inter connected loops, 
thus promoting flow of medium between different cell types.  Previous studies from our 
laboratory have shown that when normal fibroblasts and keratinocytes were grown in 
connected cultures, notable changes in global gene expression were observed in both cell 
types.  
 
4) Interestingly, experiments in the current study on influence of different flow rates on 
fibroblasts and former studies on effect of flow on fibroblast-keratinocyte connected cell 
culture have both shown that the GoTERM enriched gene set are functionally associated 
with processes such as angiogenesis and cell motion.  Future studies aim to explore the 
functional effect of fibroblast conditioned media and fibroblast-keratinocyte conditioned 
media in inducing angiogenic response in endothelial using tubule formations assays. 
 
Studies planned for future will provide deeper insight into cell-cell communication 
mechanisms and novel molecules which can be selectively targeted for anti-fibrotic 
therapeutic purposes. 
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